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ABSTRACT
The purpose  of th is  thes is  was to  investiga te  the value In c l in ica l s i tua t ions  of 
the well known ir. vi tro an t l-ad ren e rg lr  e ffects of magnesium. Research Interest 
In m agnesium  has been grow ing rap id ly  over the last tw en ty  years However, 
m ost c f  th is  in terest has focused on the c l in ica l consequences of magnesium 
d e f ic ie n c y  s ta te s  and l i t t le  a t te n t io n  has been g iven  to  m a gnes ium  as a 
the rapeu t ic  agent. Despite  the w ide use of In fus ions of m agnesium  su lphate  in 
obs te tr ic  prac t ice , there  Is a dearth  of know ledge regard ing  the ac t ions  o* 
m agnesium  on a ca rd iovascu la r system. In labo ra to ry  stud ies, m agnesium  was 
shown to  Inh ib it  the release of ca techo lam ines from  adrenerg ic  nerve term inals, 
an action w h ich  m ight have great c l in ica l Im plica tions.
The effects of Increasing dosages of magnesium  on the ca rd iovascu la r  system 
of the in tac t baboon were investigated. It w%s found that m agnesium  p roduced 
a cons is ten t vasod ila to r  effect w h ich  corre la ted  well w ith  the  serum magnesium 
levels but the  hypo tens ive  effects at serum levels be low  5m m oi/ l were minimal 
due to  a concom itan t Increase card iac  ou tpu t wh ich  was pr im ari ly  mediated 
th ro u g h  an Inc rease  s l r o i . *  vo lu m e  There  was no e v id e n ce  o f nega t ive
I n o t r o p i c  e f f e c t s .  The  a c t io n s  o f  m a g n e s iu m  on a d r e n a l in e - in d u c e d  
ca rd iovascu la r  d is tu rbances  were investigated. Magnesium su lphate  in fus ions 
exerted vasod i la to r  and anti a rrhy thm ic  effects of n m agn itude  l ike ly  to  be of 
c l in ica l  benefit  w ithou t p roduc ing  negative in o trop ic  e ffects. To dem onstra te  
the safety of magnesium Infusions in the presence of alpha and beta b lockade , 
the  In te rac t ions  of magnesium  in the presence of adrena line  w l 'h  phento lom ine  
and p rop rano lo l were investigated. No de le te r ious  In te rac t ions  were noted and 
it appeared that m agnes ium /p roprano lo l com b ina t ions  d id not po ten t ia te  the 
negative  ino trop ic  effects of beia b lockade
In th e  c l i n i c a l  s tu d ie s ,  th e  a b i l i t y  o f  m a g n e s iu m  In fu s io n s  to  in h ib i t  
ca techo lam ine  release in response to the stress of endotrachea l In tuba t ion  was 
d e m o n s t ra te d .  C o n d i t io n s  In w h ic h  c a te c h o la m in e  e xce s s  c o n s is te n t ly  
p roduces  m ajor d i f f icu l t ie s  include te tanus and phaeoch rom ocy tom a. These 
tw o cond it ion s  are re la t ive ly  uncom m on and th is  fact p rec luded  con tro l led  
tr ia ls. Nevertheless, when suitable patien ts  presented s tud ies  on the use of 
m a g n e s iu m  In these  c o n d i t io n s  w ere  c o n d u c te d .  In te ta n u s  m agnes ium  
In fu s io n s  Im p ro v e d  c a rd io v a s c u la r  c o n t r o l  and  re d u c e d  c p te c h o la m ln e  
p io d u c t lo n .  In phaeo ch rom ocy tom as  m agnes ium  enhanced In tra -opera t ive  
c o n t ro l  of c a rd io v a s c u la r  d is tu rb a n ce s  and apa rt  from  p e r io d s  of tu m o u r  
hand ling  reduced ca techo lam ine  p roduc t ion . It Is conc luded  that magnesium 
Infus ions may be a va luable ad junct to  the anaesthe t ic  m anagem ent of patients  
w ith  high ca techo lam ine  ou tpu t states.
Ill
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ass is tance  acknow ledged  In the preface. !t Is being subm itted  fo r  the degree 
of D oc to r o f Ph i losophy  In Medic ine, Johannesburg. It has not been subm itted  
before fo r  any degree or exam ination In any  other Ur.iversity.
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3rd August, i9 8 8
To my fam ily  fo r  all the ir  support over the years.
Table of Contents
P r e f a c e ....................................................................................................................................
1. In troduction ...........................................................................................................................1
1.1 The M etabo lic  S ign if icance  of M agnes ium ....................................................2
1.2 Assessment of Magnesium S ta tus ...................................................................3
1.3 In te rac t ions  w ith Calc ium  and Potass ium .................................................. 5
1.4 Magnesium in the Cantral Nervous System ................................................6
1.5 Magnesium and the Peripheral Nervous System .....................................8
1.6 Magnesium and the C ard iovascu la r S ys tem .............................................9
1.7 Magnesium and the Resp ira tory  System ...............................................  13
1 8  Magnesium in P regnancy ............................................................................  14
1.9 Magnesium and O ther Organ Sys tem s....................................................... 15
2. C lin ical Consequences of H y p e rm a g n e s a e m la ................................................ 18
2.1 Central Nervous System .................................................................................19
2.2 Peripheral Nervous System ........................................................................... 20
2.3 C ard iovascu la r S ys tem ................................................................................... '-2
2.4 G en itou r ina ry  S ys tem ....................................................................................... 28
2.5 Endocr ine  System s........................................................................................... 30
2.6 C oagu la t ion  of B lo o d .........................................................................................31
V)
3. T h e ra p e u t ic  Use o f  M a g n e s iu m ...............................................................................34
3.1 H is to ry  of Magnesium Therapy .................................................................... 35
3.2 P re-ec lam psia  and E c lam ps ia ......................................................................37
3.3 M agnesium  and A rrhy thm ias ........................................................................ 39
3.4 Mag les ium  and Ischaem ia .. ........................................................................... 41
4. A im s  and  Scope  o f  th is  T h e s is ..................................................................................46
4.1 Animal S tud ies ....................................................................................................47
4.2 C lin ica l Studies. ...............................   47
5. C a rd io v a s c u la r  E f fe c ts  o f M a g n e s iu m ................................................................... 49
5.1 M e thods ..................................................................................................................50
5.2 Resu lts .....................................................................................................................53
5.3 D iscuss ion ..............................................................................................................65
6. In te ra c t io n s  W ith  A d re n a l in e  And Its  A n ta g o n is ts .......................................... 73
6.1 M e thods ..................................................................................................................74
6.2 R esu lts .....................................................................................................................76
6.3 D iscuss ion ............................................................................................................ 85
6.4 In te ra c t io n s  w ith  A lp h a  a d re n e rg ic  B lo c k in g  D ru g s .......................89
6.5 M ethods ..................................................................................................................90
6.6 R esu lts .................................................................................................................... 91
6.7 D iscuss ion ..............................................................................................................98
6.8 In te ra c t io n s  w i 'h  B e ta -a d re n e rg ic  B lo c k in g  D ru g s ....................... 100
6.9 M e thods .................................................................................................................101
6.10 Results ..............................................................................................................102
6.11 D iscuss ion ........................................................................................................ 106
6.12 C o n c lu s io n s ...................................   1 ° 7
dl
7. C a techo lam ine  Release at Endotracheal In tu ba tion   .......................... 109
7 2 M e th o d s .................................................................................................................1" 1
7.3 R esu lts .................................................................................................................
7.4 D iscuss ion ........................................................................................................... 117
8. M agnesium  And The M anagem ent 0  . >  cr« Tetan us ..................................122
8.1 M e th o d s ............................................................................................................... 124
8.2 R esu lts ..................................................................................................................127
8.3 D iscuss ion ........................................................................................................... 135
8.4  Magnesium And Catecholam ine Release In T e tan u s ......................141
8.5 Case R eport .......................................................................................................141
8.6 D iscuss ion ........................................................................................................... * 47
9 . M agnesium  And Anaesthesia For Phaeochrom ocytom a............................ 150
9.1 Patients And M e th o d s ..........................................  151
9.2 R esu lts ..................................................................................................................157
9.3 D iscuss ion ........................................................................................................... 169
10. C on c lu s io n s ..................................................................... ...................................... .......175
10.1 C ard iovascu la r E ffec ts ................................................................................. 173
10.2 An tl-ad rene rg lc  E ffec ts ................................................................................176
10.3 C lin ica l S tud ies ...............................................................................................177
10.4 Unanswered Q ues t ions ................................................................................177
10.5 Further s tud ies ................................................................................................180
R eferen ces ............................................................................................................................183
A p p e n d ic e s .........................................................................................................................234
#List of Illustrations
F igure 5.1 Scattergram  of changes In sys to l ic  b lood  pressure against
serum magne&ium leve ls ................................................................................... 55
F igure 5.2 S ca tte ig ram  of changes In d ias to l ic  b lood  pressure against
serum magnesium le v e ls .....................................................................................  57
F igure  5.3 Systo lic  and D iasto lic  Blood Pressure and Heart Rate v.
Serum Magnesium for grouped data ..................................    57
F igure 5.4 Scattergram  of change** In heart rate aga ins t serum
m agnesium  levels. .................................................................................................. 58
F igure  5.5 Scatte rg ram  of system ic vascu lar res is tance against serum
magnesium leve ls ...................................................................................................  59
F igure 5.6 Scatte rg ram  of changes In card iac  ou tpu t against serum
magnesium leve ls .................................................................................................. 60
F igure 5 7 Card iac Output v. Serum Magnesium for g rouped d a ta .................... 61
F igure 5.8 Scatte rg ram  of changes In s troke volume against serum
magnesium  leve ls .. ................................................................................................  62
F igure 5 9 S troke Volume v. Serum Magnesium for g rouped  d a ta ...................  62
F igure 5.10 Scattergram  of changes in s troke work aga inst serum
m agnesium  leve ls ...................................................................................................  63
F igure 5.11 Stroke Work v Serum Magnesium for g rouped  d a ta .....................  63
kF igure  5.12 Sca tte rg ram  of changes In centra l venous pressure aga inst
serum magnesium  leve ls .......................................................................................  65
F igure  6.1. Changes in sys to l ic  arter ia l p ressure with changes In serum
m a g n e s iu m ................................................................................................................ 78
F igure  6.2. Changes In Heart Rate w ith  changes in serum
m agnes ium ................................................................................................................. 79
F igure  6.3. Changes In Card iac O utput w ith  changes in serum
magnesium  .................................................................................................................  8°
F igure  6.4. Changes In S troke Volume w ith  changes In serum
m a g n e s iu m   .....................................................................................................  81
F igure 6.5. Changes In system ic vascu la r res is tance w ith  changes
In serum m agnes ium     82
F igure  6.6. Changes Ir. centra l venous pressure with changes In serum
m a g n e s iu m ...............................................................................................................  83
F igure 6.7. Changes Ir. sys to l ic  arter ia l pressure  dur ing  adrena line
Infusion w ith  phento lam ine-m agnes ium  or m agnes ium ............................ 92
F igure 6.8. Changes In heart rate du r ing  adrena line  In fus ion with
phento lam ine-m agnes ium  or m agnes ium ......................................................  93
F igure 6.9. Changes In card iac ou tpu t du r ing  adrena line  Infusion w ith
phento la  m ine-magnesium or m agnes ium ...................................................... 94
F igure  6.10. Changes in stroke vo lume dur ing  adrena line  Infusion
with p h e n to lan .m em agnes ium  or magnesium a lo n e ................................ 95
F igure  6.11. Changes In system ic vascu la r res is tance du r ing  a d re n i l ln e
Infusion with phento lam lne magnesium  or m agnes ium ............................ 96
F igure  6.12 Changes In stroke vo lume dur ing  adrena line  Infusion w ith
phen to lam lne-p roprano lo l-m agnes ium  s e q u e n c e .......................................103
F i ' j j r t  7.1 The effect of e ither MgSCU or selme on heart rate
at the t im e of endotrachea l Intubz ir n ..........................................................  113
Figure 7.2 The effect of elthe, MgS04 or saline on sys to l ic  b lood
pressure at the time of endotrachea l in tu b a t io n ..........................................114
Figure 7.3 The e ffect of Ither MgSCU or saline on adrena line  levels at
the  time of endotrachea l In tuba t io n ..................................................................116
Figure 7.4 Tha effect of e ither MgSO« or saline on noradrena line  levels
at the t ime of endotrachea l In tuba t io n .............................................................116
Figure 8.1 Severe ca rd iovascu la r d is tu rbances in a patient w ith  te tanus
at Day 7 p r io r  to adm iss ion to  the t r ia l ........................................................  130
Figure 8 2 The same patient as in f igure  8.1 at Day 9, two days after the
com m encem ent of magnesium th e ra p y ........................................................... 129
Figure 8.3 Card iovascu la r d is tu rbances  on Day 12. the day of
com m encem ent of magnesium th e ra p y ........................................................... 130
Figure 8.4 The same patient as In f igu re  8.3 at Day 13......................................... 130
Figure 8.5 Hourly  heart rate and b lood pressure chart on uay 18...................  i43
Figure 8.6 H ourly  heart rate and b lood pressure changes on day 19
dur ing  the In troduc t ion  of m agnes ium .............................................................145
Figure 8.7 Hourly  heart rate and b 'ood  pressure changes on day 20 ..........  145
Figure 8.8 Hourly  heart rate and b lood pressure changes on day 21...........  146
Figure 8 9 Hourly  heart rate and b lood pressure changes fo l low ing
the w ithdrawal of all sedation  on day 22 ........................................................ 146
Figure 9.1 In it ia l ca rd iovascu la r changes In response to  Infusion
of MgSO* In phaeochrum oc. toma case 1...................................................... 157
Figure 9.2 Filood pressure response to insert ion  of a CVP line,
and Its con tro l by MgSOs....................................................................................  '5 8
F igure 9.3 C a /d lovascu la r  responses and MgSO* adm in is tra t ion  dur ing
tum ou r  h a n d l in g ...................................................................................................... 158
Figure 9.4 .ys to l lc  b 'ood  pressure In case 8 In whom con tro l was
des igna ted  as g o o d ............................................................................................... 159
Figure 9.5 Systo lic  b lood  pressure In case 12 In whom con tro l was
des igna ted  as fa ir .....................................................................................................16°
Figure 9.6 SBP changes dur ing  caesarean section  In case 4 ............................. 161
Figure 9.7 C3P changes In case 4 dur ing  tum our rem ova l.................................. 162
Figure 9.8 SBP changes dur ing  anaesthesia and surgery  in case 16............... 163
Figure 9.9 SBP changes In case 15 where the d iagnos is  was made
In traope ra t lve ly .......................................................................................................  164
Figure 9.10 Changes In adrena line  concen tra t ions  In 5 pa t ien ts ........................ 167
Figure 9.11 Changes In noradrena line  concen tra t io ns  In 5 pa t ie n ts ................. 168
List of Tables
Table 1.1 M an ifes ta tions  of magnesium d e f ic ie n c y .................................................... 17
Table 2.1 Effects of Hyperm agnesaem la .........................................................................33
Table 5.1. Date g roups de term ined by serum magnesium leve ls ........................ 54
Table 6.1. S ign if ican t ca rd iovascu la r changes fo l low ing  magnesium
In jec t ion  In adrena line-treated baboe ns ............................................................84
Table 6.2. P rinc ipa l card iovascu la r changes fo l low ing  magnesium
In jec t ion  In adrenaline treated a- and p-b locked  baboons. ................... 105
Table 8.1 Sequence and dosage in wh ich sedative d rugs were
adm in is te red  to adu lt patients w ith severe te ta n u s .................................... 124
Table 8 2 Pulse rates and blood pressures In te tanus pa t ien ts  before
and a f t i r  m agnesium th e ra p y .............................................................................132
Table 8.3 C ard iovascu la r Indices In six te tanus patients be fore  and after
magnesium  therapy had been Ins t i tu ted ......................................................... 133
Table 8.4 Catecho lam ine  levels In te tanus during  the In it ia t ion  of
m agnesium  th e ra p y ................................................................................................. 147
Table 9.1 Summary of phaeochrom ocy tom a patient d e ta i ls ................................. 154
Table 9.2. Intra opera tive  con tro l of ca rd iovascu la r events 165
Preface xlii
PREFACE
My In te re s t  In m a g n e s iu m  as a t h e r a p e u t i c  a g e n t  In th e  p r e s e n c e  of 
c a te c h o la m in e  excess  was o r ig in a l ly  a roused  oy the  p ro b le m s  posed by 
pa t ien ts  su ffe r ing from  te tanus In Z imbabwe. The neurom uscu la r e ffects of 
magnesium  and the ir  po ten t ia l benefit In reduc ing  the muscle spasms of te tanus 
was o r ig ina l ly  suggested to  me as a poss ib le  therapeu tic  m oda li ty  by Dr. E.D.M. 
M anson whose key role In a rous ing my Interest In th is substance  I g ra te fu lly  
acknow ledge. It was o r ig ina l ly  hoped that magnesium m ight p rov ide  a cheap 
and simple m ethod of m anagem ent of te tanus on a conserva t ive  base w h ich  
w ou ld  enable the trea tm ent of th is  l l te - th rea ten lng  cond it ion  to  be c o n d u c e d  
In areas where Intensive care the rapy  was Im pract icab le . However, It rap id ly  
b e c a m e  a p p a re n t  th a t  In th is  c o n d i t io n  m a g n e s iu m  p ro d u c e d  p ro fo u n d  
neurom uscu la r b lockade w hich requ ired the use of pos it ive  pressure ven t i la t ion  
and th is  l ine of research was abandoned. However, It was no ticed  in passing 
tha t patients g iv e r  magnesium appeared more ca rd iovascu la r ly  s table than 
those  treated conven tiona l ly .  This raised the poss ib i l i ty  that magnesium  m ight 
be exert ing  anti adrenerg ic  e ffects and a l i te ra tu re  search revealed that such 
e ffec ts  had been well estab lished In labo ra to ry  cond it ion s  but had never been 
put to  any c l in ica l use C onsequently  the animal work deta iled  In th is thesis
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was undertaken to  Investigate th is  poss ib i l i ty  and the resu lts  of using the agent 
In the m anagem ent of te tanus were encourag ing . The Invest iga t ions  cu lm ina ted  
In the f irs t use of th is  agent In a patient severely ca rd lovascu la r ly  unstab le  due 
to  a p h a e o c h ro m o c y to m a .  The re m a rka b le  resu lts  a ch ieved  in th is  case 
con f irm ed  the theore t ica l concep t that th is  drug ought to  have a va luab le  place 
In a n a e s th e t ic  m a n a g e m e n t .  The s tu d ie s  r e p o r te d  In th is  th e s is  w e re  
undertaken w ith  the approva l of the animal anu human e th ics com m ittees  of the 
Unive s ity  of Rhodesia (la ter Z im babwe), w ith  the excep tion  of the s tudy on 
endotrachea l in tuba t ion  which was approved by the human e th ics com m lt t tee  
of the U n ivers ity  of the W ltwatersrand (c learance ce r t i f ica te  No. 18/2/88).
As both te tanus and phaeochrom ocy tom as are re la t ive ly  uncom m on cond it ion s  
It has taken several years to  com pile  the  c l in ica l materia l necessary fo r  this 
thesis. It has also Involved the co -opera t ion  of a number of my co l leagues to 
whom I w ish to  express my thanks. F irs tly , I wou ld  like to  thank Dr. Randall C. 
' ;o rk  of Tucson, Arizona, whose s ta t is t ica l advice on the an mal s tud ies section 
of the  th e s is  was Inva luab le  S econd ly ,  I w ou ld  l ike  to  thank  my c l in ica l  
co l le a g u e s  w hose c o -o p e ra t io n  enab led me to  co l le c t  the  c l in ic a l m ateria l 
reported. In pa rt icu la r I wou ld  like to  thank Mr. R. Dent, Dr. K.R.L. Hudd Dr. 
A. Manell and Dr. M. Plant, whose Interest and enthusiasm helped me tc  gather 
la rge  se r ies  of pa t ien ts  w ith  p h a e o c h ro m o c y to m a s .  Mr. J.F. W hite , Sr. J. 
Dennett, and Sr. G M. Harlen of the Departm ent of Anaesthesia, Un ive rs ity  of 
Z imbabwe, assisted w ith  all of the animal studies, and much of the c l in ica l work
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and the ir  he lp  Is g ra te fu l ly  acknow ledged. I am also g ra te fu l to  P ro fessor G. 
Harr ison and Professor C. Rosendorf for the ir  advlcr, and suggest ions . F ina lly  
I wou ld  l ike  to  thank a number of people whose en thus ias t ic  ass is tance  enabled 
me to p roduce  th is  docum ent. In part icu la r I w ou ld  l ike to  thank  Mrs. Rita 
Mendelson who helped with much of the transc r ib ing  of o r ig ina l pub lica t ions  
Into the thes is . In add it ion  I w ish to record my g ra t i tude  to  Mrs. S. King who 
assisted w ith  the p roduc t ion  of several of the  com pu te r  genera ted I l lus tra t ions  
and Mrs. S. Green whose secretar ia l assistance has proved Invaluab le. As a 
co nc lud in g  note I wou ld  l ike to  comment that this thes is  has been p roduced 
using a desk top pub lish ing  package and I would l ike to  thank Mr N. Dennett 
o l  the Departm ent of Anaesthe tics  of the Un ivers ity  of the  W ltwatersrand fo r  his 
ass is tance In running the program m e. The entire p rocess ing  of th is  docum ent 
was my own work.
Several publlened art ic les  have arisen from  th is  thesis. They are as fo l lows:
1.James, MFM; Cork, AC; Dennett JE. Card iovascu la r e ffects  of magnesium 
sulphate In the baboon; Magnesium 1987 6: 314-324
2. James, MFM; Cork, AC; Harlen, GM; W hite JF. In te rac t ions  of adrena lin  and 
magnesium  on the ca rd iovascu la r  system of the baboon. Magnesium  1988 7: 
37-43
3. James, MFM; Manson EDM. The use of magnesium  su lphate  In fus ion In the 
managem ent of very  severe tetanus. In tensive Care M edic ine 1985 11: 5-12
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4 .James, MFM. Magnesium sulphate In phaeoch rcm ocy tom a . Anesthes io logy 
1985 '32: 188-189
5. James MFM, Huddle KRL, Owen AD, van der Veen BW. Use of magnesium 
su lphate  In the anaesthetic  management of phaeoch rom ocy tom a In pregnancy. 
Canadian Journa l of Anaesth sla 1988 35: 178-182.
6. Jam es, MFM. M agnes ium  su lp h a te  In the a n a e s th e t ic  m anagem e n t of 
p h a e o c h r o m o c y to m a  - a re p o r t  of 17 a n a e s th e t ic s .  B r i t is h  J o u rn a l  of 
Anaesthesia 1989 62: 616 623.
7. James, MFM, Beer, RE. Inh ib it ion  of ca techo lam ine  release at In tubation 
using magnesium sulphate. Anesthesia and Analgesia 1989 68. 772-776
8. James, MFM. Magnesium In anaesthesia. In: Zorab JSM (Ed) Lectures In 
Anaesthes io logy  1988/1, B lackwell Sc ien tif ic  Pub lica tions, London pp 63-78.
9. L lpm an, J; James, MFM; Ersk lne, J; P l l t t ,  ML: E ide lm an , J; Esser, JD 
Autonom ic  dys func t ion  In severe te tanus : magnesium su lphate  as an ad junct 
In deep sedation . Crit ica l Care M edic ine 1987 15: 987-988.
Introduction 1
1. Introduction
M agnesium  has been an im portan t substance In b io log ic  evo lu t ion  s ince the 
process f irs t  began. Present In large quantit ies  In the p r im ord ia l seas, the ion 
appears to  have acqu ired  a centra l ro le early In the evo lu t iona ry  process since 
a lmost all reactions Involved in fundam enta l cell p rocesses such as pro te in  
b io s y n th e s is  and anae rob  e ene rgy  p ro d u c t io n  a re  m agnes ium  dependen t 
(A lkawa, 1981). The Ion Is a lso  know n to  ca ta lyze  many c ru c ia l  p re b io t lc  
condensa tion  reactions. Despite the centra l Im portance  of these processes, 
magnesium  has an even more fundam enta l role than  th is  In the genesis of life 
on th is  p lanet. Central to  all form s of life Is the m echan ism  w hereby the energy 
of the sun Is captured and converted Into chem ica l energy In the p rocess of 
pho tosyn thes is . Some three b i l l ion  years ago, the  po rphy r in  ring, the basic 
s truc tu re  of such vital substances such as haem f'n lob in  and the cy tochrom es, 
had been synthesized. The Incorporation lum In the  centre of th is
m olecule, resu lted In the g .oen p lgm er :yll. This s truc tu re , which
produces  ca rbohyd ra te  by the reduc t ion  of ca rbc i.  d iox ide  w ith  the l ibe ra t ion  
of oxygen using so lar energy, Is respons ib le  for the la rge quan tit ies  of oxygen 
that has made life In Its present fo rm  poss ib le  on th is  p lanet. Whilst o ther 
metals can be Incorpora ted  Into the po rphyr in  r ing, m agnesium  appears to  offer
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the best com b ina t ion  of pho tochem ica l a c t iv i ty  and m o lecu la r s tab il i ty . In a 
study o f tha reasons why various metals p lay the ir  h igh ly  se lec tive  ro les In 
b iochem ica l processes. Fuhrhop and Mauzerall (1969) conc luded  "If the aim of 
the b io lo g ic a l  sys tem  is m in im um  redox p o ten t ia l  com b ined  w ith  m axim al 
s tab i l i ty  In a p ro ton ic  solvent, then magnesium is a good m ln l-m ax so lu t ion  to 
these requirem ents".
I . 1 The M etabolic  S ignificance of Magnesium
The emergence of com pounds  w ith  high energy bonds from  which energy cou ld  
be read ily  released such as adenosine r lphospha te  com ple ted  the chain  of 
energy u t i l iza t ion  from  the sun to  the In trace llu la r spaces of cells. The process 
of ox ida t ive  phosphory la t ion  In which energy stored In carbon com pounds  Is 
released and bound to  ATP Is the essentia l step which enables the aerob ic  cell 
to  harness the energy of ox ida t ion . Magnesium is the main ca ta iys t invo lved In 
ox ida t ive  phosphory la t ion  and Is the essentia l co fa c to r  w ithou t w h ich  ATP 
ca n n o t  fu n c t io n .  W h e re v e r  ATP ex is ts ,  t h e re  is  an o b l i g a t o r y  n e e d  f o r  
magnes ium  (Aikawa.1981). In fact, v ir tua l ly  all enzym atic  react ions  In which 
p h o s p h a te - c o n ta in in g  c o m p o u n d s  p la y  a ro le ,  and  th u s  a l l  b io lo g ic a l  
energy-prc  ' r in g  processes, are dependent on magnesium  for ac t iva t ion  (Ebel 
4  G u n th e r .  1980). O ve r  300 o th e r  e n z y m e  s y s te m s  are d e p e n d e n t  on 
m a g n e s iu m  fo r  a c t iv a t io n  In c lu d in g  th o se  Invo lved  In p ro te in  s y n th e s is ,
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c a rb o h y d r a te  m e ta b o l is m ,  DNA and RNA m e ta b o l is m  and  re g u la t io n  of 
In trace llu la r  e lec tro ly te  con ten t (Wacker & Rarisi, 1968; Ebel & Gunther, 1980; 
O lhaberry  et al, 1983 a & b). So extensive Is the Involvement of magnesium In 
ce llu la r  phys io logy  that It has been suggested that the Ion be given serious 
cons ide ra t ion  as a pervasive regu la to r of In trace llu la r responses (V idalr & 
Rubin, 1981). In his extensive review of the b iochem ica l role of magnesium 
W acker (1980) conc luded that "all ce lls  require  It fo r the com p le t ion  of major 
m e ta b o l ic  fu n c t io n s ,  In c lu d in g ,  f o r  e x a m p le ,  p h o to s y n th e s is ,  o x id a t iv e  
phosphory la t ion , nerve conduc t ion , muscle con trac t ion , m em brane transport, 
and nuc le ic  acid and pro te in  synthesis".
1.2 Assessment of k.agneslum Status
Despite th is  vital role In b iochem ica l processes, magnesium has received scant 
a tten tion , and It Is on ly re la t ive ly  recen tly  that Its im portance  In human b io logy 
has becom e apparent. Part of the exp lana t ion  for th is Is that m agnesium  is 
d if f icu lt  to  measure accurate ly , and It Is on ly since the deve lopm ent of a tom ic 
abso rp t ion  spec tropho tom etry  (Walsn, 1955; Wacker and Vallee 1964, Wacker, 
1980) that s imple and accura te  m ethods of measurement of the Ion have been 
availab le  Durlach has recently  reviewed the app lica t ion  of th is techn ique  to 
the m easurem ent of magnesium levels In various t issues (Durlach, 1988). There 
Is cons ide rab le  con trove rsy  as to  the lower level at which hypom agnesaem la
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can be said to  exist, w ith  quoted labo ra to ry  lower l im its  rang ing  from 0.65 to 
0.9 m m oi/ l.  The general co..census appears to  centre  around a value of 0.75 
m mol/l, w ith  an upper l im it of 1.1 - 1.3 mmol/ i.  and a mean of 0.88 m m ol/ l 
a lthough there  Is much debate as to  whether serum levels are of any value In 
p red ic t ing  to ta l body magnesium states (See Durlach, 1988 for a review). It Is 
genera lly  fe lt  that serum magnesium values are a re la t ive ly  poor gu ide to  the 
overall magnesium  status In the body and that s ign if ican t d e f ic i ts  can exist in 
com pany w ith  a re la t ive ly  normal serum value. However, there  is no c lea r cut 
agreement as to  w h ich  measurement can be said to  be superio r, w ith  var ious 
c la ims be ing made fo r red cell magnesium, leukocyte  m agnesium  anu mu'-cle 
b iopsy as the best gu ides (Llm et al, 1969), w ith magnesium load test! ig being 
regarded as the on ly  abso lu te  method of de tec t ing  whole  body m r.qnesiiim  
de f ic its  (Seelig, 1980). However, as magnesium penetra tes ce lls  w l i  . c Iff!', -'fy. 
It Is genera l ly  accepted  that serum magnesium levels ar i i  a tM a c  ory  Index 
of the the rapeu t ic  level, and thus these levels will be used :h rou . jhou t th is  study.
The hom eosta t ic  mechanisms which con tro l to ta l body m agnesium  are boyond 
the scope of th is  review, but the Interested reader Is re ferred to  W acker (1969), 
Soelig (1980), Ebel & Gunther (1980), Durlach & Durlach (1984) and Durlach 
(1988). It is, however, w orth  no ting  that a number of fac to rs  of re levance to 
anaesthetis ts  may dep le te  body stores of magnesium. These Inc lude surgery  
(Heaton, 1964; Sawyer et al, 1970; Henzel et al. 1967), poss ib ly  on the basis of 
a ldos te rone  release (Horton & Big lierl, 1962) ca techo lam ine  excess (Whyte et 
al, 1967; Job u rn  et al, 1985; R ayss iguer. 1977), d iu re t ic s  (v ide  In fra) and
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emo'Jonal s tress (Henrotte, 1986). Anaesthe tis ts  ought, there fore , to  be aware 
of th is  p rob lem , and the hazards w h ich  It may provoke (see W hang. 1984; 
A ldrete, 1987; Gambling et al, 1988; James, 1988 for reviews).
1.3 In teractions with Calcium and Potassium
Calc ium  exerts  a nearly universal ro le  in s tim ulus response coup l ing  (Gevers. 
1981; Rasmussen, 1986 a & b), and pa r t icu la r ly  In the com m un ica t ion  between 
exc itab le  ce l ls  th rough the release of neuro transm itte r  substances (Cara fo ll & 
Pennlston, 1985). It has been known since the beg inn ing  of th is  cen tu ry  that 
magnesium  can antagon ize  many of the ac t ions  of ca lc ium  (M e ltzer & Auer, 
1908) and It does so by com peting  w ith  ca lc ium  at va r ious  sites. Magnesium 
Inh ib its  the release of ca lc ium  from  endop lasm ic  re t icu la r s torage sites, no tab ly  
the sa rcop lasm ic  re t icu lum  In ske leta l and card iac  m uscle  (Dunnett & Naylor, 
1978; V ie r l lng  et al, 1978; Meissner & Henderson, 1987). The Ion a lso  regulates 
cy to so l ic  ca lc ium  levels by enhanc ing  ca lc ium  uptake by the sarcop lasm ic  
re t icu lum  (S tephenson & Podo lsky, 1977) and ac t iva t ing  ATPase dependent 
p um ps  w h ic h  e x tru d e  ca lc iu m  f ro m  the In t ra c e l lu la r  space. In a d d i t io n ,  
m a g n e s iu m  c o m p e te s  w ith  c a lc iu m  fo r  b in d in g  s i te s  on t r o p o n in  C and 
c a lm o d u l i n  ( P o d o ls k y  & C o n s t a r t i n ,  1 96 4 ;  P o t t e r  e t a l, 197 6 ,  1981 ).  
Furtherm ore , and perhaps most Im portan t ly  from the anaesthe t ic  v iewpoin t, 
m agnesium  com petes w ith  ca lc ium  for membrane channe ls  (Jenklnson.1957)
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and consequen t ly  can regulate the ease of Ingress of ca lc ium  to  the In trace llu la r 
space. As a result of th is m u lt ip l ic i ty  of ac t ions, m agnesium  has been described 
as the phys io log ica l ca lc ium  an tagon is t (Iserl & French, 198 ; Levine & Coburn, 
1984) w h ich  can, and does, modify  many ca lc ium -m ed ia ted  responses. This 
a b i l i ty  of magnesium  to  regulate ca lc ium  dependent processes has Im portant 
phys io log ica l and pharm aco log ica l consequences.
Magnesium Is a v ita l regu la to r of In trace llu la r potass ium  stores, Inh ib it ing  efflux 
and s t im u la t ing  active t ransport of po tass ium  Into the cell (Bara & Guiet Bara,
1984). Depletion of In trace llu la r magnesium decreases the a c t iv i ty  of Na > /K + - 
ATPase and Increases potassium  efflux from the In trace llu la r  space (Shine & 
Douglas, 1974; D o rd e rk k  et al, 1976; Shine, 1979; Whang & Welt, 1963). Low 
se rum  po ta ss iu m  leve ls  acco m p a n ie d  by m apnes ium  d e f ic i ts  can o n ly  be 
co rrec ted  with p r io r  rep lacem ent of m agnesium  (Dyckner & Wester, 1984) and 
skeleta l po tass ium  Is s im ila r ly  magnesium dependen t (D yckner & Wester, 1978; 
W hang & W elt, 1963). M usc le  p o tass ium  c o n te n t  c o r re la te s  d i re c t ly  w ith 
muscle magnesium levels and In trace llu la r m agnes ium /po tass ium  de f ic iency  
results  In dow n-regu la t ion  of the sod lum -potass lum  pum ps (Dorup et al, 1988).
1.4 Magnesium  In the Central Nervous System
In the centra l nervous system (CNS), the m agnesium  level of the cerebrosp ina l 
f lu id  (CSF) Is t ig h t ly  con tro l led  by an active t ranspo rt  m echan ism  w hich not only
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m ainta ins the  CSF above normal plasma levels, but a lso  appears to  prevent 
s ign if ican t r ises In CSF magnesium In the face of hyperm agnesaem la  (Pritchard, 
1955; Chutkow , 1981). Whilst the exact role» of ca lc ium  and magnesium  In the 
exocy tos ls  of potentia l CNS neuro transm itte r  substances have not been well 
w orked out. there Is some data to Ind icate that c o m p e t i t io n  between ca lc ium  
and magnesium  regulates the release of certa in  puta tive  neu ro transm it te r  j  such 
as ace ty lcho line , g lu tam ate, asparta te  and gamma am lnobu ty ra te  (Bl och  et al, 
1968; Chutkow, 1981). Clark and Roman (1980) showed that m agnesium can 
inh ib it  the sodium mediated release of ca lc ium  from  bra in  m itochondr ia , and 
th is  may prov ide  a mechanism whereby magnesium  may con tr ibu te  to  the 
con tro l of neuronal func t ion . A centra l ro le for m agnesium  In the regu la t ion  of 
a d e n o s in e  recep t rs has a lso  been sug g e s te d  (C o o p e r  et al, 1984), and 
m agnesium  may a f lcc t  central op ia te  recep to r b ind ing  (Sadee et al, 1982). In 
the face of susta ined hypom agnesaem la the active t ranspo r t  m echanism s for 
magnesium fail, and a fall In CSF magnesium results. M agnesium  de f ic iency  is 
a s s o c ia te d  w i th  a v a r ie ty  of CNS d is o rd e rs  in c lu d in g  a p a th y ,  a n o re x ia ,  
nystagm us, vert igo  and psych ia tr 'c  abnorm alit ies  (V r l lee  et al, 196C; Fishman 
1965; Hanna 1961; Hanna et al, 1960), and u lt im ate ly  com a and convu ls ions 
(P a u n ie r  et al, 1968; B e rk e lh a m m e r & Bear, 1985; M a tthey  et a l, 1986; 
Ravindran & Corre ll l,  1987). A lcoho l dep le tes the body  of magnesium  and 
hypom agnesaem la has been suggested as a fac to r w h ich  may c on tr ibu te  lo  the 
ae t io logy  of de lir ium  tremens (M ilner & Johnson. 1965).
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1.5 M agnesium  and the Peripheral Nervous System
Periphera lly , the role of magnesium In nervous system func t ion  Is more c learly  
estab lished. Magnesium Is necessary for axona l s tab i l i ty ,  and can subst itu te  
for ca lc ium  In th is  role (Frankenhause & Meves, 1958). H ypom agnesaem ia is 
assoc ia ted w ith  te tany even In the face of normal ca lc ium  levels and normal 
ac id-base states (Wacker et al, 1962; W ilk inson et al, 1986; James & Wright. 
1 9 8 6 ) .  W h i ls t  m a g n e s iu m  can  p r o d u c e  d i r e c t  s u p p r e s s io n  o f  axon».i 
t ransm iss ion , the levels of magnesium requ ired to  do th is  are so great as to 
have no c l in ica l s ign if icance  (Mordes & Wacker. 1978), and th is ac t ion  will not 
be fu r the r  cons idered  It has been known s ince the end of the last cen tu ry  that 
ca lc ium  w a- essentia l for the con trac t ion  of skeletal muscle  In response to 
afferent nerve s t im u la tion  and la ter Investiga to rs  have shown that the role of 
ca lc ium  was to  tr igge r the release of ace ty lcho l ine  In response to  p re -synap tlc  
denerva t ion  (Lllnas, 1982; Rubin, 1970; Landau, 1969; Boullln , 1967). The 
release of ace ty lcho line  at the m oto r end-p la te  Is not on ly  ca lc ium  dependent 
but can be a n tago n ized  by m agnesium , and the re  is a d ire c t  c o m p e t i t io n  
between ex trace l lu la r  ca lc ium  and m agnesium for the fac i l i ta t ion  or Inhlbi o n  
of ace ty lcho l in e  release at both the m otor end plate and In au tonom ic  ganglia 
(Wacker, 1980; Del C asti l lo  & Engbaek, 1954; Del C asti l lo  & Katz, 1954; Mutter 
& Kostia l, 1954; Hubbard et al, 1968; L iv ingston & Wacker, 1971 & 1976; Mordes 
& Wacker, ,978). In trace l lu la r magnesium does not appear to  exort th is effect, 
p resum ab ly  because the com pe t i t ion  between ca lc ium  and magnesium  Is fo r 
t ra n s m e m b ra n e  t ra n s fe r  (K ha rash  et al, 1981). S im i la r ly ,  the  re lease  of
Introduction 9
adrena line and noradrena line  from  the adrenal gland and at ad renerg ic  nerve 
term ina l'.  Is also ca lc ium  dependent (Rubin, 1970; Rasmussen, 1986 a & b, 
Knight & Baker, 1982). Low magnesium concen tra t io ns  augm ent ca techo lam ine  
release from  adrenerg ic  granules In response to  d irec t s t im u la t ion  (Baker & 
Rink, 1975; D oug las  & Rubin , 1963) and  h yp e rm a g n o sa e m la  In h ib i ts  th is  
func t ion  at levels reao ily  ob ta ined In c l in ica l p rac t ice  (B irm ingham  et al, 1960; 
Boullin , 1967; K lrpekar & Mlsu, 1967; Chutkow, 1981; Burn & G ibbons. 1964). 
Surpr is ing ly , a lthough  th is  action  of magnesium has been known fo r over 25 
years, no c l in ica l use has been made of th is  po ten t ia l ly  va luable phenomenon.
1.6 M agnesium  and the Cardiovascular System
The role of magnesium in regu la ting  the ca rd iovascu la r system has been a 
m ajor focus  for study.
1.6.1 M yoca rd ium :  On the m yocard ium  m agnesium  appears to  play a ca lc ium  
an tagon is t ic  role both at a membrane level and w ith in  the m yocard ia l cell 
(Kerr lck  & Donaldson. 1975; Guilla in, 1982). M, card ia l ce lls  have a 
h igh  m agnes ium  co n te n t  w h ich  Is t l p h " *  reg u la te d  In to  subce l lu la r  
com partm en ts  resu lt ing  In a free cy toso l ic  m agnesium  of app rox im ate ly  
1 m m ol/ l (Ebel & Gunther, 1980; Pollmenl & Page, 19>3). W ith in  the 
m yocard ium , m agnesium plays a vita l ro le In energy m etabo lism  and in 
the regu la t ion  of ca lc ium  release from, and re uptake by, sarco tubu la r 
s to res  (Hasselbach et al. 1981; Ford & Podolsky, 1972; Pollm enl & Page,
1 9 7 3 ) .  In th e  p r e s e n c e  o f m a g n e s iu m  d e p le t io n ,  ATP b e c o m e s
Introduction 10
inactivated and ox ida t ive  phosph o ry la t ion  is inh ib ited  (Krasner, 1979). 
There Is m uch curren t Interest In the  ro le of hypomagnesaemlfa and the 
suscep t ib i l i ty  of the m yocard ium  to  Ischaemic In ju ry  Ca lc ium  "'as been 
suggested as an Im portant com ponen t of the so-ca lled  reperfus lon  Injury 
(McCord, 1985) and Increases In free  cy toso l ic  m yocard ia l ca lc ium  have 
been shown to  occu r fo l low ing  Ischaem ic  damage (Bers, 1985; Nayler et 
al, 1979). There Is an assoc ia t ion  between m agnesium de f ic iency  and 
an Inc reased  r isk o f sudden  d e a th  due to  c o ro n a ry  a r te ry  d isease  
(Anderson et al, 1975; Johnson et al, 1979; Karppanen, 1981; Lenry & 
Reyes, 1983 a & b, C h ipperf le ld  & C h ipperf le ld , 1977; Leary, 1986). 
Myocard ia l losses of magnesium fo l low ing  ischaem ic events have been 
w ide ly  reported  (Boddy et al, 1978; Leary & Reyes, 1983 a & b; Page & 
Folimenl, 1972; Sheehan & Seellg, 1984; Abraham et al, 1977; Ebel & 
G un the r,  1983; C h ip p e r f le ld  & C h ip p e r f le ld ,  1973; D yc kn e r ,  1980; 
S ch roede r,  1960; Shen & E nn lngs , 1972; Jo h n s o n  et al, 1979) and 
h y pom a g n e saem la Is a s s o c ia te d  w i th  an In c re a s e d  In c id e n c e  of 
p o s t- is c h a e m lc  a r rh y th m ia s ,  and a dec reased  to le -a n c e  o f hypox ia  
(Chang e\ ai, 1985; B orchgrev lnk  et al, 1987; Solom on, 1984; Bloom,
1985). Magnesium appears to  exert an Im portant role In the  genesis, 
severity and outcom e of ischaem ic  heart d isease (Seellg & Heggtvelt,
1974). H y p o m a g n e s a e m la  has a ls o  been d e s c r ib e d  as a co m m o n  
causative fac to r  in arrhy thm ias  of many other types (Loeb et al, 1968; 
K ra s n e r  e t  a l, 1981 ; Laban  & C h a rb o n ,  1986; E ls e n b e rg ,  1986), 
pa rt icu la r ly  In assoc ia tion  w ith the use of d iu re t ics  and d igox ln  (Iserl & 
French, 1984; Chadda et al. 1958 & 1972; Burch & Giles, 1977; Fisher & 
Abrams, 1977; Rude & Singer. 1981; H o ll l f ie ld , 1984; DeCa.ll et al, 198G; 
Schipperheyn, 198*). These a rrhy thm ias  may prove re frac to ry  to  any 
therapy o the r  than rep lacem ent of magnesium. Magnesium Is a cruc ia l 
regu la tor o f potassium  exchange across  th r  m yocard ia l sarco lem ma, 
opposing eff lux (Hearse et al, 1978; Sheehan .1 dq«lig, I t  34; Dyckner &
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W ester,  1982) and Inc reas ing  up take  of po tass ium  In to  the cy to so l 
(V incent 1982; Dyckner & Wester, 1978 & 1979) A poss ib le  basis fo r  this 
assoc ia t ion  between magnesium, potass ium  and d ig ita l is  sens it iv i ty  has 
been p ro v id e d  re c e n t ly  by the  d e m o n s t ra t io n  th a t  m a g n e s iu m  and 
po tass ium  de fic iency  In skeletal muscle results  In dow n-regu la t ion  of 
sod ium  potass ium  pumps, thus preventing  the muscle from  re ta in ing 
po tass ium  adequate ly  (Derup et al, 1988).
M agnes ium  has a lso  been d e sc r ib e d  as be ing  a m a jo r  re g u la to r  of 
co rona ry  artery  tone and hypomagnesaem ia may worsen m yocard ia l 
Ischaemia by p rovok ing  co ronary  arte ry  spasm (Vide Infra). Magnesium 
d e f ic ie n c y  may a lso  w orsen  m y o c a rd ia l  Ischaem ia  by a l lo w in g  ATP 
oep le t lon  (Borchgrev ink  et al, 1987). Stress is a m ajor fac to r  p rovok ing  
magnesium  loss (Sheehan & Seelig, 1984), p robab ly  at least pa rt ly  due 
to  the ac t ions  of ca techo lam ines on l lpo lys is  (Rayss lgu le t, 1977), and 
th is  m a y  w o r s e n  th e  o u tc o m e  f o l l o w in g  m y o c a r d ia l  I n f a r c t i o n .  
Magnesium de f ic iency  can, of Its own, aggravate  the ca rd iovascu la r  
damage assoc ia ted with stress and d ie ta ry  magnesium  supp lem en ta t ion  
may p ro tec t  against th is  (Iserl et al. 1975; Classen, 1986) Magnesium 
de f ic iency  has also u en Implicated In the a rrhy thm ias  assoc ia ted with 
m itra l valve pro lapse (Galland et al, 1986; Frances et al, 1986) and those 
of the to rsades de po ln tes type (Ramee, 1985).
The role of magnesium In m yocard ia l co n tra c t i l i ty  Is unclear. There Is 
some ev idence that reduc ing magnesium levels may p roduce  a loss of 
m yocard ia l ATP and consequently  a reduc t ion  In m yocard ia l co n tra c t i l i ty  
(Skou et al, 1971), and that th is  may add to the card iac  fa i lu re  fo l low ing  
Ischaem ic  In ju ry  (B o rch g re v in k  et al, 1987). M agnes ium  leve ls  were 
noted to  be low In assoc ia t ion  w ith card iac  fa i lu re  (W ilk ins & Cullen,
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I9d3 ; Iseri et al, 1952). H is to log ica l damage assoc ia ted  w ith  magnesium 
d e f ic ie n c y  has been desc r ibed  by many au tho rs . H ypom agnesaem la  
renders  the m yocard ium  more susceptib le  to  ca techo lam ine- induced  
in ju r y  (V o rm a n n  et a l, 1983), and has been  a s s o c ia te d  w i th  the  
deve lopm ent of ca rd iom yopa thy  (Kurnlk et al, 1988; B loom, 1986, A ltura 
& A ltura , 1986; see Seellg, 1980 fo r  a review) M agnesium Is essentia l 
fo r  the Ino trop ic  ac t ion  of the  catecho lam ines, and even h igh levels of 
ex trace llu la r  magnesium do not b lock m yocard ia l con trac t i le  responses 
to  adrena line  (Paddle & Kaugaard, 1971; Levin et al, 1976).
1.6.2 B lo o d  Vessels:  There Is a wealth of ev idence assoc ia t ing  a lte ra t ions  in 
m agnesium homeostas is  w ith  d isordered  vascu la r co n trac t i le  states. It 
has been extens ive ly  shown that magnesium  func t ions  as a ca lc ium  
an tagon is t on b lood  vessels and that magnesium d irec t ly  a lte rs  baseline 
vascu la r tone (Haddy, 1960; Haddy et al, 1973; Haddy & Scott if/73, 
F roh l lch  et al, 1962; Altura & Altura, 1974; 1978 a & b; 1979; 1980; 1981
a, b & c; 1982 a, b, & c; 1984 a, b & c; 1985 a & b; A 'tu ra  et al., 1983). 
Magnesium Is also known to  alter vascu la r responsiveness to  a w ide 
range of vasocons tr ic to r  substances inc lud ing  noradrena line , seroton in, 
v a s o p r e s s i n ,  a n g i o t e n s i n  I I , p r o s t a g l a n d i n s  a n d  p o t a s s iu m ,  
hyperm agnesaem ia reducing and hypom agnesar mla increas ing  vascular 
responsiveness to  &r ese agents (Altura & A ltura, 1976 a & b; 1978 b. 1981
b, 1982 a, 1984 a, b It c; Altura et al, 1976; Overbeck et al. 1969; Frohllch 
et al 1962; V lveros & Somjen, 1968; Carrier et al, 1976; Fujiwara et al, 
ig7b ; Turlapaty, 1981; Turlapaty  & A liura, 1982 a & b; N ish io  et al, 1985). 
In add it ion , m agnesium  appears to be essentia l fo r  the vasod lla to ry  
ac t ion  of a num ber of substances Inc lud ing  be ta -adrenerg ic  agonists, 
s o d iu m  n l t r o p r u s f i ld e ,  c a lc iu m  a n ta g o n is t s ,  p r o s ta g la n d in s  and
adenosine, and elevations In extrace llu lar magnesium levels potentia te  
the ac t ions  of these vasod ila to rs  (Altura & A itura, 1971, 1976 a & b, 1981 
b, 1984 a & c, 1985 b; A ltura, 1985; Askar & Mustafa, 1983; Foley, 1983; 
Turiapaty , 1981; Tur lapa ty  & A 'tura, 1982 a & b; A rno ld  & Tackett,  1985; 
T h o m a s  & R anda l l .  1985). D e sp ite  th is  c le a r -c u t  e v id e n c e  o f the 
Im portance  of magnesium In regu la t ing  vascu la r tone, the re la t ionsh ip  
between magnesium and hypertens ion  is less c lear cut than m ight be 
Imagined. Hypom agnesaem la has been Implica ted as a causative  factor 
In the genesis of a the rosc le ros is  (Raysslguier, 1964; Ryan & Brady, 
1984) and In the deve lopm ent of hypertens ion  (Resnlck et al, 1983; 
Emerson et al, 1970) but the role of magnesium In the  management of 
hypertens ion  Is uncerta in . Lau & Oasa (1984) conc luded  that the role of 
d is tu rbances  In m agnesium homeostasis, If any, has not been su ff ic ien t ly  
defined In the pathogenesis  and /or m ain tenance of hypertens ion  to  allow 
log ica l therapeu tic  dec is ions  to be made. On the o the r hand Dyckner & 
Wester (1983) c la imed that magnesium supp lem en ta t ion  Improved the 
response to  an tihypertens ive  m ed ica tion , and Karppanen (1985) stated 
that Increased d ie ta ry  Intakes of magnesium  and po tass ium  are safe and 
p o t e n t i a l l y  b e n e f i c i a l  In p r e v e n t i o n  a n d  t r e a t m e n t  o f a r t e r i a l  
h y p e r te n s io n .  In an e x te n s iv e  d ie ta ry  s tu d y ,  J o f f r e s  et al (1987) 
suggested that magnesium may have a role to  play In hypertens ion , but 
his resu lts  were Inconclus ive
1.7 Magnesium  and the Respiratory System
The role of magnesium In resp ira to ry  func t ion  has not been ex tens ive ly  studied 
At a per iphera l level, magnesium Is essentia l for ox ida t ive  phosph o ry la t ion  (vide
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supra) but l i t t le  Is known about the role of magnesium  In lung mechanics. It 
has. how eve r ,  been show n th a t  p u lm o n a ry  vesse ls  d e m o n s tra te  a s im i la r  
response to  magnesium  to that shown by vessels In o ther part; of the body 
(Altura & A ltura. 1981c). It has a lso been shown that b ronch ia l sm ooth  muscle 
re a c ts  In a s im i la r  fa s h io n  to  v a s c u la r  s m o o th  m u s c le  to  v a r ia t io n s  In 
m agnes ium  leve ls  (Haury , 1938). It was sugges te d  by Maury (1940) tha t 
m agnesium sulphate In fusions may be benefic ia l In as thm atic  pa tients  and this 
e f fe c t  has re c e n t ly  been c o n f i rm e d  (O kayam a, 1987; R o l ls  et a l, 1987). 
M agnes ium  d e f ic ie n c y  decreases  the  s ta b i l i ty  of mast ce l ls  and increases 
h is ta m in e  p ro d u c t io n ,  w h ich  may p ro v id e  an e x p la n a t io n  fo r  th is  ro le  in 
bronch ia l asthma (Bols. 1963). There Is no ev idence of a centra l ven t i la to ry  
d e p re s s a n t  a c t io n  o f  m a g n e s iu m  and the  o n ly  a c t io n  o f m a g n e s iu m  on 
ven t i la t ion  appears to  be as a result of Its neurom uscu la r b lock ing  propert ies.
1.8 Magnesium In Pregnancy
M a g n e s iu m  p la y s  a v i ta l  ro le  In th e  p h y s io lo g y  o f  n o rm a l  p re g n a n c y .  
M agnesium  levels have been shown to  dec line  dur ing  p regnancy reach ing their 
lowest po in t at the end of the f irs t  tr im ester (De Jo rge  et al, 1965), and In her 
extensive review of magnesium de f ic iency , Seellg (1980) stated that magnesium 
Intake du r ing  pregnancy was l ike ly  to be suboptlm al. There Is a g row ing  body 
of ev idence  that m agnes ium  d e f ic ie n c y  Is co m m on  In p regnan cy  and may
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c o n t r ib u t e  t o w a rd s  p la c e n ta l  In s u f f i c ie n c y  and  to  th e  d e v e lo p m e n t  of 
pre ec lam ptic  toxaemia and to  frank eclampsia (Flowers, 1965; McGanlty. 1965; 
S e e l lg ,  1 9 8 0 ;  W e a v e r ,  1 9 8 6 ) .  T h is  a p p a r e n t  a s s o c i a t i o n  b e tw e e n  
hypom agnesaem ia  and toxaem ia of pregnancy has been s trengthened by recent 
w o rk  which has suggested that the essentia l regu la to ry  ro le  of m agnesium In 
p ros tag land in  synthesis may play a crucia l ro le in the genesis of th is  syndrom e 
w hen m agnesium  Is de f ic ien t (Watson et al, 1986). It has a lso been shown that 
magnesium  de fic iency  can produce um bil ica l a r te ry  spasm and that th is  may 
con tr ibu te  to  foeta l g row th  re ta rda tion  as well having a poss ib le  causative part 
to  p lay In the deve lopm ent of pre ec lam ptic  toxaem ia (A ltura et al, 1983). A 
recent s tudy has suggested that magnesium supp lem en ta t ion  during  p regnancy 
can reduce maternal m orb id ity  and In prove foeta l ou tcom e, but the study was 
to o  sm all and n o n -s p e c i f ic  to  Ind ica te  any e f fe c t  on th e  d e v e lo p m e n t of 
p re -ec lam ps ia  (Spatllng & Spatling, 1988).
1.9 Magnesium and Other Organ Systems
Magnesium appears to play an Im portant role In the func t ion ing  of various other 
o rgan  systems. Magnesium Is an Im portant regu la to r of gas tro in tes t ina l smooth 
muscle  and hypom agnesaem ia has been assoc ia ted w ith dysphag ia  (Named & 
Llndeman, 1978; Fllnk, 1978).
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Renal fu n c t io n  ; f  » !so  c r i t ic a l ly  d epen den t on m agnes ium  and m agnes ium  
de f ic iency  has been associated w ith  nephroca lc lnos ls  and tubu la r  dam age 
(Leder, 1980; see Seelig, 1980 fo r  an extensive review). D iu re t ics  which resu lt 
In po tass ium  loss a lso produce magnesium  dep le t ion  (Duarte, 1968; D yckner & 
Wester, 1979; Reyes & Leary, 1982, 1984 a & A; Reyes et al, 1984; Leary, 1987). 
Magnesium  has a lso been shown to  bo essentia l for normal bone deve lopm ent 
and may con tr ibu te  to  os teosc le ros is  and abnormal v itam in  D m etabo lism . 
Magnesium  appears to  be necessary fo r normal func t ion ing  of v itam in D (see 
Seelig, 1980 fo r  a review). Magnesium Is necessary fo r  normal ca rbohyd ra te  
m etabo lism  and is an im portant coheren t con tro l le r  of g lyco lys is  and the Krebs 
cyc le  (G arf lnke l & Garf lnke l, 1985). M agnesium  d e f ic ie n cy  inh ib i ts  in su l in  
secre t ion  and results  in an Impaired g lucose to le rance  curve (Durlach & Colle ry , 
1984; Legrand et al, 1987; Thomas, 1977). As d iabetes Itself may cause losses 
o f m agnes ium , the  I j n  may be of c ruc ia l  Im po rtance  In d ia b e t ic  pa t ien ts .  
M agnes ium  may a lso  be of Im p o r ta n ce  In re g u la t in g  th y ro id  fu n c t io n  and 
magnesium  de f ic iency  may accom pany  thy ro id  dys func t ion  (Rlzek et al. 1965. 
1966).
It can thus be seen that magnesium plays a vast and cruc ia l ro le  In most of the 
b iochem ica l processes essential to  life. Consequently , m agnesium  de f ic iency  
Is assoc ia ted  w ith  an array of well defined syndrom es, (see tab le  1.1) w h ich  are 
cu rren t ly  be ing extensive ly stud ied, and the ir  Im portance quanti f ied . O n ly  30 
years ago magnesium was regarded as merely a trace element. It Is now be ing
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realized tha t th is  Ion Is o r e  of the most Important regu la to rs  of b iochem ica l 
ac tiv ity .
Table 1.1
alterations In potassium, calcium and phosphate balance 
Hypokalemia 
Hypocalcemia 
Hypophosphatemia 
Neuropsychiatric manifestations
Personality changes (including apathy, depression, agitation, 
confusion, delirium)
Seizures
Vertigo, nystagmus, ataxia, coma, movement disorders (rarely) 
Neuromuscular manifestations
Chvostek's and Trousseau's signs 
Muscle twitching and tremor 
Spontaneous carpopedal spasms 
Muscle cramps
Muscie (Including respiratory) weakness 
Paresthesia 
Cardiac manifestations
Predisposition to dlgoxln-mediated arrhythmias 
Electrocardiographic changes (including prolonged (QT Interval)
Cardiac arrhythmias (Including ventricular premrture beats ventricular 
tachycardia, torsades de pointes, ventricular fibrillation)
Alterations In vascular tone and Wood pressure
Increased vascular smooth muscle tone and reactivity, leading to spasm 
Increased Wood pressure
Table 1.1 M an ifesta tions of magnesium de f ic iency
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2. Clinical Consequences of Hypermagnesaemia
Raised serum magnesium levels arc e In c l in ica l m edic ine as the ion is 
re la t ive ly  poor ly  absorbed from the gastro in tes tina l trac t (Agus, 1982, Aikawa, 
1980) and the 'ena l e l im ination  of any excess magnesium  Is extrem ely  rapid 
(Barker et i l ,  1959; Chesley & Tepper, 1958; Pritchard , 1955, A ikawa et al, 1968; 
Quamme, 1986), excre t ion  of a magnesium load by the k idney being com ple te  
w ith in  4-8 hours (Smith et al, 1962). Hype-magnesaem la was f irs t  reported In 
assoc ia t ion  v ..h renal fa ilure by Salveson and Linder (1923), and It Is now well 
recogn ized  that Impaired renal func t ion  he most com m on prerequ is ite  fo r  the 
d e v e lo p m e n t  of h yp e rm a g n e sa e m ia  (W acke r & Paris), 1968). In o rd e r  to 
p ro d u ce  a s ig n i f ica n t  Increase in serum m agnes ium  leve ls  fo r  th e ra p e u t ic  
purposes In the presence of normal renal func t ion , It Is necessary to  adm in is ter 
the agent In travenously  or In tram uscular ly . Magnesium has a m odera te ly  large 
vo lum e of d is tr ibu t ion  which approx im ates to  the vo lum e of the extrace llu la r 
space (Chesiey, 1979) and this, coup led w ith  the rapid renal e l im ina t ion , means 
that la rge load ing  doses and con t inuous  in fus ions or In tram uscu la r in jec t ions  
are necessary to mainta in  serum magnesium levels In the genera lly  accepted 
the rapeu t ic  range of 2-4 mmol/l. Despite the extensive the rapeu tic  use to  which
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m agnesium has been put, there Is a surp r is ing  am ount of con trove rsy  regard ing 
Its precise m echanism s of action.
Hyperm agnesaem la affects  a lmost every organ system In the body.
2.1 Central Nervous System
Until recently  It was w ide ly assumed that magnesium Is a powerfu l centra l 
sedative and may even have anaesthetic  propert ies  (M eltzer & Auer, 1905 a & 
b, 1906a, Peck & Meltzer, 1916; Engbaek, 1952b; A ldrete et al, 1968, Fishman, 
1965; Katzman, 1966; Crossland, 1971). Meltzer and Auer (1905 a & b, 1906a) 
descr ibed  general anaesthesia, resp ira to ry  and ca rd iovascu la r  depress ion , and 
re f le x  s u p p re s s io n  w h ic h  th e y  a s c r ib e d  to  c e n t ra l  e f fe c ts  of p e r ip h e ra l  
In je c t io n s  o f  m a g n e s iu m  sa l ts ,  In p a r t ic u la r  d e p re s s io n  o f the  m e d u l la  
ob longata . When adm in is tered d irec t ly  Into the CSF by ve . lr lcu la r  In jection 
magnesium produces a s leep-like state (Feidberg, 1958; Feldberg & Sherwood. 
195 /) .  It Is now known that magnesium penetrates the b lood  bra in  barrier 
extrem ely  poor ly  and that Its level In the CSF Is t igh t ly  con tro l led , p robab ly  by 
an active transpo rt  mechanism (Chutkow, 1981). Even In cases whsre  high 
le ve ls  of se rum  m agnes ium  have been m a in ta in e d  fo r  seve ra l days  CSF 
magnesium has been found to be only m arg ina lly  above normal (Pritchard,
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1955). There fo 'e , s ince magnesium pensna tes  the bra in w ith  such d if f icu lty ,  
several au thors  have queried whether parentera .ly  adm in is te red  magnesium can 
produce s ign if ican t sedative effects (Berns & Kollmeyer, 1976; Guthrie & Ryan, 
1910; Rubin et al, 1943). Somjen et al (1966) dem onstra ted  In three sub jects  
that full consc iousness  was mainta ined at serum m agnesium  levels in excess of 
14 mEq/l p rov ided that ven t i la t ion  was a r t i f ic ia l ly  supported . Mordes & Wacker 
(1978) conc luded  that "magnesium Is not an anaesthetic  nor even a major 
centra l nervous system depressant". More recently , however, Thurneau et al 
(1987) descr ibed  a small but h igh ly  s ta t is t ica l ly  s ign if ican t Increase In CSF 
magnesium concen tra t ions  fo l low ing  magnesium trea tm ent In pre ec lam ptic  
patients. They suggested that th is  small Increase m ight be su ff ic ien t to  explain 
some of the  a n t ic o n v u ls a n t  a c t io n s  of the  agent. Thom pson  et al (1988) 
d e s c r ib e d  a re d u c t io n  In m in im um  a lveo la r  c o n c e n t ra t io n  of h a lo tha ne  in 
m agnesium  treated rats which they  ascr ibed to  a centra l e ffect of the Ion.
2.2 Peripheral Nervous System
M agnes ium  p r im a r i ly  a f fec ts  the  pe r iphe ra l nerves by In te r fe r in g  w ith  the 
ralaese of n e u ro t ra n s m itn r  substances at all synaptic  junc t ions .
2.2.1 M o to r  End Plate:  It has been known since the m idd le  of the 19th century  
tha t magnesium can exert a curare like effect, ano early th is  cen tury  It 
was shown that this ac t ion  cou ld  be reversed by neostigm ine  (Joseph & 
Meltzer, 1910). It Is now well docum ented  that th is  e ffect Is due to
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pre synap t ic  In h ib i t io n  of a ce ty lch o l in e  re lease c o m p e t i t io n  w ith  
ca lc ium  for membrane channels on the p re -synaptlc  te rm ina l (Engbaek, 
1952 a & b; Del Casti l lo  & Engbaek, 1954; Jenk inson & Engbaek, 1954; 
H otte r  & Kostia l, 1954; Jenkinson, 1957; L iv ings ton  & Wacker, 1971; 
M ordes & Wacker, 1979). As a result, m agnesium will po ten t ia te  the 
ac t ion  of the non-depo la r is ing  muscle  re laxants (Ghonheim  & Long, 
1970; Glesecke et al., 1968; Morris  & Giesecke, 1968; Sinatra et al, 1985). 
The In te rac tion  of magnesium w ith  the depo la r iz ing  muscie re laxants Is 
less  c le a r -c u t .  A l th o u g h  It Is g e n e ra l ly  assum ed  th a t  m agnes ium  
p ro longs  the ac t ion  of depo la r iz ing  re laxants as well as those of the 
non depo la r is ing  group (Glesecke et al, 1968; Skaredoff et al, 1982), th is 
is no t Inva r iab le  (S ina tra  et al. 1985) and the  In te ra c t io n  be tw een  
magnesium and suxamethon ium  is much more com plex  than that w ith  the 
com petit ive  re laxants Patients trea ted with magnesium su lphate  do not 
dem onstra te  fasc lcu la t lons  (De Vore & Asraml, 1980). W hilst p ro longed 
trea tm ent w ith magnesium may p ro long  the du ra t ion  of suxam ethon ium  
b lo c k a d e ,  a cu te  hype rm a g n e sa e m ia  does  no t (Jam es et a!, 1986). 
Baraka and Yazlgl (1987) found no p ro longa t ion  of the «c tlon of a s ingle 
dose of suxam ethon ium  In magnesium -trea ted pre ec lam ptic  mothers. It 
Is p o s s ib le  th a t  G h o n h e lm 's  In v i t r o  s tu d y  c re a te d  an e r ro n e o u s  
Im p ress ion  of p ro lo n g a t io n  of the a c t io n  of su xa m e th o n iu m  due to 
w a s h o u t  o f p s e u d o c h o l ln e s te r a s e  f ro m  th e  p r e p a r a t io n  A c u te  
adm in is tra t ion  of magnesium sulphate p r io r  to  the  use of suxam ethon ium  
appears to  prevent the release of ru ta ss lu m  provoked by u 'e laxant 
(AUlrate et al, 1970; James et al. 1986). To the present tlrm  ,  c l in ica l 
use h5s been made of these In teractions, a lthough the poss ib, v x ls ts  
t h a t  m a g n e s iu m  m a y  r e d u c e  th e  I n c id e n c e  a n d  s e v e n . )  o f 
suxam e lhon lum -lnduced  muscle pains, and may make suxam ethon ium  
u-.able in those c ircum stance In wh ich the risks of excessive potassium  
release cu rren t ly  make the re la -an t con tra - ind ica ted
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2.2.2 Autonomic  Nerve Terminals  Magnesium exerts a sim ilar, a lthough  iess 
w e l l  know n , e f fe c t  on a u to n o m ic  g a n g l ia  (M u tte r  & K o s t ia l .  '9 5 4 ;  
Stanbury, 1948) and on vagal nerve te rm ina ls  (Kurlyama, 1964; i om jen 
& B a s k e rv l l le ,  1968) to  tha t d e m o n s tra te d  at the m o to r  end p la te . 
M agnes ium  s im ila r ly  inh ib i ts  the  neu roge n lca l ly  m edia ted re lease o 
c a te c h o la m in e s  from  the ad rena l g land  art , f rom  a d re n e rg ic  nor- a 
te rm ina ls  (K irpexar & Misu, 1967; Bou ll l ln , 1967; Douglas & R u t in ,  ' 9 6 j ;  
Burn & G ibbons, 1964; George & Leach, 1 9 7 V
2.3 Cardiovascular System
The com p lex  in te rre la t ionsh ips  between magnesium and card iac  and vascular 
co n tra c t i l i ty  have a lready been mentioned. Raised serum le i ls  of magnesium 
ought to  p roduce  marked hypotens ion  as a result of the negative Ino trop ic  
action of the ion on the m yocard ium , the d irect vasod ila t ing  p ropert ies  of 
magnesium on b lood  vessels and the reduc t ion  In sym pathe t ic  d r ive  which 
magnesium ought to  produce. C lin ica lly , however, ev idence for magnesium 
In d u ce d  h y p o te n s io n  is va r ie d  and c o n f l i c t in g .  In e a r ly  in v e s t ig a t io n s  
hypnter.s lon fo l low ing  the in fus ion of magnesium was noted In several studies 
using animal models (Meltzer & Auer, 1905b, 1906a; Hoff et al, 1939; Rubin et 
al, 1943; Lee et al, 1984). More recently , Maxwell et al (1965), A ldrete et al 
(1968) and M cCubbln et al (1981) have also supported  th is  observa t ion  In 
various In tact animal models, whereas Dandavlno et al (1977) using pregnant 
sheep, found only trans ien t hypotens ion
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In  h u m a n s ,  v e r y  c o n f l i c t i n g  r e s u l t s  nave  b e e n  r e p o r t e d  W h e re  
hype inragnesaem la com p lica ted  renal fal ure, several au thors  have found that 
marked reduc t ions  In b lood pressure occurred  In assoc ia t ion  w ith  raised serum 
m agnesium  levels (B lackfan & Hamilton, 1925; Randall et al, 1964, Alfrey et al, 
1970), anu there have been a number of other case reports  of s ign if ican t 
hypo tens ion  in assoc ia t ion  w ith  hypermagnesaamia w ithou t renal fa i lu re  (Boos, 
1910, M oo re  & W ln g o ,  1942; G ran tham  et al, 1960: M o rd e s  et al, 1975; 
Bourgeo is  et al, 1986; Prestloy, 1912). Most Investigato rs  s tudy ing  human 
vo lun tee rs  have found soms evidence of a reduction  in b lood  pressure as a 
result of m agnesium Infusions but these changes have been genera lly  m in imal 
and of short du ra t ion  (Kelly et al, 1960; Somjen et al, 1966; W ink ler et al, 1942; 
Mori, 1978; Mroczek et al, 1977; Young & Weinstein, 1977). However, some 
au thors  have reported  litt le, If any, card iovascu la r e ffect even at high Infusion 
rates of magnesium  (Flowers et al, 1962; Kelly et al, 1960), a lthough In both 
o f  th e s e  r e p o r t s  b o lu s  d o s e s  a p p e a re d  to  p r o d u c e  a g r e a te r  e f fe c t .  
H y p o te n s io n 's  not cons is ten t ly  produced by magnesium In the m anagem ent of 
p regnancy- induced  hypertens ion  (Flowers et al, 1962; P r itchard  et al, 1984, 
P r itchard  & P r itchard , 1975), and consequently , magnesium has been descr ibed  
as a poor vasod ila to r  (Scott et al, 1968; Morris  & Assail, 1981)
2.3.1 Vascular  Resis tance :  C learly, magnesium can exert p ro found  effects on 
v a s c u la r  s m o o th  m u sc le  and has been show n  to  be an Im p o r ta n t  
regu la to r of b lood vessel tone In a w ide varie ty  of tissues. The ev idence 
fo r th is  was reviewed In the prev ious chapter. There Is also extensive 
ev idence of Increased periphera l b lood  flow, reg ional vasod ila ta t ion  and 
Increased m lc ro c lrcu la to ry  perfus ion as a result of magnesium In fusions
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(Haury, 1939; Overbeck et al, 1969; Mroczek et al, 1977; A ltura & Altura, 
1985 a, b & c; Dandavlno et al. 1977). In add it ion  to  Its d irec t  effects on 
th e  vesse l wo.il, ra ised  se rum  m a gnes ium  le ve ls  m ay a ls o  reduce  
periphera l vascu lar tone by a number of o ther m echanisms:
a) Centra l  Nervous System.  A lthough there Is some jv id e n c e  that d irect 
a dm in is tra t ion  of magnesium Into the ven tr icu la r  system may produce a 
reduc t ion  In the ou tpu t of the vasom oto r centre  (Leusen, 1949), available 
data tend to  argue against a major centra l ro le  fo r  the hypotens ive 
e ffec ts  of hypermagnesaemla (Lau & Oasa, 1984). The leve ls of CSF 
magnesium  required to  Inhibit vasom oto r centre  func t ion  are very high 
(10 m m ol/ l)  and It Is extrem ely un like ly  that periphera l adm in is tra t ion  of 
m agnesiun. salts cou ld  increase CSF magnesium  levels su ff ic ien t ly  to  
ca u se  a s ig n i f ic a n t  a l te ra t io n  In v a s o m o to r  o u tp u t .  As has been 
d iscussed In the previous chapter, CSF m agnesium  is t ig h t ly  con tro l led  
and l i t t le  a ffected by a lte ra t ions  In magnesium levels of the b lood.
b) Sympathet ic  Gangl ia.  Syr .pathetic b lockade  has been shown to occur 
In heart- lung prepara tions  (Mutter & Kostlal, 1954; Stanbury, 1948) w ith  
e leva tions  In the magnesium conten t of the perfusate, and It Is possib le 
th . i t  th is  e f fec t  may p lay a ro le  In hyp e rm a g n e sa e m lc  h y p o te n s io n  
(F.ordes & Wacker, 1978). Against th is  Is the fac t that an im a ls  with a 
to ta l ly  ab la ted  cen tra l nervous system  sti l l  p ro d u ce d  a hypo tens ive  
response to  m agnesium In jections (Hoppe & Emmerson, 1974; Haury, 
1939) Ind ica ting  that o ther mechanisms than Just sym pathe t ic  contro l 
must be Involved.
c) Catecholamines.  As has been reviewed above, there Is no doubt that 
levels of hypermagnesaemla com m on ly  used In c l in ica l p rac t ice  can 
Inh ib it  the release of ca techo lam ines from  both the adrenal medulla and 
from  periphera l nerve term inals However, th is  e ffect had un t i l  now on ly
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been dem onstra ted  on iso la ted tissue and there Is cu rren t ly  no evidence 
to  suggest tha t th is ac t ion  of magnesium  p lays a s ign if ican t role In 
h y p e r m a g n e s a e m lc  h y p o te n s io n .  U n d e r  n o rm a l  c i r c u m s ta n c e s ,  
c i r c u la t in g  c a te c h o la m in e s  exert l i t t le  re g u la to ry  e f fe c t  on re s t in g  
vascu la r tone  (Cryer, 1980) and It seems un like ly  that th is  mechanism 
p la y s  a m a jo r  ro le  in  the  r e d u c t io n  o f v a s c u la r  to n e  c a u s e d  by 
magnesium  Infusions under normal c ircum stances  However, as none of 
the  s tud ies  on m agnes ium -induced  hyp o te n s io n  has cons ide red  the 
p o s s ib le  e f f e c t  th a t  th e  m a g n e s iu m  In fu s io n  m a y  have  had  on 
c a t e c h o la m in e  le v e ls  In ;h e  e x p e r im e n ta l  m o d e l ,  t h is  r e m a in s  
specu la t ive . Magnesium may also Interfere w ith  the periphera l ac t ion  of 
ca techo lam ines. Noradrena line has been reported  as be ing ineffective  
In seve re  hum an h y p e rm a g n e s a e m lc  s h o c k  (M o rd e s  et al, 1975). 
D im in ished responsiveness to vasocons tr ic to r  ca techo lam ines has been 
dem onstra ted  on perfused rat mesentery (George & Leach, 1971; Suzuki 
et al, 1982), In the fo ra l im b  of dogs (Haddy, 1960) and on vessels In the 
ear of rabb its  (Farmer & Campbell, 1967). In add it ion , several authors 
have shown the dependence of va so co n s tr ic to r  agents on normal serum 
m agnesium  levels (vide supra). All of these stud ies have lookeJ  at 
Iso lated tissue  or l im ited  areas, and there is no data availab le  on the 
effect that magnesium may have on ca techo lam ine- induced  vascular 
re sp o n se s  In f i e  In ta c t  sub jec t.  M agnes ium  o u g h t  to  have usefu l 
an t i-ad renerg ic  propert ies, but th is  poss ib i l i ty  awaits fu r the r  study.
When all of these fac to rs  are cons idered , there  can be l i t t le  doub* that 
magnesium produces periphera l vasod ila ta t ion  desp ite  the fact that the 
hyootens lve  effect of parentera l adm in is tra t ion  Is Inconsistent.
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2.3.1 M y oc a rd ium :  M yoca rd .a l  d e p re s s io n  may or m ay not p lay  a part In 
m agnes ium  Induced hypo tens ion . Because m agnes ium  Is a ca lc ium  
an tagon is t, Increased levels of m agnesium ought to  p roduce  a reduction  
In m yocard ia l con trac t i le  fo rce , and Indeed, Iso la ted skinned f ibres of 
ven tr icu la r  muscle do show a reduc t ion  In tens ion deve lopm ent In the 
presence of e levated magnesium levels (Donaldson & Kerrlck, 19 /8 , 
Fab la to  & Fablato, 1975). There Is genera lly  assumed to  be l i t t le  change 
In the  card iac ac t ion  potentia l p roduced  by nigh levels of magnesium In 
Isolated heart perfusates (Hoffman & Suckling, 1956). Recent work has, 
however, questioned this assum ption  (Katholl et al, 1979; Kraft et al, 
1980; Moe, 1984) and Altura (1985) believes that magnesium  Inh ib its  the 
c a lc iu m  d e p e n d e n t  Inw ard  c u r re n t ,  w h ic h  m ay he lp  to  e x p la in  Its 
an t i-a rrhy thm ic  effects pa r t icu la r ly  In the  presence of ischaemia. Using 
an iso la ted heart/ lung prepara tion , S tanbury and Farah (1950) found a 
decreased stroke volume and Increased r ight and left atrla i pressures 
p ropo rt iona te  to  the ex trace l lu la r  magnesium level. On the Isolated 
h e a r t ,  In c re a s e d  c o n c e n t r a t io n s  of e x t r a c e l l  ' l a '  m a g n e s iu m  Ion 
p roduc t 's  marked depress ion of con trac t i le  fo re?  (Puddle & Haugaard, 
1971; Shine & Douglas, 1971 & 1975; Kovacs & O 'D onnell,  1975; Levin 
et al, 1976). Wallis  et al (1986) reported severe m yocard ia l depress ion 
w ith  com b ina t ions  of magnesium and d llt iazem, but not w ith  magnesium 
alone. In all of t f  e above studies, ra ther high leve ls of magnesium (10 - 
40 mmol/I) were ised, and th is  makes It very d i f f ic u l t  to ex trapo la te  the 
data to  the c l in ic il  sett ing In w h ich  serum magnesium levels are un like ly  
to exceed 4-6mmol/l. In the Intact animal, the evidence fo r  card iac 
depress ion  by c l in ica l ly  useful levels of raised magnesium is less clear 
Various studies In both an imals and humans have shown some evidence 
of a nega t ive  In o t ro p ic  a c t io n ,  p r in c ip a l ly  a ra ised  c e n tra l  venous 
pressure  (Szekely, 1945; A ldre te  et al, 1968; B i ls to w  et al, 1977 a & b; 
C r lte l l i  et al. 1977; Mori, 1978; Charbon 1983). However, o the r studies
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have fa i led  to  d e m o n s tra te  any m yo ca rd ia l  d e p re ss io n  and several 
au thors  have found an Increase In card iac ou tpu t assoc ia ted w ith  raised 
serum magnesium levels (Cotton et al, 1984; Dandavlno et al, 1977, 
Maxwell et al, 1965; M roczek et al, 1977). Mordos & W acker (1978) 
co n c lu d e d  that some fo rm  of m yoca rd ia l  co m p ro m ise  was p robab ly  
necessary fo r the maintenance of hyperm agnesaem ic hypo tens ion  and 
e x p re s s e d  the  o p in io n  th a t  m ore  re s e a rc h  on the  h a e m o d y n a m lc  
consequences of hypermagnesaem la was necessary. As it appears that 
c l l n , r a l l y  e m p lo y e d  le v e ls  o f  se ru m  m a g n e s iu m  d o  no t p ro d u c e  
s ign if ican t m yocard ia l depress ion , sustained, or even Increased card iac 
ou tpu t may be the exp lana tion  for the minimal hypotens ive  effect of 
m agnesium  Infusions desp ite  s ign if ican t vasod ila ta t ion .
The Inhe ren t e le c t r ic a l  r h y th m lc l ty  of the  heart seem s p a r t ic u la r ly  
res is tant to  the effects of magnesium, w ith  card iac  arrest on ly occu rr ing  
when the serum m agnesium levels are extrem ely  h igh - above 12.5 
m mol/l - levels not norm ally  a tta inab le  In the c l in ica l s ituation. It Is 
genera lly  accepted tha i excess magnesium In the range of 2.5 - 5 mmol/l 
p roduces p ro longa tion  of the PR and QT Intervals (Wacker A Parisl, 
1968; Wacker, 1980) as a result of the reports  of f i l l e r  and Van Dellen 
(1938 & 1941) and Smith et al (1939). However, other reports  have failed 
t o  s h o w  s i g n i f i c a n t  c o n d u c t i o n  d e f e c t s  f o l l o w in g  m a g n e s iu m  
a d m in is t ra t io n ,  p ro v id e d  the ca lc iu m  leve l Is m a in ta ined  (Young  & 
Welnstoln, 1977; Surawlcz et al, 1961) or that there are no major changes 
In the serum potassium level (Watanabe & Dreyfus, 1972). DICarlo et al 
(1986) s tudy ing  human vo lun tee rs  found an Increase In the PR Interval 
w ith  rapid bolus In jec tion  of MgS04, but no change In the QT or QTc 
Intervals. On the Isolated heart, magnesium p roduces a bradycard ia  
(Stanbury, 1948; S tanbury & Farah.1950; Haury, 1939), and there  have 
b e e n  c l i n i c a l  r e p o r t s  o f  b r a d y c a r d i a  In a s s o c i a t i o n  w i th
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hyperm agnesaem >a and renal fa i lu re .  Berns and K o l lm e ye r  (1976) 
descr ibed  a patient In whom  the use of magnesium con ta in ing  an tac ids  
was assoc ia ted with junc t iona l b radycard ias  at re la t ive ly  low  levels of 
serum magnesium (2.25 - 2.4 r,-mol/I). On the o ther hand, Enselbe g et 
al (1950) found an in it ia l Increase fo llow ed by a s light s low ing  of heart 
rate w ith  rapid Intravenous In jection  of magnesium sulphate, and D iCarlo 
et al (1986), W inkler et al (1942) and Szekley (1946) found no change In 
heart rate fo l low ing  magnesium Infusion. C a rd io resp ira to ry  arrest has 
been described fo l low ing  magnesium Infusion (R ichards et al, 1985) but 
It is l ike ly that resp ira to ry  arrest due to neurom uscu lar parara lys ls  was 
the p rec ip ita t ing  event. In normal subjects, there  may be an Increase in 
hea r t  rate w ith  Increased serum m agnes ium  leve ls  as a resu lt  of a 
reduc t ion  In vagal tone due to the inh ib it ion  of ace ty lcho line  release 
w h ich  can result from Increased magnesium (Somjen at al, 1966; Somjen 
& Baskervll le , 1968, Toda & West, 1967). Magnesium Infus ions increase 
bo th  atrial and ven tr icu la r re frac to ry  periods, and th is may accoun t for 
its general anti a rrhy thm ic  action.
2.4 Genitourinary System
The e f fe c ts  of hype rm agnesaem la  on rena l fu n c t io n  are unc lea r. Several 
authors  have described a reduc t ion  In g lom eru la r f i l t ra t ion  rate In assoc ia tion  
w ith hyperm agnesaem la (de Alvarez & Richards, 1952; Hammarsten et al, 1957, 
Heller et al, 1953), whereas Kelly et al (1960) found an Increase In renal p lasma 
f low . A ltu ra  & A ltu ra  (1985b) have d e sc r ib e d  renal v a s o d i la t in g  e f fec ts  of 
m a g n e s i u m  and v a s o c o n s t r i c t io n  r e s u l t in g  f ro m  h y p o m a g n e s a e m la  A
tmm
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m agnesium load is rap id ly  f i l tered th rough  the k idneys, and th is  m ight be 
expected to  exert a d iu re t ic  effect. There appears to be a tubu la r  m aximum for 
m agnesium  w h ich  Is c lose to the upper l im it normal serum magnesium  values, 
and the re fo re  any excess magnesium f i l te red th rough  the g lom eru lus  Is rap id ly  
excre ted, whereas, at normal serum m agnesium values, 95-99% of the  fi l tered 
load Is reabsorbed (Alkawa, 1981). Duarte (1968) suggested the poss ib i l i ty  of 
an ac tive  tubu la r  excre to ry  mechanism for magnesium but th is has not been 
con firm ed (Roy, 1985). Hypermagnesaemla reduces the tubu la r reabsorp tk . i 
of both water and sodium (LIBona & Sawln, 1971) which would  also be likely to  
have a d iu re t ic  effect. As a result of the renal vasod ila ta t ion , the reduced 
reabsorp t ion  of sodium and water, and the rapid excre tion  of magnesium  Itself, 
magnesium Infus ions ough t M  produce a brisk d iuresis, but there is very l i t t le  
data on the ac t ion  of Infused magnesium on renal output. Calc ium excre tion  Is 
also Increa? d by Increased ur ine .y  exc etlon of magnesium (Kelly et al, 1960), 
but Is unclear whether or not th is Is uue to  Intra-renal e ffects or to  the negative 
feed-back loop  which exists between para thyro id  horm one release and serum 
magnesium levels (Dawson 1984; Massry et al, 1970; Zumkley & Lehnert, 1984). 
Certa in ly , p ro longed  e levations In serum magnesium may produce  a reduction  
In se rum  c a lc iu m  leve ls ,  but w h ich  m echan ism s  p re d o m in a te  Is not we ll  
established.
Sj
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The use of m agnesium In the management of pre ec lam ptic  toxaem ia  will be 
d i s c u s s e d  In m o re  d e t a i l  l a t e r ,  b u t  t h e r e  a re  s e v e r a l  e f f e c t s  o f
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hyperm agnesaem la on the female rep roduc t ive  system w h ich  are pert inen t to 
the p re se n t  d is c u s s io n .  A l th o u g h  It g e n e ra l ly  assum ed  th a t  m agnes ium  
In fu s io n s  d o  no t In te r fe re  w i th  no rm a l la b o u r  ( H u tc h in s o n  et al, 1964), 
magnesium can reduce uterine tone (M il le r et al, 1982; Reece et al, 1984). 
M agnesium a lso vasod ila tes the uterine b lood  vessels (A ltura et al, 1983) and 
Inc reases  u te i in e  b lood  f lo w  w lth o t  re d u c in g  s y s te m ic  a r te r ia l  p ressure  
(Dandavlno et al, 1977). A lthough magnesium does cross the p lacenta readily, 
th e  e f f e c t s  on  th e  n e o n a te  a re  d i f f i c u l t  to  d i s t i n g u is h  f r o m  th o s e  of 
p re -ec lam psia  Stone & Pritchard (1970) noted no III e ffects In a large series of 
Infants born to  ♦oxrem ic  m others who had been given magnesium, and Green 
et al (1983) w ere  unable to  dem o n s tra te  any re la t io n s h ip  be tween serum  
magnesium levels In neonates and d im in ished neurobehavioura l scores.
2.5 Endocrine Systems
N e g a t iv e  f e e d  b a c k  lo o p s  a p p e a r  to  e x is t  b e tw e e n  m a g n e s iu m  and 
c a te c h o la m in e s ,  p a ra th y ro id  ho rm one , c a lc i to n in  and In s u l in  (D u r la c h  & 
Durlach, 1984). It Is well known that susta ined hyperm agnesaem la car. result 
In Inh ib it ion  of para thyro id  hormone release (Buckle et al, 1968; Gite lman et al, 
1968; M assry  et al, 1970; Sherwood et al, 1970) and p o s s ib ly  In reduced 
horm one recep to r  sens it iv ity  (S la topo lsky et al, 1976), w ith consequent fa lls  In 
serum ca lc ium . In view of the evidence that magnesium de f ic iency  worsens
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d iabe t ic  c o n tro l  and reduces Insulin sensit iv ity , It m ight be an t ic ipa ted  that 
hyperm agnesaem ia m ight Increase Insulin sens it iv i ty  and reduce b lood  sugai. 
T h e r e  Is , h o w e v e r ,  n o  I n f o r m a t i o n  on  t h is  s u b je c t .  D e l i b e r a t e  
h y p e r m a g n e s a e m ia  h a s  b e e n  u s e d  o c c a s io n a l l y  In th e  t r e a t m e n t  o f 
th y r o to x ic o s is ,  but It has been shown tha t m agnes ium  In fus ions  have no 
cons is ten t In fluence on the periphera l ac t ions of thy ro id  horm one (Wiswell, 
1961).
2.6 Coagulation  of Blood
An In c re a se  In the m a g n e s iu m /c a lc iu m  ra t io  w il l  In c rease  c lo t t in g  t im es  
(Genvllle  & Lehman, 1944) and reduce plate let adhesiveness (Davies el el, 1968; 
H ughes  & T o n k s ,  1965; R ayss lgu le r ,  1986). It has been sug g e s te d  th a t  
m a g n e s iu m  m ay Inc rease  th ro m b o re s is ta n c e  in v a s c u la r  e n d o th e l iu m  by 
Increas ing the  p roduc t ion  of PGI2 (Watson et al, 1986), but there is l i t t le  c l in ica l 
ev idence tha t hypermagnesaemia s ign if ican t ly  a lters coagu la tion . Such reports  
as there are relate to  abnorm alit ies  of coagu la t ion  w ith  hypermagnesaem ia 
c o m p o u n d in g  renal fa i lu re  w here  the a c t io n  of m agnes ium  Is d i f f ic u l t  to  
d e te r m in e  w i th  a n y  p r e c is io n  It seem s s ig n i f i c a n t  th a t  c o a g u la t io n  
a b n o r m a l i t ie s  have no t been repo rte r ,  In o b s te t r ic  p a t ie n ts  t re a te d  w ith  
m a g n e s iu m  In fu s io n s ,  d e s p i te ,  o r  p e rh a p s  b e c a u s e  o f ,  t h e  fa c t  th a t
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d is s e m in a te d  In t rp v a s c u la r  c o a g u lo p a th y  Is f r e q u e n t ly  a s s o c ia te d  w ith  
pre-eclam pcla.
H vpermagnesaem ia has a wide varie ty of ac t ions, many of w h ich  have been 
Im perfec t ly  investigatad (see table 2.1). Several aspects  of the action  of this 
agent are po ten t ia l ly  of great c l in ica l Interest, pa r t icu la r ly  the unique capab il i ty  
of m agnesium  to  Inh ib it the release of ca techo lam ines, the  anti adrenerg ic  
e ffec ts  of the agent, and Its value as a vasod ila to r  and a n t l-anhy th m ic ,  In 
add it ion  to  Its in te rac t ion  w ith neurom uscu lar b lock ing  drugs. If these actions 
cou ld  be con firm ed In c l in ical c ircum stances, then magnesium  would  appear 
to  o ffe r a useful add it ion  to the anaesthetic  arm am entar ium .
Hypermagnesaemia
Table 2.1
Central Nervous System
Cerebral vasodilatation 
Minimal central sedation 
Peripheral Nervous System
Inhibition of transmitter release
Motor end plate - paralysis 
Autonomic Nerve terminals 
Cardiovascular System
Possible myocardial depression 
Possible alterations In electrical conduction 
General and regional vasodilatation 
Moderate hypotension 
Genitourinary System
Relaxes pregnant uterus 
Vasodilates uterine Wood vessels 
Metabolism
Inhibits parathyroid hormone and lowers serum calcium 
May Improve diabetic control 
Coagulation
Mild anticoagulant effect
Table 2.1 Effects of Hypermagnesaemia
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3. Therapeutiv Use of Magnesium
Magnesium has been used as a therapeu tic  agent fo r  centuries. The firs t 
m edic ina l use of th is drug was descr ibed  In Renaissance Ita ly when magnesium 
salts were amployed for the ir  aperient properties. The medic ina l p ropert ies  of 
the  waters of the Epsom Spa were d lscove ied  In 1618 and accounted  In large 
m e a s u re  f o r  th e  p o p u la r i t y  o f  E p s o m  as a r e s o r t .  A c c o r d in g  to  th e  
F.ncyclopedia Br l t tanica  magnesium sulphate was Isolated from Epsom water 
by Grew In 1695 and Sir Hum phrey Davy f irs t Isolated the metal In 1808. In the 
early 19th Century oral a d m ln lc t ra tk  , . *  magnesium ox ide was used to  treat 
patien ts  w ith  urinary ca lcu l i  and by thv .d ie  of that cen tury  It had been shown 
th a t  In t ra v e n o u s  m agnes ium  s u lp h a te  g iven  to  an im a ls  m im ic ke d  cu ra re  
(W scke1’ 1980). With the poss ib le  exception  of the trea lmen* of ur inary  ca lcu li,  
w here  the o b je c t  Is to  Increase  the  u r ina ry  co n te n t  of m a g i . js iu m ,  o ra l ly  
adm in is te red  magnesium Is m ote p roper ly  regarded as a d ie ta ry  supplem ent 
ra ther than as a therapeu tic  agent. This Is because It Is Im possib le  in normal 
c ircum stances  to achieve any s ign if ican t Increase In serum magnesium levels 
by oral adm in is tra t ion  of the agent Uecruse of the rapid renal e l im ination . 
Therefore, a lthough oral adm in is tra t ion  of magnesium salts has been wl ely 
advocated In a variety of cond it ions  In which magnesium de f ic iency  Is l ike ly  to
Magnesium Therapy 35
occur, th is review Is confined to the parentera l adm in is tra t ion  of magnesium 
salts to  achieve de l ibera te  hypermagnesaemla.
3.1 History of Magnesium Therapy
At the beg inn ing  of th is  century, several a ttem pts were made to  use parentera l 
m agnesium sulphate as a therapeu tic  agent. Blake (1906) descr ibed  the effects 
of magnesium sulphate adm in is tered by me In trathecal route. His review noted 
that magnesium sulphate In ject ions i n d u c e d  pro found muscle re laxation In 
most patients w ith  a variab le  sensory block. The unpred ic tab le  nature of the 
b lo c k  leu h im  to d o u b t  tha t  In t ra th e c a l  m agnes ium  In je c t io n s  shou ld  be 
advocated  for anaesthesia but tha p ro longed dura t ion  of effect prom pted  him 
to  use th is  te c h n iq u e  In the  m a n a g e m e n t of te ta n u s .  He a d m in is te re d  
In tra theca l magnesium sulphate to  two patients suffering from  the end stages 
of tetanus. In both cases the In jec tions  produced re lie f of sym ptom s for a 
var iab le  period  of t im e from four to  twelve hours and one patien t made a 
com p le te  recovery. Blake also noted that If enough magnesium sulphate was 
given, and pa r t icu la r ly  If the patient was olaced In a head dow n posit ion, 
p r o fo u n d  lo s s  o f  c o n s c io u s n e s s  c o u ld  be p r o d u c e d  by t h is  ro u te  o f 
adm in is tra t ion . A cco rd ing  to Meltzor (1916), a surgeon - Thedor Kocher - made 
a favourab le  report on the action c? magnesium sulphate In te tanus and Maltzer 
h im self lepo r ted  the use of magnesium sulphate by Intravenous, In tr^sp lna l and
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subcutaneous In jections. He asserted t h f t  "no o the r rem edy Is capab le  of 
re l iev ing the fu r ious  sym ptom s [o f te tanus) to such a sa t is fac to ry  degree i s  do 
the In jec t ions  of magnesium sulphate (Meltzer, 1916). Ho Included In this 
paper a report of one patient who received a to ta l of 131 gms of magnesium 
sulphate paren tera lly  over a seventeen day period w ith  com p le te  recovery. 
Meltzer and Auer reported stud ies on animals and humans If. w h ich  they c la imed 
to  p ro d u c e  a n a e s th e s ia  by In t ra v e n o u s  and s u b c u ta n e o u s  In je c t io n s  of 
magnesium sulphate (Meltzer & Auer, 1905 a & b, 1906 a & b). Reck and 
Meltzer (1916) descr ibed  the perform ance of surgery on several pa tients  In 
whom In travenous magnesium sulphate was tho sole anaesthetic  agent used. 
Meltzer a lso described the use of magnesium sulphate as an an t iconvu lsan t 
when given by In trathecal In jection  (Meltzer & Auer, 1906b). Subsequently, 
th e re  have  bean  seve ra l o th e r  re p o r ts  o f th e  use o f m a g n e s iu m  as an 
an ticonvu lsan t (B lackfan & McKhann, 1931; Moore and W lngo, 1942; W inkler 
et al, 1942). However, th is  use of i ig n e s lu m  has now la rge ly  d isappeared 
except for the use of magnesium sulphate In tho trea tm ent of pre ec lam ptic  
toxaemia, p robab ly  because of the very poor levels of CSF magnesium  that can 
be achieved by Intravenous adm in is tra t ion  (vide supra). It seems most l ikely 
tha t the m a jo r i ty  of the e f fec ts  obse rved  by ea r ly  w o rke rs  were due to  a 
c o m b in a t io n  of p e r iphe ra l n e u rom uscu la r  In h ib i t io n  and ce reb ra l hypox ia  
secondary to  resp ira to ry  Insuffic iency. In the ir review of the effects of excess 
m a g n e s iu m  M o r d e s  a n d  W a c k e r  (1 9 7 8 )  c o m m e n te d  th a t  th e  c e n t r a l  
an ticonvu lsan t ac t iv i ty  fo l low ing  periphera l adm in is tra t ion  of magnesium Is 
unproven.
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3.2 Pre-ecl»m psle and Eclampsia
Probab ly  the most w ide ly  accepted use of m agnesium sulphate has been the 
parentera l adm in is tra t ion  of th is  agent In the management of p re -e r la m p t lc  
toxaem ia. This form  of the rapy  which was f irs t In troduced In the  1920's was 
popu la r ized  by the extensive work of Pritchard  and his co l leagues (Pritchard, 
1955; P r itchard  & Pritchard , 1975. Pritchard et al, 1984). in the United States 
th is  form  of therapy Is now standard p ractice  but Its use is con trovers ia l.  In 
B rita in  It Is w ide ly  assumed that magnesiur as no an t lconvu isan t effect and 
produces pure ly  pe i lphe ra l con tro l of convu ls ions (Crawford 1902), and even 
In centres where the use of magnesium Is accepted there  Is a f ie rce  debate over 
Its m echan ism  of ac tion . S lbal and others  (1984) were unable to  show any 
a l te ra t io n  In p re -c o n vu lsa n t  EEG pa tte rns  In pre e c la m p t ic  pa t ien ts  g iven 
m agnesium  infusions, and questioned the effectiveness of magnesium  as an 
an ticonvu lsan t.  Donaldson (1986) has recently  reviewed the evidence against 
magnesium  exert ing s ign if ican t an ticonvu lsan t ac t ions  and has queried Its value 
In pre-eclam psia. Much of the con troversy su rround ing  the ro le  of magnesium 
In the  m a n a g e m e n t o f pre e c la m p t ic  to x a e m ia  Is d i e  to  the  In c o m p le te  
In fo rm ation  available as to  the pathogenesis of ec lam ptic  convu ls ions  and the 
Influence of magnesium on the disease process. The cerebra l pa tho logy  has 
been a ttr ibu ted , at least In part, to severe cerebra l v a socons tr ic t ion  (Pritchard, 
1980). This theory  neatly  expla ins the p robab le  role of m agnesium  in reversing 
the convu ls ions  as magnesium is known to  be a powerfu l cerebra l vasod ila to r 
(Seellg et al, 1983; Altura & Altura, 1984) and w ou ld  thus antagon ize  the
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reg iona l vasocons tr ic t ion  and Improve cerebra l oxygena tion . On the other 
hand, Dona ldson (1986) a ttr ibu tes  the cerebra l pa tho logy to  endothe lia l Injury 
and vasod ila ta t ion  leading to  local cerebral oedema. The evidence for this 
arises from  post-m ortem  stud ies and Its exact relevance to  the c l in ica l cond it ion  
p r io r  to  a convu ls ion  Is unclear. If however, th is  were the case, magnesium 
w ou ld  be expected to worsen cerebral oedema. There Is no evidence that this 
o ccu rs .  It I f  p oss ib le  tha t the loca l vascu la r  In ju ry  a l lo w s  pene tra t ion  of 
magnesium Into the damaged brain tissue, thus exp la in ing the an t iconvu lsant 
e f fe c t  (B o rg e s  & G tice r,  1978) There  Is c le a r  e v idence  of the  fa i lu re  of 
m agnes ium  to  reduce  b lo o d  p ressure  s ig n i f ic a n t ly .  The s tud ies  tha t are 
availab le  tend to  suggest that the fa ilure of magnesium Infus ions to  produce 
hypotens ion  In pre-eclampsia ,s p r im ari ly  due to  a com pensa to ry  Increase In 
card iac  ou tpu t but th is Is by no meant estab lished No dosv  response curves 
fo r  magnesium Infusions exist and there  If cons iderab le  con trove rsy  over the 
precise ac t ions  of magnesium on the ca rd iovascu la r system (vide supra).
More recently  o ther authors have suggested that magnesium may p lay a role In 
genes is  and m anagem ent of pre ec lam ps ia  by a lte r ing  the p ro d u c t io n  and 
ac t iv i ty  of vasoactive  substances. It has been shown that hypermagnesaemla 
Increases the p roduc t ion  of the vasod ila to r p rostag land in  RGE2 w h ich  may not 
on ly Improve ‘.Issue perfus ion In t i . 's  cond it ion  but may also antagon ize the 
hype rcoag u lab i l i ty  which Is associated with pre eclampsia (Watson et al, V.186). 
Fuentes and Goldkrand (1987) reported a reduct ion  In the levels of ang io tens in
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convert ing  enzyme In pregnant women with p re-ec lam psia  fo l low ing  the use of 
magnesium sulphate. Surpris ing ly , there  are no con tro l led  tr ia ls  com paring  
seda tive /vasod ila to r regimes w ith  the results of magnesium  therapy. The role 
of m agnesium  In the management of th is  po ten t ia l ly  l i fe - th rea ten ing  cond it ion  
there fo re  remains con trovers ia l.
Magnesium possesses to co ly t ic  p ropert ies  which po ten t ia te  the uterine relaxant 
p ropert ies  of the B-adrenergic s t im ulants  (Osa & Ogasawara, 1979), and this 
has re c e n t ly  p ro m p te d  In v e s t ig a t io n  of the  a g e n t  In the  m a nagem e n t of 
p rem ature labour. In it ia l results have been prom is ing  (Miller et al, 1982; Reece 
et al, 1984) pa r t icu la r ly  In v iew of the fact that the use of m agnesium  appears 
to  enhance foeta l w e ll-be ing (Reece et al. 1984) poss ib ly  on the basis of u terine 
vasod ila ta t ion  (Suresh & Nelson, 1987).
3.3 M agnesium and Arrhythmias
In the  las t  few years in te res t  has rev ived In the  th e ra p e u t ic  p o te n t ia l  of 
m agnesium  Infusions and has focused on Its anti a rrhy thm ic  propert ies  and Its 
role as a ca lc ium  antagonist. Magnesium has been used as an an t l-a rrhy thm ic  
agent s ince  the 1930 ’s In pa roxysm a l a tr ia l ta c h y c a rd ia  w ith  v e n tr icu la r  
e x trasyn to les  m agnesium  appeared to have cons ide rab le  benefic ia l e ffec ts
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(B o y d  & S h e r i ,  1943; Szeke ly , 1945; Op t H o f et a l. 1980). The ro le  of 
m a g n e s iu m  In d ig i t a l i s  In to x ic a t io n  Is w e l l  e s ta b l is h e d  and  th e  use of 
m agnesium Infus ions fo r the management of d ig ita l is  assoc ia ted arrhy thm ias  is 
w ide ly  accep ted  (Enselberg et al, 1950; Rude & S inger. 198 i;  Seller, 1971; 
Seller et al, 1970; Szekely & Wynne, 1951; DeCarli et al. 1985; Ne<t et al, 1972). 
As many of these reports  focused on patients w ho were magnesium defic ien t it 
was unclear whether or not the benefic ia l e ffec ts  noted were due to  m agnesium 
and potass ium  rep lacement part icu la r ly  In the  in trace l lu la r  space (Watanabe & 
Dreyfus, 1972; Whang, 1936; Wills, 1986; Sheehan & Seelig, 1984) or w hether 
th is  was a pha rm aco log ica l effect of magnesium itself. Podell (1985) regarded 
the case fo r  magnesium In the pathogenesis  and trea tm ent of a rrhy thm ias  as 
In teresting but unproven. Recently, de l ibe ra te  hyperm agnesaem ia has been 
suggested as being an t l-a rrhy thm lc  In Its own right even in pa tients  who have 
normal serum magnesium levels (Enselberg et al, 1950; Ghani & Rabah, 1977; 
ise r l  et al, 1983 & 1985; Iserl, 1986; Hayward & Zwerllng, 1986; Zwerllng  1987), 
and the mechanisms of action of m agnesium on m yocard ia l e lec trophys io logy  
have been reviewed (D lCarlo et al, 1986; Dyckner & Wester, 1962; Ghanl & 
Rabah, 1977; Shattock et al, 1987). Recent s tud ies have sho.vn tha t In travenous 
m agnesium sulphate Is extremely effective In te rm ina t ing  a rrhy thm ias  of the 
torsades de polntes type  (Topo' & Lerman, 1983; Tz lvon i et al. 1984; Iserl, 
1986). The arrhythm ias associated with m itra l v u ve  pro lapse have also been 
shown to  respond to  magnesium therapy (Frances et al, 1986; Gal,and et al. 
1386). It has also been suggested that magnesium in fus ions may reverse
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v e n t r i c u l a r  f i b r i l l a t i o n  due  to  h y p o th e rm ia ,  or  Inc rease  the  l i k e l i h o o d  of 
successful  dfcf ibrl l lat lon (Buky, 1970).
3.4 Magnesium and Ischaemia
The j  has been muc. i  recent Interest In the role of magnesium as a protect ive 
agent dur ing per iods of myocard ia l  ischaemia.  Harr is et al (1953) showed that 
magnesium ei ther as the sulphate or the chlor ide could suppress vent r icu lar  
ar rhythmias fo l l owing myocard ia l  Infarct ions.  In the mid 1970's It was shown 
that the use of magnesium In card iop leg ia  Infusates had a pro tect ive effect 
dur ing Ischaemic card iac arrest  (Hearse & Humphrey,  1975: Hearse et al, 1975, 
1978, 1981) anu It Is has been demons trated that magnes ium can Inhibit
ca lc ium Influx Into the sarcoplasmic ret iculum (Koomen et al 1983; Bers 1985). 
It was shown tha t  the a d d i t i o n  of l 5 m m o l / l  to  the c a r d io p le g ia  s o lu t i o n  
p re v en ted  po ta ss ium  and m ag nes iu m  ef f lux  f r om  and c a lc iu m  In f lux Into 
Ischaem c cel 's res ' i l tmg In fewer post - ischaemic  ar rhythmias  and Improved 
tens ion development.  DOrlng & co workers  (1976) showed that magnesium- 
as p a r ta te  p ro c a in e  c o m b in a t io n s  p rov ided  bo th  m e ta b o l i c  and s t ruc tu ra l  
protec t ion dur ing Ischaemic arrests. Since then, other  worke rs  have conf i rmed 
the p r o te c t i v e  e f fe c ts  of h y p e rm a g n e s a e m la  In the h y p o x i c  m y o c a r d iu m  
(Shapi ro,  1980; Bersohn et al, 1982; Kyosol  M al, 1985; Yano et al, 1985; Bers, 
1985; Woods & Chapman,  1985), a l though Engelman et al (1978) quest ioned the
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value of low levels of magnesium In the card iop leg ia  Infusate. Ferra ' i  et al 
(1986 )  c o m p a r e d  the  b e n e f i c ia l  e f fec ts  of n i f e d ip in e  w i th  t h o s e  of h igh  
magnes ium/ low ca lc ium infusates and found that the lat ter  of fered s ign i f icant ly  
bet ter pro tec t ion  to the arrested heart. Gal loway et al (1986) .epor ted a case 
In which infus ion of magnesium reversed early Ischaemic con t rac tu re In the 
myocard ium fo l lowing card iopu lmonary  bypass. As a resul t of these repor ts , 
the add i t ion of magnesium to ca rd lop leg lc  solu t ions remains popular ,  and 
Manners & Nielson (1981) noted that the re urn of the per fusate to  the pat ient  
was harmless, and might  offer the advantages of avo id ing hvpomagnesaemia to 
the post -bypass pat ient.
Several fur the. s tudies have shown that pat ients  dy ing  f rom acute  myoca-dla!  
Ischaemic events had a lowered myocard ia l  magnesium (Abraham et al, 1977; 
Chlpper f le ld  & Chlpper f le ld . 1973; DycKner, 1980; Johnson  et al. 1979; Leary 
and Reyes, 1983b; Schroeder,  1960; Shen & Ennlngs. 1972). Magnesium has 
be en  s h o w n  to  be an I m p o r t a n t  r e g u l a t o r  o f  c o r o n a r y  a r t e r y  t o n o  and 
m ag nes iu m  de f i c ie n c y  shown tc  p io d u c e  spasms of the co ro n a ry  ar ter ies 
(Tur lapaty & Al tura.  1980). Acute magnesium de f i c iency reduces myocard ia l  
to lerance  to ischaemia (Borchgrov lnk * t  al. 1987) and magnesium def ic iency 
extends he size of myocard ia l  Infarct ions (Chang et al. 1985). Recent ly,  there 
have been several  studies suggest ing t;-at magnesium Infus ions resul t ing In 
de l iberate hypermagnesaemia may produce an Improved ou tcom e In pat ients 
suf fer ing f rom myocard ia l  Ischaemic events by reduc ing Infarct  size (Weinstein
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et .1. 1986; Mor ton  et al, 1984; Hughes & Tonks.  1965; Rasmussen et al. 1986). 
W o o d w a r d  and  Za ka r la  (1983)  re p o r t e d  th a t  p o t a s s iu m  and m a g n e s iu m  
i n f u s io n s  p r o t e c t e d  rat hear ts  aga in s t  r e p e r f u s io n - i n d u c e d  a r r h y th m ia s  
f o l l o w i n g  c o r o n a r y  a r te ry  l i ga t io n .  C l in ica l  s tu d ie s  have c o n f i r m e d  tha t  
magnesium can reduce the inc idence of ar rhythmias af ter  myocard ia l  Infarct ion 
(Abraham et al. 1987; Pasmussen et al. 1987; Harr is et al. 1953) and fo l low ing  
co ronary  revascular izat ion procedures (Harr is et al,1988). Benef icial  ef fects of 
Infusions of magnesium have also been c laimed In pat ients  wi th angina and with 
per iphera l  vascular  disease (Browne, 1969. 1984). Magnesium thus appears to 
of fer  cons iderab le myocard ia l  protect ion to the Ischaemic heart.
The d l ract  vasodi la tor  ef fect  of magnesium on co ronary  vessels has been used 
In the te rm inat ion and prevent ion of Pr inzmetal 's  var iant  angina (Cohen & 
Kl tzes.  1984, 1986). It has a lso been suggested that  the va so d i la to r  and 
ant icoagulan t  effects of magnesium may have benef icia l  ef fects on f lap survival  
In pat ients  undergo ing microvascular  surgery (Acland,  1972).
Real izat ion that  calc ium may be the f inal common pathway  media t ing hype :ic 
ce l lu lar  In jury  (Schanne et al. 1979) has led to suggest ions that  magnesium 
may be potent ia l l y  benef icial  In the protect ion of var ious other  t issues from 
Ischaemic events. The successful  use of magnesium In resusc i ta t ion of the 
Ischaemic brain was repor ted by Whi te et al (1983) and this repor t was fo l lowed
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by fur the r  evidence of this act ion (Ames & Nesbett ,  1983; Vacant !  & Ames ,1984). 
Keane et al (1988)  have recent ly  shown Im proved  cereb ra l  recovery  f rom 
as ph y x ia t i o n  w i th  enhanced  cerebra l b lood  f l ow  In pos t -asphyx ic  new born  
lamb On the othe r  hand, Ruiz et al (1986) were unable to  demons trate  any 
benef i t  In cerebra l  resusc i tat ion from the use of magnesium or any of several 
o ther  agents.  Magnesium, In var ious concentrat ions,  has been employed  In 
f lush solu t ions for  the preservat ion of human cadaver ic  k idneys,  with a value of 
5 m m o l / l  appea r in g  to o f fer  op t imal  benef i t  (Schwe i tzer  & Sutphen.  1982;
Col l ins  et al, 1984).
Appl icat ion of the concept  of magnesium as a ca lc ium an tagon is t  to skeletal  
musc le has led some Invest igators to s tudy the role of the Ion In mal ignant  
hyperpyrex ia .  Sair et al (1970) reported Improved preserva ' ion of porc ine 
m u s u .d  c r e a t i n e  p h o s p h a t e  d u r i n g  h y p e r p y r e x i a  w h e n  m a g n e s i u m  was 
a d m i n i s t e r e d ,  a n d  s o m e  I m p r o v e m e n t  In s u r v i v a l  w a s  r e p o r t e d  in 
h y p e r p y r e x i a - s u s c e p t i b l e  sw ine f o l l o w i n g  I n t r a v e n o u s  a d m ' n l s t r a t l o n  of 
m agn es ium  su lpha te  (F lewel len & Nelson.  1980) Never the less .  It seems 
unl ike ly  that magnesium wi l l  have a major  role to play In this Intracel lular  
d i sorde r  since It penetrates the Intracel lular  space so poor ly.  Gordon (19Z6) 
noted that magnesium decreased the responsiveness of chronica l ly  denervated 
muscle to acety lchol ine,  and Cl inton et al (1985) made use of this ef fect  to t reat 
gainful  muscle spasms In a parapleg ic pat ient.
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The fact that  ATP exists only as a magnesium chelate has rasul tea in the 
Invest igat ion of the role of a combina t ion  of ATR-Mg In the management  of 
low-pe r fus lon sta.ss Some success In amel iorat ing the ef fects of reper fus ion 
on the k idney (Hlra tawa et al. 1985) and the l iver (Clemens et al, 1985) has been 
repor ted .ecent ly ,  and fur ther work Is needed In this f ield. The ra t ionale for  the 
use of th is combina t ion  In Ischaemia and shock has recent ly  been reviewed
(Chaudry et al, 1986).
Magnesium In com pany  with alkal i  has been repor ted to be of benef i t  In the 
m a n age m e n t  of s ick le  cel l  anaemia In ch i ld ren  (H ugh -Jon e s  et al, 1964), 
probably  on a mul t i fac tor la l  basis Involving the vasodi lator,  ant icoagulant  and 
ca lc ium antagonis t  proper t ies of magnesium.
O
Magnesium, thus, has a wide var iety of app l icat ions and potent ia l  benefi ts,  
some of which remain to be ful ly explored.  Despi te the wel l -known abi l i ty of 
magnesium to Inhibi t the release of catecholamines no at tempt  has been made, 
up ti l l  the present t ime, to use this potent ia l ly  valuable act ion In the cl in ical
sphere.
*
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4. Aims and Scope of this Thesis
Magnesium appears to of fer  many act ions that may be of benef i t  In a var ie ty  of 
c l in ic a l  s i tu a t i ons  w h ich  have not  been p rev ious ly  s tud ied .  0 ,  par t i cu.ar  
interest  in anaesthesia and Intensive care Is the apparent abi l i ty of magnesium 
to antagonise adrenerg lca l ly  mediated responses which may be harmful  to the 
pat ient .  It has been uerm  ns t ra ted  I r  ihe la bo ra to ry  tha t  magnes ium has 
alpha adrenerg ic  receptor  b lock ing proper t ies and in addi t ion  has the unique 
capac i ty  to Inhibi t the release of catecholamines from the adrenal  g land and 
f rom the per ipheral  adrenerg ic  nerve endings.  A l though those proper t ies  of 
magnesium are well es tabl ished they have never been inve ' Igated >n a cl inical  
si tuat ion.  This thesis therefore a i s  to Invest igate the c l inical  potent ia l  of 
magnesium In pat ients In whom catecholamine excess is ant ic ipated and in 
whom such excess may be deleter ious.
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4.1 Animal Studies
Bt fo re  embark ing on cl inica l  studies of the use of magnesium. It appeared 
necessary to  clar i fy and to extend the knowledge of the act ion of magnesium 
on the ca rd iovascula r  system and Its interact ion with catecholamines.
4  1. 1 C a rd iovascu la r E ffects o f M agnesium  In fu s io n s : To study the act ion of a 
wide range of serum concen trat ions of magnesium In a s i tuat ion as 
c lose ly resembl ing the cl inical  env i ronment  as possible,  in fusions of 
magnesium were studied In intact  l ight ly  anaesthet ised and minimal ly 
Inst rumented baboons and a dose response re la t ionships estab l ished 
for  a range of card iovascular  variables.
4  1 2  In te ra c tio n s  o f A d rena lin e  and M agnesium : It seemed necessary t '  nd 
the knowledge regard ing the In teract ion of magnesium wi th adru t - , . c  
agonis ts  to studies in the Intact animal . Using the same model ,  studies 
of the act ion of magnesium In baboons receiv ing high dose adrenal ine 
Infusions were conducted.  The animal  exper imenta t ion was completed 
bv com par ing  the ant i -edrenerg ic  act ions of magnesium with those of 
s tandard alpha-  and beta adrenerg ic  receptor  b lock ing  agents and by 
invest igat ing the in teract ion of magnesium wi th  these agents.
4.2 Clin ical Studies
D es p i te  the  w ide  ran g e  of  c l i n i c a l  c i r c u m s t a n c e s  In w h i c h  In fu s io n s  of 
magnesium salts have been employed,  there have been no In vivo  studies of the
I n te rac t i on  of magnesium wi th ra te c h o la m ln e s  In pa t ien ts  w i th  adrenerg ic  
excess.
4.2 ? E ndo trach ea l In tuoa tlo n : In the c l inical  set t ing the commones t  s i tuat ion
In wh ich surges of catecholamine release occur  Is dur ing la ryngoscopy  
and the Insert ion of an endotracheal  tube. The potent ial  harm to pat ients 
as a resul t of these ad 'one rg lc  surges Is cons iderab le and the role of 
magnesium In prevem'ng the rei ase of catecholamines In response to 
th is stress s t imulus wa i  invest igated.
4.2.2 Tetanus: Catecholamine excess Is a com mon prob lem In the management
o f  v e ry  severe  te tanu s .  The a b l l ' t y  of  m a g n e s iu m  to  c o n t r o l  the 
c a r d l o v a s c u 'e r  c o n s e q u e n c e s  of  c a te c h o la m in e  excess  d u r ing  the 
management  of 10 pat ients with very severe te tanus was Invest igated.  A 
later  case presented the oppor tun i ty  for  study of the ef fect  of magnesium 
Infusions on c i i techolamlne levels In a pat ient wi th this condi t ion.
4.2.3 P h a e o c h ro m o c y to m a : In the  a n a e s t h e t i c  m a n a g e m e n t  of  p a t i e n t s  
u n d e r g o i n g  s u rg e ry  fo r  the rem ova l  of p h a e o c h r o m o c y t o m a s ,  the 
prevent ion of ;he release of excess catecholamines and the con t .o l  of 
card iovascular  d is turbances that Inevi tably occur  present  one of the 
greatest  chal lenges In modern anaesthesia. The f inal sect ion of this 
thes is  therefore Included an Invest igat ion of the value of magnesium 
Infus ions in the Inhibi t ion of catecholamine le lease and the ob tundmg of 
the card iovascula r  consequences of adrenerg ic  excess where release of 
these agents was not preventable.
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5. Cardiovascular Effects of Magnesium
Despi te the wide range of cl inical  cond i t ions  In which magnesium has been 
used, the mechan ism of ac t ion  of the agent  remains con t r ove rs ia l  la rge ly  
because  of d i s c re p a n c ie s  be tween  l a b o r a t o r y  data and observ ed  c l in ica l  
effects. Magnesium has wel l  establ ished vasodi la tor  ef fects In v itro  and in  vivo  
(Al tura & Al tura, 1981a), but the hypotens ive ef fects appear  to be t rans i tory  
(K.rpekar & Misu, 1967; Wink ler  et a l , 1942), and myocardia l  depress ion may be 
requi red for  the maintenance of magnesium Induced hypotens ion (Mordes & 
Wacker , 1978). A l though magnesium has been shown to inhibi t  con t ract i le  
force In Isolated, perfused hearts and In cardiac muscle str ips (Kovacs & 
O'Donnel l ,  1975; Levin et al, 1976; Paddle & Haugaard,  1971; Shine & Douglas,  
1974) .  s tu d ies  In In tact  an im a ls  and humans have been less c o n c lu s i v e ,  
negat ive Ino t rop ic  effects being demonstrated In some studies (Cot ton et al, 
1984; Dandavlno et al, 1977; Maxwel l  et al, 1965; Mroczek et al, 1977), but not 
in o thers  (Aldrete et al, 1968; Crl tel l l  et al. 1977; Mori ,  1978; Szekely, 1946; 
Al tura & Al tura, 1985 a & b; Fr iedma’ i et al, 1987).
There have been surpr is ing ly  few deta i led studies of the ef fects of magnesium 
on card iovascula r  func t ion in intact animals ,  and d o s , - re s p o n s e  re la t ionships 
have not been well desc r ibed .  This s tudy  was under taken in orde r  to def ine 
more accurate ly  the ef fects of a wide range of serum magnesium concen t ra t i ons  
on the card iovascula r  system. In order  to approx imate as c lose ly  as possib le 
to the c l in ica l  s i tuat ion, l ight ly  anaesthet ized,  intact and min imal ly  Inst rumented 
baboons  were chosen as the exper imenta l  model.
5.1 METHODS
Seven adul t  male chacma baboons  were studied wi th the approval  of the animal  
exper imentat ion ethics commit tee  The animals were in i t ial ly sedated wi th 
ketamine 10 mg/kg l .m. and then t ransfer red to a heated operat ing  table. 
Anaes th es ia  was Induced  w i th  t h i o p e n to n e  4 m g /k g  i .v. .  and the t rachea  
in tubated under muscle re laxat ion Induced with suxamethon ium 1 mg/kg. The 
lungs were vent i lated wi th 25% oxygen  in ni trous oxide. End expi red carbon  
d iox ide was moni tored us ing a Datex CD300 infra-red capnog raph  wi th n i t rous 
ox ide compensat ion,  and minute ven t i la t ion ad justed tc keep the CO:  w i th in  a 
range of 32-36 mmHg The capnog raph  was ca l ibrated against  a mix ture of 
o x y g e n  and c a rb o n  d i o x i d e  c o n t a i n i n g  a kno w n  par t ia l  p re s s u re  of COz 
(approx imate ly  40mmHg),  pr ior  to each exper iment .  The use of a known part ial  
pressure rather than pe rcentage of C O :  to ca l ibrate the capnog ra ph  prevents
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errors  In measurement  due to a l terat ions in barometr ic  pressure,  and is the 
most  accura te way to use this Instrument at a l t i tude (James & Whi te.  1984). 
B lood gas analysis was not  avai lable for  animal  samples In Z imbabwe at this 
t ime,  as fac i l i t ies  were l imi ted and rest r icted to human spec imens  only.  Urine 
was co l lec ted by b ladder express ion,  and plasmalyte B infused to replace 
excreted vo lume so as to maintain  f luid balance. E lec t rocard iog raph ic  leads 
were at tached to each l imb, and lead II moni tored th roughout  the exper iment .
A 21 gauge cannula was inset ed into the femoral  artery,  and an Edwards  
7-f rench gauge t r ip le- lumen the rmod i lu t ion pu lmonary  ar tery cathe ter  (Edwards 
9 3 A - 1 31-7F) Inserted via the femoral  vein into the p j lm o n a r y  artery.  All l ines 
were placed by percu taneous  push- in  In order  to leave minimal residual pain 
f rom catheter  Insert ion si tes dur ing the exper imenta l  per iod and fo l low ing  the 
exper iment  as these were survival  exper iments.  Systemic arter ial ,  pu lmonary  
arter ial ,  and central  venous pressures pressures were moni tored us ing Hewlet t  
Packard strain gauge t ransducers (HP 1280C), pressure module (HP 8805D). A 
con t inuous wr i t ten record was made ol the t ransducer  output  and of the EGG 
on a Hewlett  Packard 4 channel  pen recorder  (HP 7754A) at a char t  speed of 
25mm/sec  The t ransducers were e lec t ron ica l ly  zeroed using the zero fac i l i ty  
bui l t  Into the equipment,  and the ca l ibrat ion of the t ransducers was checked 
a g a i n s t  a m e r c u r y  c o l u m n  p r i o r  to  and a f t e r  each  e x p e r i m e n t .  C o r e  
temperatu res were mon i tored  th roughou t  using the the rmis tor  probe  on the 
p u l m o n a r y  a r te r y  c a th e t e r .  P u lm o n a r y  c a p i l l a r y  w e d g e  p r e s s u r e s  w e re  
measured Intermi t tent ly.  Muscular  re laxat ion was maintained with a lc u ron ium 
0.3 mg/kg.  Utable condi t ions  such that heart rate, arterial  b lood pressure and
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card iac ou tput  remained within a range of 10% on ei ther  side of preced ing  
readings were maintained for  1h before any record ings were taken.
Basel ine record ings  of hear t rate, pu lm onary  and systemic ar ter ia l  pressures, 
cent ra l  venous  pressure ,  pu lm onary  cap i l la ry  wedge  pressure  and card iac  
output  were then made. Cardiac ou tput  (CO) was est imated by the rmod i lu t ion 
(see Append ix  A) using 5 ml of co 'd  5% dextrose using a Hewlet t  Packard 
ca rd iac  ou tpu t  c o m p u te r  (HP 78231C). Systemic and pu lm o na ry  vascular  
resistances, s t roke vo lume  and s t roke work were ca lcu la ted Ar ter ial  b lood 
samples for  serum calc ium and magnesium levels were taken,  and the samples 
analysed by the methods detai led in appendix  A. The f i rst baboon was used to 
val idate the methods used and to ensure that stable exper imenta l  c o » d l t ’ , n s  
could oe maintained and that  app ropr ia te  card iovascular  measurements could 
be achieved .  In the rem a in ing  six an imals ,  a lo ad ing  dose  of 60 mg/kg  
magnesium sulphate (MgSOO as a 50% solut ion In water  was admin is tered over 
one minute and all the measurements repeated. A con t inuous  infus ion of 50% 
MgS04 w as  c o m m e n c e d  at a ra te  o f  12.5 m g / m M  and  c o n t i n u e d  un t i l  
card iovascula r  stabi l i ty,  judged by var ia t ion in success ive measurements of 
less than 10%, had been maintained for  at least 5 mi All measurements were 
again repeated. The infus ion rate was increased to 25 mg/m in  and then by 25 
m g /m in  i n c r e m e n t s  up to  a m a x im u m  of 200 m g /m m ,  w i th  r e p e t i t i o n  of 
measurements at each Infusion rate once card iovascular  s tab i l i ty  had been 
achieved. Ai.y ECG abnormal i t ies  vere noted. At the end of each exper iment ,  
no i i rnmuscula r  reversal  v as per formed using neost igmine and at rop ine  and
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adeq u a te  reversa l  c h e c k e d  us ing a nerve s t im u la to r  be fo re  re tu rn in g  the 
animals to the animal  house. Calcium was added if necessary This lat ter  
p recau t ion was necessary as two fatal i t ies had occured In earl ier exper imen ts  
as a resul t of inadequate recovery f rom neuromuscu lar  b lockade  fo l low ing 
wi thdrawal  of vent i la tory  suppor t .
Data f rom al l  6 b a b o o n s  was poo led  fo r  each va r ia b le  and rank o rde re d  
accord ing  to the serum magnesium. The data for  each var iable was then d iv ided 
in t o  g r o u p s  as f o l l o w s :  g r o u p  1 In c lu d e d  al l  da ta  c o l l e c t e d  at a se rum  
magnesium of 1 mmol / l  or less. Subsequent  groups represented data co l lec ted  
within a g roup width of 1 mmol / l  above the previous group.  The Individual  
groups were then analyzed by analysis of var iance for d i f ferences f rom basel ine 
values and f rom  o ther  groups.  Where ana lys is  of va r iance  Ind icated  that  
s i g n i f i c a n t  d i f f e r e n c e s  ex is ted  b e tw een  g ro u p s ,  tne g r o u p s  w h ic h  were  
s ig n i f i c a n t l y  d i f f e ren t  at the 5% level  were  de te rm in ed  using the Duncan  
mul t ip le- range  procedure.
U s in g  u n g r o u p e d  p o o l e d  d a ta ,  c a r d i o v a s c u l a r  p a r a m e t e r s  and  s e r u m  
m a g n e s iu m  leve ls  were ana ly zed  for  a s s o c ia t i o n  by re g re s s io n  ana lys is .  
Final ly, data obta ined wi th serum magnesium levels between 1 and 5 mmoi / l  
w e re  c o m p a r e d  w i t h  b a s e l i n e  va lu es  and  w i th  da ta  o b t a i n e d  at s e r u m  
m a g n e s iu m  leve ls  g re a te r  than  5 m m o l / l  us ing  S tu d e n t  s t - te s t  w i th  the 
Bonferron l  modi f i ca t ion  for mul t iple compar isons.  S ign i f icance was def ined as 
p < 0  05. Data analysis was per formed using the Stat ist ical  Package for Social  
Sc iences (SPSS) stat ist ical  package on a mainf rame computer .
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5.2 RESULTS
Sat is factory  anaesthes ia was establ ished readi ly,  and no addi t ional  doses of 
musc le re laxants were necessary after the one hour  s tabi l izat ion per iod. As no 
painful  procedures  were per formed dur ing the exper imenta l  per iod,  the l ight 
leve ls  of an aes th es ia  used appea re d  adequa te  at al l  t imes.  Resul ts  are 
presented as means ,±_ 1 Standard er ror  of the mear  (SEM).
5.2 1 Serum M agnesium : The mean basel ine serum magnesium was 0.617 _±_
0.015 mmol / l  Bolus inject ion always produced  h igher  serum magnesium 
levels than subsequent  Infusions of less than 50 mg/min (3 g/h). The 
max imum serum magnesium lavel at ta ined was 9.4 mmol / l  and values 
greater  than 8 mmol / l  were achieved on only three occas ions.  Values of 
greater  than 7 mmol / l  were therefore grouped toge ther  g iv ing eight 
groups cover ing a range of serum magnesium f rom <1 to 7 +  mmol/ l .  
The number  of data points obtained In oach group  Is shown In table 1.
Table 5.1
Group SeMg Number
1 < 1 9
2 1-2 13
3 2-3 12
4 3-4 10
5 4-5 3
6 5-6 6
7 6-7 7
8 7 + 6
Table 5.1. Data groups determined by serum magnesium levels 
SeMg - serum magnesium In mmol / l
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5.2.2 Serum C a lc ium : Serum calcium was unchanged throughout .
5.2.3 A rte ria l B lo o d  P ressure. A scat tergram plot  of systol ic  b lood pressure 
changes against serum magnesium levels showed a moderate negat ive 
cor re la t i on (r = -0 555). and is s igni f icant  s lope to the l ine f i t ted to the 
data points ( p < 0.001, Ftgufc? ii.l)
SBP (mmHg)
y = -8.11x - 2.81
-20
-40
-60
-80
r = -0.44
p < 0 001-100
-120
Serum Magnesium (mmol/I)
Figure 5 .1 Scattergram of changes in systolic blood pressure against serum magnesium levels
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In the grouped  data analysis, the only g roup of those wi th serum magnesium 
mmol / l  to show a s igni f icant  reduct ion In SBP vras the 2-3 mmol / l  group (-20.1 
±_ 7 . 3  mmHg,  p<0 .0 5 ) .  The mean reduct ion  In SBP for all the gro' -ps wi th 
serum magnesium levels below 5 mmol / l  was 15.6 Jt. 3.5 ( p < 0  01). At higher  
serum magnesium levels SBP fell to 47.8 _±_ 12.8 mmHg below basel ine values 
In the 5-6 mmol / l  group (p<0 .0 5 ) ,  and decl ined s teadi ly to  a mean value of 60.2 
m mHg below basel ine In the 7 +  mmol / l  group ( p < 0 .0 5 ) .  These changes 
ere summar ized In f igure 5.3. There was a smal l  but s ign i f icant  reduct ion in 
systol ic pressure In the group wi th serum magnesium levels < 5 m m o l / l  of 15.67 
mmHg ( p < 0.01). The mean reduct ion In SBP f rom basel ine at serum magnesium 
levels of > 5  mmol / l  was 54.23 z L ?  46 mmHg which was s ign i f icant ly  d t ' - e re i t  
f rom the reduct ion  obtained In the -  5:nmol / l  group (p < 0.001).
D ia s to l i c  a r te r ia l  p ressu re  (DBP) c o r re la te d  wel l  w i t h  ch a n g e s  In serum 
magnesium levels (r = -0.72, p <  0.001). but the changes were smal l  (Figure 5.2). 
and In the grouped data only reached s ign i f icance at levels of serum magnesium 
greater  than 5 mmol / l  (Figure 5.3). In the 5 6 mmol / l  group,  the mean decrease 
in DBP was 27.4 ± . 5 . 4  mmHg and In the 7 +  mmol/ l  group  was 44.5 _±_ 11.5 
mmHg ( p < 0  05). The me^n reduct ion In d iastol ic  b lood  pressure wi th serum 
magnes ium  levels < 5 m m o l / l  was 4.09 ± . 3 . 5 8  m m H g wh ich  d id  not  reach 
s tat ist ical  s igni f icance. There was a h igh ly  s ign i f icant  reduct ion In d iasto l ic 
p re s s u re  at se rum m a g n e s iu m  leve ls  > 5 m m o l / l  of  54.23 ± . 7 . 4 6  m m H g  
( j < 0.001) and this group  was s ign i f icant ly  di f ferent f rom the < 5m m o l / l  group
( p < 0  0001).
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-20
40 r = -0.72
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Figure 5.2 Scattergram oi c. ing«s in diastolic blood pressure against serum magnesium
BP
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&
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Figure 5.3 Systolic and Diastolic Blood Pressure and .«*rt Rate for grouped data 
•  - p < 0.05
Cardiovascular Efleets 58
5.2.4 H eart Rate: Chang R c o r r e c t e d  poor ly  wi th magnesium leve ls  on
the  sca t te rg ram  p lo t  ( r -  0 .391) ,  a l th o u g h  a l ine wi th  a s i g n i f i c a n t  
negat ive s lope could  be f i t ted to the data poin ts ( p < 0 .0 1 .  F igure 5.4).  In 
the grouped data (F igure b . i ) ,  the only s igni f icant  change at magnes ium 
levels of mrro l / l  was a smal l  dec l ine  In HR of 9.8 ± . 2 . 7  bpm ( p < 0 .0 5 )  
In the 1-2 mmol / l  g roup  (Figure 5.3).  In the 5-6 mmol/ t  group,  HR fell 
sha rp ly  to 23.5 jfc_ 7.1 bpm b e low  basel ine ( p < 0 . 0 5 ) ,  and d e c l i ned  
s l ight ly  thereafter.  The overal l  change  In HR for magnesium levels  of 
<5 m m o l / l  was -9.8 ± . 1 . 9  bpm (p < 0 .0 1 ) .  whereas for  the h igher  group  
the mean was -24.5 j ^ 4 . 6  bpm (p < 0 .0 1 ) .  The di f ference between  these 
tw o  groups was h igh ly  s ign i f icant  ( p <0.001).
40
20
0
-20
-40
-60
0 2 4 6 8 10
Serum Magnesium (mmol/l)
Figure 5.4 Scattergram of changes in heart rate against serum magnesium levels
5 .2 .5  R hythm  and  C o n d u c t io n :  A r r h y th m ia s  were unc o m m o n .  At se rum 
m a g n e s iu m  lev e ls  a b o v e  6.5 m m o l / l .  t h i e e  a n im a ls  s h o w e d  br l .U
HR (beats/min)
y *  -2.87x - 3.48
+ ++ +++ + +
+
r -  -0.391 ' +  -+- +
p < 0.01
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episodes of nodal  rhythm, always of less than 30 seconds durat ion,  
which reso'vod snrmtaneously as the exper iment  proceeded,  despi te  
Increasing s e t "  n magnesium levels. PR Intervals were not s ign i f icant ly  
al tered at any t ime except  tor  the per iods of nodal  rhythm. QTc Intervals 
and QRS complexes were not al tered at any stage, and there was no 
evidence of in t ravent r lcu lar  conduct ion defects
5.2 6 System ic Vascular H es is tanca : There was a s teady dec l ine In SVR 
which  corre lated well wi th serum magnesium levels (r = -0 67. pc U .001)  
on the  s c a t t e r g r a m  p lo t  (F igu re  5.5) .  The r e d u c t i o n  In SVR was 
s ign i f icant  In all groups wi th magnesium levels above 1 mmol/ l .  In the 
ove ra l l  g r o u p  wi th  a se rum m agn es ium  va lue < 5 m m o l / l  the mean 
reduct ion  In SVR was 357 49 dyne.sec .cm"5 (pcO.001) .  The reduct ion
In SVR In the >5m m ol / l  group  was also highly s tat is t ica l ly s igni f icant and 
the mean value In this group  was 1008.51 _±_ 152.36 dyne .sec .cm"5 below 
b a s e l i n e  ( p < 0  001) .  The d i f f e r e n c e  b e tw e e n  th e s e  g r o u p s  was 
s igni f icant at the 0 031 level.
y -  -153.4x + "7R
•500 -
1000
1500 r -  -0.671 
p < 0 001
2000
6 8 10420
Serum Magnesium (mmol/l)
Figum 5.5 Scattergram of systemic vascular resistance against serum magnesium levels
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5,2.7 Ca rd iac Output :  There was no co r re la t i on  ( r » - 0 .1 6 0 ,  n.s.)  between 
card iac output  and serum magnesium levels on the scat tergram plot 
(Figure 5.6). When the grouped data was cons idered (Figure 5.7), the 
change In CO was seen to be blphaslc with CO s ign i f icant ly  Increasing 
at all levels of serum magnesium between 1 nr mol / l  and 5 mmol / l ,  the 
mean Increase for  the group being 286.5 _±_60 rnl/min ( p < 0.001) Above 
5 mmol/ l ,  CO returned towards the basel ine, and the mean change in the 
5m m o l / l  g rou p  was a decrease of 38 149 m l /m ln  w h ic h  was not
s i g n i f i c a n t l y  d i f f e r e n t  f rom  base l ine .  The d i f f e r e n c e  b e tw ee n  the 
< 5 m m o l / i  and th e  > 5 m m o l / l  g r o u p  was  s t a t i s t i c a l l y  s i g n i f i c a n t  
(p <0 .05) .
CC (li^es/min)
r -  -0 .160
y -  -0 04x + 0.34
n.s.
05
+ +
-0.5
1086420
Serum Magnesium (mmol/i)
Figure S.S Scattergram of changes in cardiac output against serum magnesium levels
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Figure 5.7 Cardiac Output v. Serum Magnesium for grouped data.
* - p <0.05
5.2.8 S troke  Volume: A l though there was a s igni f icant  slope to the regression 
l i n e  f o r  s t r o k e  v o lu m e  a g a in s t  se rum  m a g n e s i u m  (p < 0 .01 ) ,  the  
co rre la t ion was poor  ( r - 0 . 2 5 6 ,  Figure 5.8). Sl ight ly bet ter  corre lat ion 
could  bo demonstrated between SV and serum magnesium values below 
5mmol / l  (r = 0.367, pcO .O 1). Changes In SV for  the grouped data are 
shown In Figure 5.9 SV was elevated above basel ine at all levels of 
Increased magnesium. There was a 15% Increase above basel ine In the 
1-2 m m o l / l  g ro u p  (5.28 _±_ 1 1 3  m l /b ea t ,  p <  0.05)  w h i c h  rose to  a 
max imum of 34.6% above basel ine (11.0 d_2 .6 ml /beat) in the 6-7 mmol / l  
g roup ( p < 0.05).
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r = 0.256
p < 0.01
y = 0.80x + 3.85
-10
Serum Magnesium (mmol/l)
Figure 5.8 Scattergram of changes in stroke volume against serum magnesium levels.
Stroke
Volume
Serum Magnesium
Figure 5.9 Stroke Volume v. Serum Magnesium for grouped data 
* - 0.05
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Figure 5.10 Scattergram of changes in stroke work against serum magnesium levels.
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Figure 5.11 Stroke Work v. Serum Magnesium for grouped data. 
* - p <0.05
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5.2.9 S troke  Work . A l though  there was a s ign i f icant  nega t ive co r r lea t ion  
between serum magnesium concent rat ions and SW (Figure 5.10), the 
r e s p o n s e  was  b ip h a s i c .  SW In c re a s e d  in al l  g r o u p s  w i th  se rum  
magnesium values of less than 5 mmol / l  (Figure 5.11), g iv ing a mean 
increase f rom basel ine of 4.1 ±_ 1.2 gm.m/beat  In the < 5  mmol/ l  group 
( p <0.001) .  In all groups wi th magnesium levels above 5 mmol / l ,  SW fell 
s ign i f icant ly  below basel ine ( p < 0  001), the overal l  change in this group 
being -10.2 ± .  1.9 gm.m/beat
5.2.10 Pulm onary A rte ria l P ressure : PAP was not s igni f icant ly  al tered at any 
s tage of the exper iment  and there was no corre la t ion between PAP and 
serum magnesium levels.
5.2.11 Pulm onary Vascular R esis tance : PVR did not change s ign i f ican t ly  dur ing 
the exper iment .
5.2 .12  P u lm o n a ry  C a p illa ry  W edge P re s s u re : The re  we re  no s i g n i f i c a n t  
changes In PCWP demonstrab le  in the grouped data analysis,  and on the 
scat te ig ram there was no corre la t ion between changes In PCWP and 
serum magnesium levels.
5.2.13 C entra l Venous P ressure : CVP also showed a b iphas ic  response,  but 
the changes  were ex t reme ly  smal l  (F igure 5.12). There was a weak 
p o s i t i v e  c o  r e l a t i o n  b e t w e e n  s e r u m  m a g n e s i u m  l e v e l s  and CVP 
(r = 0.338, p < 0 .0 1 )  but In the grouped  data, no single data poin t was 
s ign i f i can t l y  d i f fe ren t  f rom basel ine The only de tectab le  s ign i f icant  
change was a small  decrease in the < 5  mmol / l  group  (-0.97 ±_ 0.287 
mmHg),  and a small  Increase in the > 5  mmol / l  g roup (1.23 ±_ 0.65 
m m H g ) .  The g r o u p s  were  s i g n i f i c a n t l y  d i f f e r e n t  f r o m  each  o the r  
( p < 0.01) but not f rom basel ine.
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Figure 5 12 Scattergram of changes in central venous pressure against serum magnesium levels
5.2.14 Bolus In ject ion:  Fol lowing bolus Inject ion, two of the animals reached 
serum magnesium levels In the 1-2 mmol/ l  range, two In the 2-3 mmol/ l  
range and two In the 3-4 mmol / l  range. All of the resul ts produced by 
bolus In ject ion were wi thin  one s tandard dev ia t ion of the mean of the 
appropr ia te  group.
6.3 DISCUSSION
The dose  re la ted redu t  sy s tem ic  vascu la r  res is tance  shown In the
present  s t u j y  conf i rms the vasodi la tor  proper t ies  of magnesium prev ious ly  
demonstra ted  in a variety  of t issues In var ious species (Altura & Al tura, 1981 a, 
b & c; Al tura & Altura. 1978 a 4 b; Tur lapaty  4 Altura, 1978; Tur lapaty  et a:
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1980), and also In Intact animals and humans (Haddy, 1960; Haury,  1939; 
Overbeck el al, 1969). This ef fect  Is due to the d i rect  act ion on vascular  smooth 
muscle (Al tura & Altura, 1981b; Al tura & Altura, 1984c), to Inter ference wi th the 
act ion of var ious vasoconst r i c tor  agents (Altura & Altura, 1981 b & c; Al tura & 
Al tura,  1977; Lev in et al, 1976; Tur lapa ty  & Al tura,  1980), and poss ib ly  
b lockade of sympathet ic  gangl ia (Mutter & Kostial,  1954; Stanbury.  1948). The 
hypotens ive ef fect  of magnesium has been ascr ibed to a comb ina t ion  of all of 
these ef fects (Engbaek, 1952). The absence of effect on venous pressure 
suggests  that the major  role of magnesium In Intact animals Is on resistance 
r a t h e r  t h a n  c a p a c i t a n c e  v e s s e l s ,  a l t h o u g h  s o m e  r e c e n t  w o r k  on the 
mic roc i r cu la t ion  quest ions this not ion (Altura & Altura, 1985b).
In the face of this clear-cut  evidence of the vasodi la tor  act ion of magnesium, 
the con f l ic t ing  evidence regarding hypermagnesaemlc hypo tens ion  requires 
explanat ion. A l though a hypotensive response to acute hypermagnesaemla has 
been wel l  descr ibed  both In animals and humans (Alfrey et al, 1970; Al tura & 
Altura, 1985a; Blackfan & Hami lton,  1925; Hoff et al, 1939; Mat thews & Brooks, 
1910; Mel tzer & Auer, 1906b; Moore & Wir.go, 1942; Mordes  et al, 1975; 
Mroczek et al. 1977; Pr i tchard et al, 1984; Randall  et al, 1959; Scott  et al, 1968; 
Young & Weinstein,  1977), the effect appears to be Incons istent.  In humans, 
s o m e  a u t h o r s  have r e p o r t e d  l i t t l e  c a r d i o v a s c u l a r  e f f e c t  at h ig h  se rum 
magnesium levels (Flowers et al, 1962; Kelly et al, 1960), whi lst  o thers  have 
found marked but t ransient  hypotens ion (Mroczek et al, 1977). In animals,  both
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t r a n s i e n t  ( D a n d a v in o  et al .  1977) and s u s t a in e d  ( M c C u b b i n  et al. 1981)  
hyp o ten s io n  has been repor ted .  H ypo tens io n  Is not cons is te n t l y  p ro d u c e d  by 
magnes ium  in the management  of p regn an c y - in d uc ed  hyper tens ion  (F lowers  et 
al, 1962; Pr i tchard et al, 1984; Pr i t chard & Pr i tchard ,  1975), and c onsequen t ly ,  
m agnes ium  has been d esc r ibed  as a poor  vasod i la to r  (Scot t  et al, 1968). Part 
of the e x p la n a t i o n  fo r  t h i s  i n c o n s i s t e n t  h y p o t e n s i o n  may l ie in the rap id  
c lea rance  of magnesium f ro m  the p lasma. This s tudy i l lus t ra tes the d i f f ic u l t i es  
of ma in ta in ing  high serum m agnes ium levels in the presence  of normal  renal 
func t ion  as even massive In fus ion rates p rod uced  a max im um serum magnes ium 
level of on ly  9.4 mmol/ l  In th is  s tudy, as in o thers  (Maxwel l  et al, 1965; 
Mroczek  et al. 1977), the fall  In b lood pressure co rre la ted  m odera te ly  with 
changes  In serum magnes ium. As many of the papers desc r i b ing  the t rans i t o ry  
nypo tens lve  effect of m agnes ium  d id  not inc lude  serum magnes ium es t imat ions ,  
and inadequa te  serum m a gne s iu m  levels are co m m o n  in obs te t r i c  pat ients  
(Herber t  et al. 1968; Sibai  et al, 1981), p roba b ly  due to under ly ing magnes ium 
d e f i c i e n c y  (C ade l l  et a l .  1975) ,  I n a d e q u a t e  m a g n e s i u m  l e v e l s  m u s t  be 
c ons id e red  as part of the explana t ion of th is phenomenon  The f requen t l y  
repeated observat ion that  a bolus of MgSCU produces  a greater  ef fect  than does 
a c o n t inuo u s  infusion may also ref lect  po o r l y  ma in ta ined  magnes ium levels 
There was no ind icat ion in the present  s tudy  that  the magnes ium levels ob ta ined 
fo l low ing  the loading dose  p roduced  a d i f fe rent  e f fect  to that of s imi la i  serum 
magnes ium levels mainta ined by cons tant  in fusion.
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However ,  p o o r l y  ma in ta ined  m agnes ium  leve ls  ca nno t  p rov id e  a c o m p le te  
answer  to the prob lem of magnes ium- induced  hypo tens ion ,  ana the ef fects  of 
magnesium on CO must  a lso play a part. The present  s tudy  has shown that 
a l though there was a s ign i f i can t  reduc t ion  in svs tem lc  vascular  resis tance,  
relat ive ly l i t t le hypo tens ion  was produced  by levels of serum magnesium below 
5 m m o l / l ,  a f i n d in g  in a g r e e m e n t  w i t h  o ther  s tu d ie s  (Cohen  et al,  1984; 
Dandavlno et al ,1977; Mroczek  et al, 1977). This can on ly  be explained by a 
concomi tan t  increase in CO which large ly  compensa te d  for  the fall in SVR. In 
the present study,  s ign i f i can t  fal ls In b lood  pressure on ly occur red  once CO had 
returned to nuar-basel ine values. Magnesium a d m i m s . r a t l m  has been uhown 
to increase CO and s t roke vo lume (Mroczek et al, 1E77; Stanbury & Farah, 
1950), but an increase In SW has not been d e m o n s t ra te "  before.  In the present  
s tudy ,  SW in c reased  up to  leve ls  of se rum m a g n e s iu m  v ‘ 5 m m o l / l .  Tl . is 
Inc reased  SW, a long  w i th  an increased : 0  sugges-s im proved  m yoca rd ia l  
cont ract i l i ty .
M agn es ium  is ge ne ra l l y  r ega rded  as hav ing a nega t i ve  in o t ro p ic  ac t i on .  
Magnesium Inhibi ts the c on t r ac t i le  force of Isolated heart musc le  (Langer , 1968; 
Shine & Douglas ,  1974; S o la ro  & Shiner ,  1975; S t a n b u ry  & Farah,  1950). 
a l though the ef fect is smal l  as long as the ca lc ium levels remain wi .n in  normal  
l imi ts  (Kovacs & O 'Donnel l ,  1975; Levin et al, 1976; Shine, 1979). A reduc t ion 
In m y o c a rd ia l  p e r f o r m a n c e  In hum ans  has been  c la im e d  in some s tud ies  
(A ldrete et al, 1968; Cr i te l l i  et al, 1977; Mor i.  1978), but  the increased CO
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d e m o n s t r a t e d  In o th e rs  ( M r o c z e k  et al,  1977) a rg u e s  a ga in s t  s i g n i f i c a n t  
m yocard ia l  depression. In the present  s tudy,  there was no c lear  ev idence that 
even high levels of serum magnesium exer ted a s ign i f icant  negat ive in o t rop ic  
ef fect .  A l though  CVP was s ign i f ican t l y  h igher  at levels of serum magnes ium 
above 5 mmol / l  when compared  to the lower  magnesium group,  this d i f ference  
was smal l (1.26 _±_ 0.65 mmHg) and PCWP was unaf ected.  The return of CO to 
basel ine levels In the h igher  range of serum magnesium was the resul t  of a 
reduc t ion  of HR alone as SV was a lways above basel ine values,  "ihe reduc t ion  
in SW at h igher  magnesium levels may be const rued  as ind icat ing impai red 
c o n t r a c t i l i t y ,  but, s ince  s t roke  v o lu m e  was not reduced ,  th is  re d u c t io n  is 
ent i re ly accounted for by changes in mean arter ial  and wedge  pressures (see 
equat ion in Appendix  A). As ar ter ial  pressure Is the p roduc t  of per iphera l  
res is tance and cardiac output ,  and ca rd iac  output  was not s ign i f icant ly  d i f feren t  
f rom basel ine at the h igher  magnesium levels, It must be conc luded  that  the 
reduct  on in stroke work  was main ly  the resul t of the 'e d u c t ion  in per iphera l  
res is tance and thus un l ikely  to be due to Impai red cont rac t i l i t y .  In a nor, s teady 
state model  such as that used in these exper iments ,  In wh ich  all the 'ac to rs  that  
m ay  a l t e r  c o n t r a c t i l i t y  ( p r e l o a d ,  a f t e r l o a d  and h ea r t  ra te )  are v a r y  ng 
I n d e p e n d e n t l y ,  d i r e c t  m e a s u r e m e n t s  of  c o n t r a c t i l i t y  s u c h  as d p / d t m.x 
th e m s e lv e s  vary,  and are no l ong e r  t rue  re f l ec t ions  of co n t ra c t i l i t y .  It is 
t h e r e fo r e  d i f f i c u l t  to  make a b s o lu te  s ta te m e n ts  r e g a r d in g  the e f f e c t s  of 
magnes ium on con t ract i l i t y  but It is reasonable to co nc lude  that myocard ia l  
pe r fo rm ance  was not depressed in th is  s tudy,  and the poss ib i l i t y  that modera te 
e l e v a t i o n s  In se rum m a g n e s iu m  I m p r o v e d  f u n c t i o n  rem a ins .  A p o s s ib le
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exp lana t ion  is that p re ce p to r  agon is t  b ind ing  In the m yocard ium  may have 
been e n h an ced . M agnes ium  does  a u g m e n t p a g o n is t  re c e p to r  b in d in g  in 
ce rta in  t issues (Bird & M agu ire , 1978; M orton  & James, 1985, V incent, 1982, 
W il l iam s et al, 1978), a l thoug h  th is  e ffect has not been stud ied in m yoca rd ia l  
t issue. Both the use of ke tam ine , and the very  l igh t level of anaesthes ia  used 
cou ld  have increased ca te ch o la m in e  levels, as could the ad renerg ic  response 
to  re d u c t io n s  in a r te r ia l  p re s s u re .  H ighe r  leve ls  of m agnes ium  may nave 
inh ib ited  the release of ca te ch o la m in e s  (Douglas & Rubin, 1963; K lrpekar & 
Misu, 1967; Lishajko, 1970; Von Euler & L lshajko, 1973) thus reduc ing  the 
c ircu la t in g  level and p ro d u c in g  a dec l ine  in SW Estim ations of ca techo la m in e  
levels were not available at the t im e of these experim ents, and th is  p o s s ib i l i ty  
needs fu r the r  study. The o the r  anaes the t ic  agents used are un l ike ly  to  hav j 
In f luenced these results s ig n i f ic a n t ly  as n itrous  oxide has m inimal ca rd iac  
e ffects, and suxam ethon ium  shou ld  not a ffec t con trac t i l i ty .  A lcu ron ium  may 
produce  mild hypoten i ,  but th is  was not seen at the start of the exper im en ts , 
and as no a lcuron ium  was g iven w ith in  1 hour ot s ta r t ing  m easurem ents  th is  
e f fe c t  shou ld  not have In f lu e n c e d  the resu lts .  A c id -base  d is tu rb a n c e s  are 
ex trem e ly  un like ly  to have in f luenced  these resu lts  as the CO 2 levels were kept 
cons tan t and perfus ion was a lways good A lthough arteria l b lood gas ana lys is  
was not ava i lab le , e n d -e x p ira to ry  C O 2 e s t im a t io n  rep resen ts  a re a so n a b le  
app ro x im a t io n  in the absence  of lung d isease or gross reduc t ion  in ca rd iac  
ou tpu t,  and is pa rt icu la r ly  usefu l in de tec t ing  changes (Nunn, 1987). There is 
no e v id e n c e  tha t MgSO* In fu s io n  of I tse lf  p rovokes  an a c id o s is  e i th e r  in 
ob s te tr ics  (Pritchard, 1975) o r  In the la te r parts of th is  thesis when la rge
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In fus ions of the salt were used In the m anagem ent of pa t ien ts  w ith  te tanus  and 
phaeoch rom ocy tom a.
M agnesium  is genera l ly  th o u g h t  to p roduce  p ro longa t ion  of the PR and Qi 
in terva ls (M iller & Van Dellen, 1941; Sm ith  et al, 1939; Van Dellen & Miller, 
1939; Von Euler & L lsha jko , 1973). a l though  other epo rts  have not shown 
s ig n i f ic a n t  c o n d u c t io n  d e fe c ts  p ro v id e d  the serum c a lc iu m  and po tass ium  
levels are m a in ta ined (M cC ubb in  et al, 1981; Surawlcz et al. 1 9 6 1 ; W atanabe & 
Dreyfus. 1972; Young & W eins te in . 1977). The ECG changes found  In th is  s tudy 
were m in imal, but may th is  be the result of species var ia t ion . It Is poss ib le  that 
the u e of suxam ethon ium  fo r  in tuba t ion  con tr ibu ted  to the s low ing  of heart rate 
in the Initial g roups, but h ig h ly  un like ly  that th is effect w o u ld  have pers is ted, 
and the change at m agnes ium  levels above 5 m mol/l is m ost l ike ly  to  be a pure 
m agnesium effect. The leve ls  of magnesium  used in c l in ica l  p ra c t ice  seem 
u n l i k e ly  to  p r o d u c e  s e r io u s  ECG a b n o r m a l i t i e s  o th e r  th a n  a p o s s ib le  
p ro longa t ion  of a tr ia l c o n d u c t io n  time.
The a p p a re n t  a b s e n c e  o f e f fe c t  o f m a g n e s iu m  on p u lm o n a r y  ve s s e ls  is 
su rp r is ing  In view of o the r repo r ts  of pu lm onary  vascu la tu re  behav ing  in the 
same manner as the sys tem ic  vascu la r tree to  magnesium loads  (A ltura  & Altura, 
1981c; Howell & Carr ier, 1986) This experim ent does not shed any l igh t  on the 
reason for th is obse rva t ion , but species pecu lia r i ty  may acc o u n t  fo r It.
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M agnesium  com petes  w ith  ca lc ium  at the cell m em brane, and may be regarded 
in many c i rcum s tances  as a phys io log ica l  ca lc ium  an ta g o n is t  (A ltura & A ltura, 
1981 a & b; A ltura & A ltura, 1985 a, b 8. c; Iseri & French, 1984). The present 
s tudy lends suppo rt  to  th is  concep t.  It has been shown tha t magnes-um exerts  
a c o n s is t e n t ,  d o s e - r e la te d  v a s o d i la t o r  e f fe c t ,  a n d  th e  r e la t i v e l y  w e a k  
hypo tens ive  ac t ion  of th is substance  is p robab ly  the resu lt of com pensa to ry  
increases in CO. The absence of a r i |o r negative in o t ro p ic  e ffect has been 
dem ons tra ted , and even re la t ive ly  large e le va t lrn s  of serum  m agnes ium  d id not 
p roduce se r ious  arrhy thm ias  or conduc t io n  defects.
Prom th is  s tudy, it may be conc luded  that m agnesium  Increases pe r iphera l 
p e r fu s io n ,  bu t Is u n l ike ly  to  dep ress  m yo ca rd ia l  c o n t r a c t i l i t y  or p ro d u ce  
serious hypo tens ive  consequences. It is thus l ike ly  to  p rove a safe agent in 
c l in ic a l  c i r c u m s ta n c e s  w h e re  a re d u c t io n  In a f te r io a d  o r  an in c re a s e  in 
per iphera l pe r fus ion  is requ ired. The po ten t ia l benefit  of thood observu .ons in 
cond it ion s  of ca techo lam ine  excess are invest iga ted  in la te r sec t ions  of th is 
thesis.
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6. INTERACTIONS WITH ADRENALINE AND ITS 
ANTAGONISTS
As a resu lt of the  Investiga tions descr ibed  In the p rev ious chapter, it may be 
conc lude d  that m agnesium can exert s ign if ican t vasod i la to r  e ffects  w h ich  may, 
In part, be due to  In te rac t ions  between mag tes lum  and ad renerg ic  agon is ts . It 
has been shown in  v itro  that magnesium  in terferes w ith  the per iphera l ac t ion  of 
ca techo lam ines, and that It may regulate  the release of ca techo lam ines  from 
both the adrenal gland and periphera l nerve te rm ina ls  (A ltura & A ltura, 1977; 
Mutter & Kostia l, 1954; Levin et al , 1976; S tanbury, 1948; Tur lapa ty  & Altura, 
1982). However, these effects  h iv e  not been dem onstra ted  In the In tac t animal, 
and no a ttem pt has been made to  quan tify  the extent of the In te rac t ion  between 
m agnesium  and ca techo lam ines  in  v ivo . Before c l in ica l cons ide ra t io n  r.nuld bt> 
given to  the use of magnesium  In cond it ion s  o f '  a techo lam ine  excess, I would 
be necessary  to  estabUsh a num ber of facts. F irs tly , It wou ld  need to be 
es tab lished w he ther or not the degree of m agnesium  Inh ib it ion  of ad renerg ic  
recep to rs  was su ff ic ient to  be of c l in ica l use. Second ly , It wou ld  be im portan t 
to  know  w he ther or not the In te rac t ion  was po ten t ia l ly  hazardous in term s of 
m assive vasod ila ta t ion  or severe d is tu rbances  of heart rhythm. F inally , It Is 
known that some other a lpha adrenerg ic  an tagon is ts , such as phento lam lne,
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have an t l-a rrhy thm lc  p ropert es, and it wou ld  be in te res t ing  to  find out whether 
or not the we ll-know n an t l-a rrhy thm lc  p ropert ies  of m agnesium  extended to 
s itua t ions  of ca techo lam ine  overac t lv l ty .  This s tudy was des inned to Investigate 
the In te ra c t io n  be tw een  m agnes ium  and ad rena l in e  on the  ca rd io va s cu la r  
system of the Intact baboon. Adrenaline was chosen as the ad renerg ic  agon is t 
since the com b ined  alpha- and beta adrenerg ic  s t im u lan t e ffect of h igh doses 
o f th is  a g e n t  w o u ld  m os t c lo s e ly  a p p ro x im a te  to  th e  c l in ic a l  s i tu a t io n  
F u r th e rm o re ,  if, as seem ed l ik e ly  p r io r  to the  s tudy , m a g n e s iu m  exerted  
p r im a r i ly  a -a n ta g o n ls t  p ro p e r t ie s ,  the  use o f a d re n a l in e  w ou ld  a l lo w  the 
u n m ask ing  o f  p o te n t ia l ly  d a n g e ro u s  in te ra c t io n s  be tw een  p -a g o n is ts  and 
m agnesium  such as severe tachyarrhy thm ias
6.1 METHODS
Twelve adu lt male Chacma baboons were stud ied with the approva l of the 
animal expe r im en ta t ion  e th ics  com m ittee, and the experim enta l p rocedu re  was 
essentia l ly  s im ila r to  that used In the previous study. The anim als were In it ia l ly  
sedated w ith  ketam lne 10 rng/kg I m. and then transfe rred  to  the opera t ing  
room and p laced on a heated opera t ing  table. Anaesthesia was Induced with 
th iopen tone  4 m g/kg  i.v. and the trachea In tubated under muscle re laxation 
Induced w ith  suxam ethon ium  1 mg/kg. The lungs were ven ti la ted w ith  25% 
oxygen In n itrous  ox ide  and minute ven t i la t ion  ad jus ted  to  keep the end-exp ired
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carbon d iox ide  level w ith in  the normal range. E le c tro ca rd io g ra p h ic  leads were 
a ttached to  each l im b  and lead II m on ito red  th ro u g h o u t  the experim ent. An 
arter ia l cannu la  was Inserted Into the left femora l a r te ry  and an Edwards 7FG 
tr ip le  lum en the rm od i lu t io n  pu lm onary  arte ry  ca the te r  Inserted via the right 
fem ora l vein, and a w r it ten  record  of the t ransduced  pressures and the EGG 
made as In the prev ious  experim ent. Muscu lar re laxa tion  was m ain ta ined with 
in te rm it ten t  doses of suxam ethon ium  as requ ired to  prevent r r jv e m e n t .  This 
re laxant was chosen as the prev ious s tudy had shown that susta ined muscle 
re la x a t io n  seemed unnece ssa ry  once  all l ines  had been es ta b l ish e d . This 
t e c h n iq u e  a lso  re m o v e d  any r is k  of p ro b le m s  p e r ta in in g  to  re ve rs a l  of 
n o n -d e p o la r is in g  re laxan ts .  S tab le  c o n d i t io n s  as p rev io .  oly de f ined  were 
m a in ta ined fc r  one hour before any read ings were made. Baseline record ings 
of heart rate, pu lm onary  and system ic sys to lic , d ias to l ic  and mean arteria l 
pressures, centra l venous pressure, pu lm onary  a n e ry  wedge pressure and 
ca rd ia c  o u tp u t  were  made at th is  t im e. C a rd iac  ou tp u t was es t im a ted  by 
th e rm od i lu t io n  u. 5 ml of 5% dextrose  held between 0-5° C entig rade as the 
In jecta te. The mean of three cons is ten t readings was taken on each occas ion. 
From these  v a lu e ;  system ic and pu lm onary  vascu la r res is tances, s troke vo lume 
and s t ro k e  w ork  were  ca lc u la te d .  A r te r ia l  b lood  sam p les  fo r  ca lc ium  and 
m agnesium  levels were taken.
An In fus ion of adrena line  1 ^g /kg /m in .  was then com m enced and continued 
th rougho u t the experim ent. Once stable cond it ion s  had been present fo r  at 
least 5 m inutes of adrenaline adm in is tra t ion , all measurements were repeated.
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Stable c o n d it io n s  were defined on th is  occas ion  as a d if fe rence  of less than 10% 
b e tw e e n  s u c c e s s iv e  m e a s u re m e n ts  5 m in u te s  ap a r t .  W here  a r rh y th m ia s  
occurred , all m easurements were recorded dur ing  per iods  of sinus rhythm. At 
th is  po int, an im als were a llocated at random  to a co n tro l  g roup, or to  an 
exper im enta l g roup. Animals In the experim enta l g roup then received a bolus 
o f  m a g n e s iu m  60 m g /k g  by In t ra v e n o u s  In je c t io n ,  and  c a r d io v a s c u la r  
param eters  aga in  measured, a long w ith  serum ca lc ium  and serum magnesium 
levels Once the values had been recorded, a fu rther bo lus of magnesium  was 
In jected and all measurements again repeated. Bolus In jec tion , ra ther than an 
Infusion, of m agnesium was used In o rder to achieve a rapid increase in serum 
m agnesium  levels, the previous experim ent having snown In fus ions to  produce  
slow and unp red ic tab le  changes In serum magnesium. C ontro l an im als were 
given tw o Identica l vo lum e in jec t ions  of saline Instead of the magnesium.
The results  w ith in  the treatment g roups were analyzed by analys is  of var iance 
and s ign if ican t ly  d if fe ren t results identif ied  using Duncan 's  m ult ip le  range test. 
Between g roup  com parisons were made using S tuden t ’s t test S ta tis t ica l tests 
were perfo rm ed using the SPSS package. S ign if icance  was defined as p < 0  05.
6.2 RESULTS
As In the  p re v io u s  s tu d y ,  a n a e s th e s ia  w as m a in ta in e d  w i th o u t  d i f f i c u l t y  
th rougho u t the experiment.
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Results are presented as means ±_ 1 S.E.M., and the p r inc ipa l fea tures are 
I l lus tra ted  in tab le  1. C ard iovascu la r m easurem ents  In t rea tm ent and con tro l 
g roups were not s ign if ican t ly  d if fe ren t e ither at baseline or a fte r the In fus ion of 
a d re n a l in e ,  and th e re fo re  m e a su re m e n ts  In the  t re a tm e n t  g ro u p  o n ly  are 
reported  In the tex t fo r  the sake of c la r ity . Saline In jections p roduced  no 
s ign if ican t a lte ra t ions  In the adrena line - induced  changes and con tro l  g roup 
data is there fo re  presented on ly  where there were s ign if ican t d if fe rences  from  
the trea tm en t g roup
6.2.1 Serum  M agnesium : Baseline serum magnesium  values were s im ila r In all
an im als (0.617 j l O.OI m m ol/ l) .  In it ia l bo lus In jec t ion  p roduced serum 
m a g n e s iu m  leve ls  of 3.4 j l  0.31 m m o l/ l ,  and the  second  In je c t io n  
resu lted  In s im ilar levels of 3.33 _±_0.29 mmol/ l.  Serum magnesium was 
una lte red from  baseline In con tro l animals.
6.2.2 Serum  C a lc ium : Serum ca lc ium  levels were not s ign if ican t ly  changed at 
any stage of the experiments.
6.2.3 A rte r ia l B lo o d  P ressure  : Adrena line  p roduced  a s ign if ican t Increase In
s y s to l ic  b lo o d  p ressure  (SBP) In bo th  g ro u p s  (p < 0 .0 5 ) .  W ith in  60 
seconds of the f irs t In jec t ion  of magnesium  SBP decreased to  a mean 
va lue 167.5 ± .20 .1  mmHg, and a fter the second In jec tion , the mean value 
was 166.8 _±_ 9.0 mmHg. The post-adrena line  SBP was s ign if ican t ly  
g reater than baseline and th is  e 'evatlon pers is ted In the con tro l animals. 
Both post-m agnes lum  b lood pressures were s ign if ican t ly  lower than In 
sa l ine  t re a te d  c o n tro ls  (p < 0 .0 5 ) .  P os t-m agnes lum  va lues w ere  not 
s ign if ican t ly  d if fe rent from  baseline. These changes are sum m arized In 
f igu re  6.1.
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Figure 6 1. Changes in systolic arterial pressure.
* - p < 0 .05 for differences between MgSO* and saline
+ - p <0.05 for differences from baseline.
Diaato llc  pressures were s im ila r ly  a ffected, Increas ing s ig n if ican t ly  from 
a baseline value of 94.0 _±_ 6.5 mmHg to  125.2 _±_ 13.6 mmHg w ith  the 
adrena line  Infusion (p < 0 .0 5 ) ,  and decreas ing  to  96.7 ± . ? . 2  mmHg and
84.2 ± .4 .2  mmHg w ith  the two doses of magnesium. C on tro ls  remained 
s ign if ican t ly  above the trea tm ent g roup  (p < 0 .0 5 ) .
6.2 4 H eart Rate: HR Init ially Increased as the adrena line  In fus ion com m enced, 
but rap id ly  slowed, p resum ably  f rom  vagal reflexes as a result of the 
ra ised arter ia l pressure, and m u lt i foca l ven tr icu la r  and supra ven tr icu la r  
a rrhy thm ias  were seen In all animals. At s teady-sta te  c o n d it io n s  dur ing  
the adrena line  Infusion, the  mean HR was 89.8 _t_ 13.4 bea ts /m ln . which 
was not s ign if ican t ly  d if fe ren t from  the baseline value of 101.0 ± .  3.2
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beats /m ln . The f irs t  bolus In jec t ion  of magnesium  Im m ed ia te ly  abo lished 
the  a r rh y th m ia s  and Inc reased  the  HR to  a mean of 130.33 _±_ 9.3 
beats /m ln . w ith  the  second dose p roduc ing  a fu r the r  Increase to  145.8 
±_ 4 .9  b e a t s / m ln . ,  b o th  o f  th e s e  p o s t  m a g n e s iu m  v a lu e s  b e in g  
s ign if ican t ly  above baseline and post-adrenn llne  va lues ( p < 0  05). The 
HR a f te r  e a c h  m a g n e s iu m  d o s e  w as  s i g n i f i c a n t l y  g r e a t e r  th a n  
sa l ine-treated con tro ls  (p < 0 .0 5 ) ,  and saline had no effect on e ither the 
heart rate or the arrhy thm ias  Induced by the adrena line  In fus ion. The 
d if fe rence  between the two MgS04 doses was not s ign if ican t.  These 
changes are sum m arized In f igu re  6.2.
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cigure 6.2. Changes in Heart Rate.
* - p < 0.05 tor differences between MgSO* and saline
+ - p  < 0.05 for differences from baseline
Magnesium
.2 5 C a rd ia c  O u tpu t: The a d re n a l in e  In fu s io n  ca used  a s l ig h t ,  bu t no t 
s ign if ican t reduc t ion  In CO In both groups. The f irs t  bo lus  of magnesium  
caused an Increase In CO to  5.59 ± .  0.63 l/mln. and the second bo lus
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caused a fu r the r  Increase to  6.18 ± .0 .7 2  l /m in . The trea tm en t g roup  was 
s ig n if ica n t ly  d if fe ren t from  con tro ls  and from  base line  a fter each bolus 
( p < 0 .005  fo r  both magnesium  doses). The w ith in  g roup  d if fe rence  In 
CO after each of the tw o  doses of magnesium  was not s ign if ican t ( f igure 
6.3).
CO (lltres/mln)
MagnesiumMagnesiumAdrenalineBaseline
Magnesium SS I Control
Figure 6.3. Changes in Cardiac Output.
* - p  < 0.005 for differences between MgSOi and saline
+ -p  <0.05 for differences from baseline
6.2.6 S troke  Volum e: Baseline mean SV was 34.73 ±_ 2.60 m l/beat. Adrenaline 
in fus ion  reduced SV s l igh t ly  In both g roups  but th is  change was not 
s ig n i f ic a n t .  F o l lo w in g  the  in je c t io n s  o f  m a g n e s iu m , SV Inc reased  
s ig n if ican t ly  from  post adrenaline levels to 42.26 _±_ 4.38 m l/bea t and 
42.38 ±_ 4.29 m l/beat ( p < 0.05). The two pos t-m agnes lum  levels of SV 
w e re  s ig n i f ic a n t ly  h ig h e r  than  th o se  In the  s a l in e - t re a te d  c o n t ro ls  
( p < 0 .0 5 ) .  These resu lts  are I l lustra ted in f igu re  6.4.
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Figure 6.4. Changes in Stroke Volume.
* - p  < 0.05 for differences between MgSO* and saline
6.2.7 S ystem ic  V ascu la r R es is tance : In the trea tm en t g roup, the  adrena line  
I n f u s io n  I n c r e a s e d  SVR f r o m  a b a s e l in e  m e a n  o f  2 5 0 6  ±_ 207  
d y n e .s e c .c m '5 to  a mean of 4378 j l 497 dyne .sec .cm "5 (p < 0 .0 5 ) ,  w ith  a 
s im i la r  s ign if ican t Increase occu rr ing  In the con tro l  g roup. The f irs t 
m agnesium  In jec t ion  reduced SVR to  1809 ,±_303 dyne .sec .cm  and the 
se c o n d  p ro d u c e d  a fu r th e r  re d u c t io n  in SVR to  1451 ± .  135 dyne, 
s e c .c m '5. T h is  second  va lue  was s ig n i f ic a n t ly  be low  base line  SVR 
(p < 0 .0 5 ) .  SVR In c o n t r o l  a n im a ls  re m a in e d  u n c h a n g e d  t ro m  the  
p o s t-a d re n a l ln e  levels, and the d i f fe rence  be tw een the c o n tro ls  and 
m agnes ium -trea ted  animals was s ign if ican t at the 0.005 level fo r  each of 
the  post-m agnes ium  values (f igure 6.5).
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Finure 6.5. Changes in systemic vascular resistance.
* - p  < 0.05 for differences from baseline
+ - p < 0.005 for differences between MgSO* and saline
6.2.8 P u lm onary A rte ry  P ressure : Fo l low ing  adrenaline, pu lm onary  sys to l ic  
pressure Increased from  a mean baseline value of 18.7 _±_ 3.8 mmHg to 
36 33 ±_ 15.4 mmHg (p < 0 .0 5 ) .  The In jec t ions  of m agnes ium  produced 
a small but non s ign if ican t reduc t ion  In pressure to  means of 32.3 ± .4 .3  
mmHg and 30.7 ±_ 4.7 mmHg respective ly .
Pu lm onary  d ias to l ic  pressures showed a s im ilar pa tte rn , but none of the 
changes reached s ta t is t ica l s ign if icance .
6.2.9 P u lm onary Vascu lar R es is tance : PVR was Increased by adrena line  from
109.8 ±_ 14.7 to  182 ± .  47.4. Magnesium reduced PVR to  108.7 ±  24.5 
a n d  114 ±_ 19.2 bu t n e i th e r  o f th e s e  c h a n g e s  re a c h e d  s ta t is t ic a l  
s ign if icance  due to  the large va r iab i l i ty  In the samples.
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6.2.10 C e n tra l V jn o u s  P ressure : CVP Increased s ign if ican t ly  from  a baseline 
va lue  of 4.67 j^ O .7 6  mmHg to  9.33 ± .1 .3 1  mmHg fo l low ing  adrenaline. 
F o l low ing  the f irs t magnesium In jec tion . CVP fell to  6.50 54 mmHg
and after the second in jec t ion  to  5.33 ± .  1.36 mmHg Neither of the 
pos t-m agnes ium  values was s ign if ican t ly  d if fe ren t from  baseline. The 
d if fe rence  between sa line-treated con tro ls  and the magnesium  group 
was not s ign if ican t atte i the f irs t  dose of magnesium, but CVP was 
s ig n i f i c a n t ly  lower the  m a g n e s iu m  g ro u p  a f te r  the  second  dose  
(p < 0.02). When the change In CVP from baseline was cons ide red , the 
post adrena 'lne  increase of 4.67 ±_ 1.02 mmHg was s ign if ican t ly  d if fe ren t 
f rom  baseline and from both  post-m agnes ium  values.
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Figure 6.6. Changes in central venous pressure
•  - p  < 0.05 for differences between MgSO* and saline
+ - p <0.05 for differences from baseline
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6.2.11 Pu lm onary C a p illa ry  W edge P ressure : Adrenaline s ig n if ica n t ly  raised 
PCWP from  baseline by a mean of 1 0 . 8  j ^ 3 . 4 mmHg (p < 0 .0 5 ) .  Fo l low ing  
the  f i r s t  m agnes ium  in je c t io n ,  PCWP was 6.0 _±. 2.7 m m H g above  
baseline, and after the second In jection  PCWP was 2.83 _±_ 2 9 )  mmHg 
above b rse l ine . The changes in PCWP fo l low ing  m agnesium  In jec t ions  
w e re  n o t  s ig n i f i c a n t l y  d l f f e . e n t  f r o m  e i th e r  b a s e l in e  v a lu e s ,  or 
pos t-ad ren a l ine  levels. There was no s ign if ican t d if fe rence  between 
trea tm ent and con tro l groups.
TABLE 6.1
EVENT BASELINE ADRENALINE MAGNESIUM 1 MAGNESIUM2 SALINE
S B P  1 4 7 . 3 ^ . 8 . 2  2 1 4 .7 _ ± _ 1 6 .E *  1 6 7 . 5 ^ ^ 2 0 . 1  + 1 6 6 . 8 j ± . 9 . 0 + 2 0 7 . 5 j L . 1 4 3
DBP 9 4  0 j L 6 . 5  1 2 5 . 2 j L 1 3 . 6 *  9 6 . 7 j ^ 8 . 2 + 8 4 . 2 j L 4 . 2  + 1 2 1 . 2 ± _ 1 1  7
HR 1 0 1 . 0 J L 3 . 2  E 3 . 8 j L 1 3 . 4  1 3 0 . 3 _ l 9 . 3 *  + 1 4 5 . 8 j _ 4 . 9  + 9 4  9 j L l 0  4
CO 3  5 4 ± _ 0  3 5  2 . 8 3 J L . 0 . 3 6  5 .5 9 jL .O  8 3 * + 6 . 1 9 j _ 0 . 7 2  + 2 . 7 9 ± . 0  42
SV 3 4 . 7 j L 2 . 6  2 8 . 5 ± . 3 . 8  4 2 . 3 j L 4 . 4 * + 4 2  4 ± . 4  3  + 3 0 . 4 j L 4 . 8
SVR 2 5 0 5 _ t _ 2 0 7  4 3 7 8 ^ . 4 9 7 *  1 8 0 9 j t . 3 0 3 + 1 4 5 1 j L l 3 5  + 4 2 9 8 ^ . 3 8 7
Table 6.1. S ign if ican t changes In card iovascu la r param eters  w ith  In fus ion of 
adrena line  and subsequent In jec t ions  of m agnesium  or saline. As the va lues 
a fte r  each in jec t ion  of saline were v ir tua l ly  Identica l, a s ing le  value fo r  con tro ls  
Is shown.
SBF - sys to l ic  b lood pressure in mmHg
DBP - d ias to l ic  b lood pressure In mmHg
HR - heart rate In beats per m inute
CO - ca rd iac  ou tpu t In l i tres per minute
SV - s troke vo lum e In ml per beat
SVR - sys tem ic  vascular res is tance In dyne .sec.cm  5
* - s ign if ican t d if fe rence  from baseline va lues p < 0  05
+ . s ign if ican t d if fe rence  from  con tro l values p < 0  05
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6.3 DISCUSSION
Magnesium  Is necessary fo r  normal sm ooth  muscle phys io logy  (Altura & Altura, 
1981b) and va r ia t ions  in serum magnesium can p ro found ly  a ffec t vascu la r tone 
H y p e rm a q n e s a e m la  re d u c e s  v a s c u la r  to n e  by  a n u m b e r  o f m e ch a n ism s  
Inc lud ing  d irec t ac t ion  on vascular sm ooth  muscle (Altura & A ltura, 1981c; 
A l tu ra  & A l tu r a ,  1984 a & b), I n t e r fe r e n c e  w i th  '.he a c t io n  o f  v a r io u s  
va so co n s tr ic to r  agents  (A ltura & Altura, 1977; Levin et a l . , 1976; Tur lapa ty  & 
Altura, 1980), and poss ib ly  b lockade of sym pathe t ic  ganglia  (Mutter & Kostial, 
1954; S tanbury, 1948). The hypotensive effect of magnesium has been ascribed 
to  a com b ina t ion  of all o f these effects  (Engbaek, 1952). The reduc t ion  In 
vascu lar res is tance dem onstra ted  In th is  s tudy cou ld  be exp la ined by any of 
these m echanism s. However, In this s tudy SVR was reduced to  one th ird  of the 
p re-m agnesium  level w h ich  Is far In excess of the reduc t ion  dem onstra ted  In the 
same baboons w ithou t f d renaline In whom  sim ila r levels of serum magnesium 
reduced the SVR by 20% (vide supra). As both gang lion ic  b 'ockade  and d irect 
vasod ila ta t ion  should have been opera tive  to the same extent In th is  and the 
prev ious study, It seems reasonable to  conc lude  that the large reduc t ion  In 
p e r ip h e ra l  re s is ta n c e  s h o w n  in the  p re s e n t  s tu d y  w as p r im a r i l y  due  to  
a lpha -ad renerg lc  b lockade  as a result of the Increased serum magnesium. 
A lo h a -a d re n e rg lc  b lo cka d e  p roduced  by hyperm agnesaem id  has been well 
descr ibed  In Iso la ted vessels In various organs from  d if fe ren t species (A ltura & 
Altura 1981; Burn & G ibbons, 1964; Farmer & Campbell, 1967; Tu r lapa ty  & 
Altura, 1982) but has not p rev ious ly  been shown to  have a c l in ic a l ly  useful
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act ion  in an i n t a -  an imal. Since b lood p re s su .*  was res to red  to  baseline by 
the in fus ion of magnesium  it is h igh ly  l ike ly  that th is e ffec t will be of c l in ica l
value.
M agnesium  Is well known as an an t i-a rrhy thm ic  agent In va r ious  c ircum stances , 
no tab ly  In the presence of d ig ita l is  (Boyd & S h e *. 1943; Chadda et a l „  1968; 
E n s e .b e r g  et a l . .  1 9 5 0 ;  I s e r l  ot a, , 197 5 ;  S z e k e ly .  1 9 4 b ) .  H o w e v e r ,  
anti a rrhy thm ic  p ropert ies  of magnesium  in the face of h igh levels of adrena line  
have not been prev ious ly  shown, and th is  adds to the usefu lness of m agnesium  
in patients w ho  may have raised c ircu la t ing  ca techo lam ine  levels. In te res t ing ly ,  
pa r t  of the  a b i l i ty  of m agnes ium  to  c o u n te ra c t  c a rd ia c  g ly c o s id e - in d u c e d  
a rrhy thm ias  has recent ly  been ascribed to  a reduc t ion  In sym pathe t ic  tone 
produced by magnesium (Tackett. 1986). The fa ilure of adrena line  to  increase 
heart rate in th is exper im ent was a lm ost ce r ta in ly  due to tw o  fac to rs . The f irs t 
of these w ou ld  have been reflex vagal inh ib i t ion  of the heart in response to 
b a ro recep to r  s t im u la t ion  by the e levated b lood  pressure; the fact that a brief 
tachyca rd ia  was seen in i t ia l ly  p r io r  to  the rise on b lnod  pressure  suppo rts  this 
hypothes is . The m u lt ' fo ca ' a rrhy thm ias  w n ich  occurred  frequen t ly  resu lted In 
c o m p e n s a to ry  pauses  w h ic h  w o u ld  a lso  have c o n t  ted  to  the  o v e ra l l  
r ! ,c re a se  in rete. The Increase in heart rate seen after T In jec t ion  of M pSO , 
was p ro b a b ly  due to  the  unopposed (3 -ad renerg ic  e ffect . ' -drenaline in the 
absence of arrhythm ias. However, a lte ra t ions  In vaoa ' to  ‘ 6 p robab ly  also 
played a part. The reduc t ion  In arter ia l b lood pressure  a lone would  have 
reduced the level of vaga' Inh ib it ion , but In add it ion , m agnes ium  has been
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shown to  inh ib it  the relei se of ace ty lcho l in e  from  vagal nerve te rm ina ls  (Somjen 
& Baskerv il le , 1968: foe  a & West, 1967). The re lative im portance  of th is  ac t ion  
is d i f f icu l t  to  assess in ' lew of the d ire c t  Inh ib ito ry  a c t io r  of magnesium  on the 
SA node.
The m a rk e d  increase in c a rd ia c  o pu t and s t ro k e  vo  urn. seen  in th is  
e xp e r im e n t  fo l lo w in g  the a d m in is t ra t io n  of MgSO* w=>s p ro b a b ly  d u e  to  a 
com b ina t ion  of the reduc t ion  in a fte r load  p roduced by the fall in SVR, and the 
unopposed  p-adrenerg ic  a c t ion  o. adrena line  It is un l ike ly  that m agnes ium  
produced  any Increase in co n trac t  h ty  !n Its own right. However, an Increase In 
p -agon is t b ind ing  in the p resence  of e levated magnesium leve ls  has been shown 
In some t issues (Bi d & M aguire, 1978; M or ion  & James, 1985; V incent, 1982; 
W ill iams et al, 197 1), a lthougn  th is  e ffec t has not been s tud ied  in m yocard ia l 
t is sue . If th is  Increase in a g o n is t  b in d in g  o ccu rs  In th e  m y o c a rd iu m , tne 
increase in c a rd ia :  output and stroke vo lum e could, In part, have been due to 
In c re a s e d  a d re m rn 'r -  s t im u la t io n .  W h e th e r  or not m a gnes ium  e n h a n ce s  
p-agon is t b ind ing  its s i tua t ions  of ca techo lam ine  excess may be of value
to the m y o c a rd iu n  on o the r grounds. It has been shown tha t m agnesium  does 
n o t  In te r fe re  wi h the  I n o t r o p ic  e f fe c t  o f a d r e n e r g ic  s t i r r  u la t io n  o f the 
m yocard ium , but that h igh levels of magnesium  reduce lac ta te  p ro d u c t io n  by 
the m yocard ium , thus p resum ab ly  p ro te c t in g  the m yoca rd ium  against some of 
the adverse m etabolic  consequences  of adrena line  (Paddle & Haugaard, 1971). 
It is c lear from  th in  studv that the re la t ive ly  normal b lood  pressure obta ined 
a fter the magnasiurr In jec t ions  was due In large part to  the  increased card iac
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outpu t, as periphera l res is tance was s ign if ican t ly  lower than  baseline at this
time.
It Is In te res ting  to  note that desp ite  the use of large doses of MgSOe, serum 
m agnesium  levels were sim ilar a fte r each bo lus dose. The exp lana tion  fo r  this 
Is l ike ly  to  lie In very  rapid c learance of the substance from  the b lood, but this 
result does seem remarkable In v iew of the ra ther longer ha lf- l i fe  of magnesium 
shown In o ther studies. It Is probab le  tha t at least part of the exp lana tion  for 
th is  r e n a r k a b ly  rap id  rem ova l of m agnes ium  lies  In the  e n h a n ce m e n t of 
m a g n e s iu m  c le a r a n c e  by c a t e c h o la m in e  s t im u la t i o n  An in c r e a s e d  
d isa p p e a ra n ce  of m agnesium  from  the b lood  strea i  d u r in g  ca techo lam ine  
s t im u la t ion  has been shown a lthough  whether th is  Ind ica tes Increased renal 
losses of m agnesium  or Increased In trace llu la r uptake of the  Ion Is at present 
unc lea r. W hl.s t W hyte et al (1987) be lieve tha t ca techo la m in e  s t im u la t ion  
ca u s e s  m a g n e s iu m  to  move In to  the  In t ra c e l lu la r  space, o th e r  e v id e n ce  
suggests  that ca techo lam ines cause In trace llu la r  losses of magnesium  resu lt ing  
In In it ia l ly  raised serum magnesium concen tra t ions , but u l t im a te ly  magnesium 
de f ic iency  (see Durlach, 1988 fo r  a review). One th ing Is c lear, however, and 
that Is tha t If e ffective  serum levels of magnesium are to be ach ieved in patients 
w ith  ca techo lam ine  excess, qu ite  large doses of MgSO* of at least the upper 
dosage range . ecom m ended In obs te tr ics  (Slbal et al, 1981; P r itchard  et al. 
1984) will have to  be adm in istered. An appropr ia te  In itial dosage schedule 
m ight the re fo re  be to  start w ith  a load ing  dose of 60m g/kg MgSO* fo l low ed  by 
an In fus ion of 30m g/kg /hour.
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In conc lus ion , th is  s tudy has shown that magnesium  may be a usefu l, rapid 
ac t ing  a -ad rene rg ic  b locker, as well as a useful an t l-a rrhy thm ic  In the  presence 
of high levels of c ircu la t ing  ca techo lam ines. In add it ion , It Is poss ib le  that 
m agnesium  may inh ib it  the release of ca techo lam ines from  the adrena l gland. 
T h e re  Is th u s  a s o u n d  bas is  fo r  the  use o f m a g n e s iu m  In fu s io n s  In the  
m anagem ent of cond it ions  of ca techo lam ine  excess.
6.4 Interact ions with Alpha-Adrenergic Blocking Drugs
The above descr ibed  study dem onstra ted  that magnesium has useful edrenerg lc  
an tagon is t p ropert ies , which may be of use In ce ita ln  c l in ica l c ircum stances. 
However, pa t ien ts  w ith  cond it ions  of ca techo lam ine  excess are l ike ly  to be 
t r e a te d  w i th  o th e r  a d r e n e r g ic  b lo c k in g  d ru g s ,  p a r t i c u la r l y  a-b lockers. 
T h e re fo re ,  b e fo re  the  h yp o th e s is  tha t m agnes ium  m ay be use fu l In such  
cond it ion s  cou ld  be tested In humans, the extent of Its In te rac t ion  with o ther 
ad renerg ic  b lockers  had to be Investigated. In part icu la r,  It was essentia l to  
de te rm ine  whether or not a com b ina t ion  of magnesium and « b lockade  was 
l ike ly  to  p roduce  ca tas troph ic  hypotens ion . The purpose of th is  s tudy was to  
com pare  the ca rd iovascu la r  effects  of magnesium  In the p resence of adrenaline 
w ith  those of a standard  a-adrenerg lc  an tagon is t, phento lam lne
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6.5 METHODS
In o rder to  derive  maximum In fo rm ation  from  th is  s tudy, the same six animals 
who had served as the m agnesium group In the prev ious exper im ent were used 
for th is  study, and the results ob ta ined com pared w ith  those from  the previous 
investiga tion , he anaesthetic  p ro toco l was Identica l to  that a lready descr ibed  
In p rev ious experim ents, and Identica l Ins trum enta t ion  was used As before, 
stable cond it ion s  were m ainta ined fo r  one hour before any read ings were taken. 
Baseline reco rd ings  of heart rate, pu lmonary and system ic sys to l ic ,  d ias to l ic  
and mean arteria l pressures, centra l venous pressure, pu lm onary  arte ry  wedge 
pressure and card iac  ou tpu t were then made.
An In fus ion of adrenaline 1 ^ g /k g /m ln  was then com m enced  and con tinued 
th rougho u t the experiment. Once stable c ond it ion s  had been present fo r at 
least 5 minutes, all measurements were repeated. Where a rrhy thm ias  occurred , 
m easurem ents were recorded dur ing  periods of sinus rhythm. All six animals 
then received 0 .2m g/kg  phento lam lne  In travenously, fo l low ed  by a bo lus of 
M gS04 60m g/kg  iv. After each drug, all ca rd iovascu la r  param eters  were again 
measured, a long w ith  serum ca lc ium  and serum m agnesium levels.
The resu lts  w ith in  the trea tm ent g roups were analyzed by ana lys is  of var iance 
and s ig n if ican t ly  d if fe rent resu lts  Identif ied using Duncan 's  m u lt ip le  range test.
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B e tw e e n  g ro u p  c o m p a r is o n s  w i th  the  re s u l ts  o b ta in e d  f ro m  the  use  of 
m agnesium  alone were made using S tuden t ’ s t- test. S ign if icance  was defined 
as p < 0.05.
6.6 RESULTS
Results are presented as means _±_ 1 S.E.M.
6 6.1 Serum m agnesium : Baseline serum m agnesium values were r lm l 'a r  In all 
a n im a ls  w i th  a mean o f 0 .617 _±_ 0.01 m M o l/ l .  The MgSOa b o lu s  
In c re a s e d  se ru m  m a g n e s iu m  le v e ls  to  3 .15  j L  0.31 m m o l / l .  T h is  
com pared  well w ith  the prev ious s tudy In wh ich the Initial bo lus  in jec t ion  
p roduced  serum magnesium levels of 3.4 _±_ 0 31 mMol/l, and the second 
In jec t ion  resulted n s im ila r levels of 3 33 ± .0 .2 9  mMol/l.
6.6.2 Serum  C a lc ium : Serum ca lc ium  levels were not s ign if ican t ly  changed at
any stage of the experiments.
6.6.3 A rte r ia l B lo o d  P ressure  : Adrenaline p roduced a s ign if ican t Increase In
s y s to l ic  b lo o d  p ressu re  (SBP) f rom  a mean of 154.8 ± 7 . 9  m m H g 
(p < 0 .05 )  to  a mean of 227.3 ± 1 1 . 3  mmHg. Phento lam ine s ign if ican t ly  
reduced SBP to  110 0 ± 9  5 mmHg ( p < 0  05) and fo l low ing  the In jec tion  
of MgS04 SBP was 130.8 ±  16.4 mmHg, w h ich  was not s ign if ican t ly  
d i f fe re n t  f rom  the p o s t -p h e n to la m in e  level. Th is was a s ig n i f ic a n t ly  
g rea te r reduc t ion  than that p roduced by the f irs t  In jec tion  of magnesium 
a lone (p < 0 .0 5 ) ,  but a fter the second m agnesium In jec tion , va lues were 
not s ign if ican t ly  d if fe rent. In bo th  studies, the SBP fo l low ing  e lthar
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phento lam lne  or magnesium was not s ign if ican t ly  d i f fe ren t f rom  baseline 
(f igure  6.7).
250
200
SBP (mmHg)
Baseline Adrenaline Phent/Mag Magnesium
Magnesium ESI Phent-Mag
Figure 6.7. Changes In systolic arterial pressure during adrenaline infusion with either 
phentolamine-magnesium sequence or magnesium alone.
+ - Significant changes from baseline
* - Significant differences between groups
Phent-Mag - phentolamine-magnesium sequence
Phent/Mag - administration of either phentolamlne or MgSO*
D iasto lic  pressures were s im ila r ly  a ffected, Increasing s ig n if ica n t ly  from  
a b a s e l in e  va lu e  o f 92 5 ±_ 6 .4  to  128 .2  ± . 6 . 1  m m H g ( p < 0 .0 5 ) .  
Phento lam lne s ign if ican t ly  reduced DBP to  49.8 ± . 6  9 ( p <0 .0 5 ) ,  and 
fo l low ing  MgSCu the DBP was 65.8 ± . 9 . 2  mmHg. Again, the  reduc t ion  
In DBP was s ign if ican t ly  g reater after phento lam lne  than a fte r  the f irs t 
dose of magnesium  alone ( p < 0 . 0 l ) ,  a lthough a fter the second dose of 
MgS04 there  were no s ign if ican t d ifferences.
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6.6.4 H eart Rate: As in the prev ious experim ent, HR in i t ia l ly  Increased as the 
a d re n a l in e  In fu s io n  c o m m e n c e d ,  bu t r a p id ly  fo i l  and  b ecam e  ve ry  
Irregu lar, w ith  m u lt i foca l ven tr icu la r  and supra ven tr icu la r  arrhy thm ias  
seen in all animals. At stead> state c ond it ion s  du r ing  the adrena line 
In fu s io n ,  th e  m ean HR was 95 .7  ± . 7 . 5  b e a ts /m ,n  w h ic h  w as no t 
s ign if ican t ly  d if fe ren t from the baseline value of 116.2 ± .3 . 4  beats/m ln. 
Phento lam ine  Im m edia te ly  abo lished the a rrhy thm ias  and s ign if ican t ly  
in c re a s e d  HR to  a m ean of 188.3  ± . 5 . 8  bea ts /m ln .  Phen to lam ine  
p roouced  a s ign if ican t ly  greater Increase In HR than that seen after 
m agnes ium  alone (p < 0 .0 1 ) .  In je c t io n  of MgSO* a f te r  phen to lam ine  
p roduced  a s light d rop  In heart rate to  174.0 ± 5 . 2  beats /m ln  (f igure  6.8).
200 
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F igure  6.8. C hunges In h e a rt rate d u rin g  a d re n a lin e  in fu s io n  w ith  e ith e r  
phentolannine-.nag lesium sequence or magnesium alone.
+ - Signa/can' changes from baseline
• - SigniFcant differences between groups
Phont-Mag ■ phentolamine-magnesium sequence
Phent/Mag - administration of either phentolamine or MgSO*
HR (beats/mln)
Baseline Adrenaline Phent/Ma.'
Magnesium Phent-Mjg
Magnesium
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6.6 .5  C a rd ia c  O u tp u t: The a d re n a l in e  In fu s io n  c a u se d  a s l ig h t ,  bu t no t 
s ign if ican t reduc t ion  In CO from  a mean of 3.51 _±_0 271/mln to  a mean 
of 3.17 3.0 l/rnln. Rhentolamine caused a markeo Increase In CO to
5.98 _±_0.36 l.m in and after magnesium the CO was 6.7 ± .0 .4 9  l/m in; both 
of these values were s ign if ican t ly  d if fe ren t from  both baseline and post 
adrena line  values, but not from  each other, or from  the va lues obta ined 
us ing magnesium alone (f igure 6.9).
CO (litres/min)
lasellne Adrenaline
Magnesium
Phent/Mag 
US# Phent-f' "
Magnesium
Figure 6.9. Charges in cardiac output during adrenaline infusion with either phentolamine- 
magnesium sequence or magnesium alone.
+ - Significant differences f  om baseline
Phent-Mag - phentolamine-magnesium sequence
PhentlMeg - administration of either phentolamine or MgSOi
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6.6.6 S troke Volum e: Baseline mean SV was 30.11 ±_ 1.97 m l/beat. After the 
adrena line  Infusion SV was 33.02 ±_ 1.4 m l/beat but th is  d if fe rence  was 
not s ign if ican t.  A fter phento lam ine SV was 34.75 _±_ 3 35 m l/beat, and 
after the add it ion  of magnesium the SV was 38.91 j l 2 . 5 3  m l/beat, the SV 
after magnesium  being s ign if ican t ly  h igher than basellna ( p < 0  05). but 
not s ign if ican t ly  d if fe ren t from  o ther va lues (f igure  6.10).
SV (ml/beat)
MagnesiumPhent/MagAdrenalineBaseline
H I  Magnesium # #  Rhent-Mag
Figure 6.10. Changes in stroke volume with either phentolamine-magnesium sequence or 
magnesium alone.
+ - Signiticant differences from baseline
Phent-Mag ■ phentciamine-magnesium sequence
Phent/Mag - administration of either phentolamine or MgSO*
6.6.7 S ystem ic Vascular R es is tance : The adrena line  In fus ion Increased SVR 
from a baseline mean of 2502 J l9 1  dyne  se c .cm '5 to  a mean of 3938 ± .  
240 dyne.sec.cm *5 ( p < 0  05). Phento lam ine s ign if ican t ly  reduced SVR to
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8 0 1  ± .  5 4  dyne.SQC.cm ' 5 ( p < 0 . 0 5 )  and after magnesium the value was 
9 0 4  ±_  6 8  d yne .sec .c m ' 5 .
SVR (dyne, sec cm*5)
MagnesiumPhenVMag
Magnesium Pher.VMag
f-jqure 6.11. Changes In systemic vascular resistance, after the administration of adrenaline, with 
either phentoiamine-magnesium sequence or magnesium alone.
+ - Significant changes from post-adrenaline values
* - Significant diferences between groups
Phent-Mag - phentoiamine-magnesium sequence
Phent/Mag - administration of either phentolamn.e or MgSO*
The reduc t ion  In SVR produced by phento lam lne was s ign if ican t ly  g reater than 
that p roduced  by the f irst dose of MgSCU in the Init ia l study, but there  was no 
s ig n i f ic a n t  d i f fe re n c e  between the g roups  a fter the  f ina l m agnes ium  dose. 
When the post-adrena line  value for SVR was taken as the base po in t fo r between 
group  com parisons , there was a s ign if ican t,  but small, d if fe rence  between * he 
reduc t ion  In SVR produced by phento lam lne  after adrena line  and that p roduced
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by the f irs t m agnesium  dose, but the reduc t ion  In SVR after tne f ina l m agnesium  
dose was v ir tua l ly  Identica l In the two s tudy g roups (f igure  6.11).
6.6.8 Pu lm onary A rte ry  P ressure : Fo l low 'ng  adrenaline, pu lm onary  sys to l ic  
pressure Increased from  a mean baseline value of 21.5 .± .1 .6  mmHg to  
36.0 ± .  4.0 mmHg (p < 0 .0 5 )  which com pared  well w ith s im ila r changes 
found In the prev ious study. Neither phento lam lne  nor MgSOs produced  
a s ign if ican t reduc t ion  In PAP, and there  were no d i f fe rences  between 
the resu lts  In the two studies. D ias to lic  pressures showed a s im ila r 
pattern, but none of the changes reached s ta tis t ica l s ign if icance .
6.6.9 C entra l Venous P ressu re : Adrenaline p roduced an s ign if ican t Increase 
In CVP of 4.7 ±_ 1.0 mmHg from baseline In bo th  g roups  (p < 0 .0 5 ) .  In 
both groups, the CVP re turned to baseline after the adm in is tra t ion  of the 
vasod ila to r drugs.
6.6.10 Pu lm onary C a p illa ry  W edge P ressure : Adrenaline s ig n if ican t ly  raised 
PCWP from baseline by a mean of 1% 2 mmHg (p < 0 .0 5 ) .  Phento lam lne 
re turned PCWP to  baseline, and the levels of PCWP after phento l mine 
were s ig n i f ic a n t ly  low er than those  a fte r  adrena line  (p < 0 .0 5 ) .  This 
result com pared  well w ith  that ob ta ined  In the previous s tudy  In w h ich  
thore  was a s im ilar trend , but the changes did not reach s ta tis t ica l 
s ign if icance . There were no s ign if ican t d if fe rences between the groups.
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6.7 DISCUSSION
At the  level of serum magnesium atta ined In these experim ents, m agnesium  
a p p e a re d  to  e x e r t  s im i la r  c a r d io v a s c u la r  e f fe c ts  to  th o s e  p ro d u c e d  by 
phento lam ine. Phonto lam ine p roduced a s ign if ican t ly  grea te r Increase In heart 
rate than that p roduced  by magnesium alone, but th is was p robab ly  s im p ly  u •« 
to  a re d e x  re s p o n s e  to  th e  g re a te r  h y p o te n s iv e  e f fe c t  of p h e n to la m in e  
com pared  to  that p roduced  by magnesium alone It cou ld  be argued that the 
tendency  cf m agnesium  to  reduce heart rate m ight have con tr ibu ted  to the 
lesser Increase In heart rate, pa r t icu la r ly  In view of the tendency  for heart rate 
to  d e c re a s e  In th e  p h e n to la m in e  g ro u p  fo l lo w in g  th e  a d m in is t r a t io n  of 
m agnesium. The results of these experim ents , however, do  not perm it the 
d ra w in g  o f th a t  c o n c lu s io n ,  and th a t  m us t rem a in  a p u re ly  s p e c u la t iv e  
poss ib i l i ty .  Card iac ou tpu t changes In the two groups were sim ilar, a lthough 
magnosium  produced  an Increase In s t ro k *  volume, whereas s troke vo lume 
fo l low ing  phento lam ine  v.as unchanged. This Is p robab ly  Decause the s lower 
heart rate a fter m agnesium  allowed more time fo r ven tr icu la r  f i l l ing , a lthough  It 
shou ld  be noted that In the magnesium group the inc rea rad  stroke vo lum e was 
achieved against a s ign if ican t ly  h igher vascu.ar res is tance than that perta in ing  
fo l low ing  phento lam ine.
Phento lam ine p roduced a greater reduc t ion  In SVR than that p roduced  by 
m agnes ium , bu t the  d i f fe re n c e  was sm all .  T he a d d i t io n  of m a gnes ium  to
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phen to lam l i ie  produced r<o s ign i f icant  changes In any of the card 'ovascu la r  
var iables measured,  and it seems l ikelv, therefore,  that  the tw o  drugs were 
act ing th rough  s imi lar  mechanisms,  and that  this large dose of phento lamlne 
p roduced  rea r -m ax ima l  a-adre terglc  blockade. A l though magnesium L  well  
knov '  be a d i rect  vasodi lator,  In the presence of adrenal ine, Its u -  b lock ing 
proper t ies  appear  to predominate.
Al though It Is d i f f icu l t  to draw any conc re te  conc lus ions regard ing con t rac t i l i t y  
f rom a s tudy of this nature In which preload and af ter load are con t inuously  
varying,  there were no obv ious s igns of negat ive Inot rop ic  ef fects of magnesium 
In this s tudy. On the contrary,  fo l l ow ing the Infusion of magnesium, s t roke 
vo lume was s ign i f icant ly  Increased above basel ine despi te  the fact  that preload 
and af ter load were at '  ,. .. '*r level as those pr ior  to adrena l ine Infusion. The 
only s ign i f icant  Increase ... s troke vo lume In the phento lamlne g roup occu r red  
af ter  the add i t i on  of magnesium. This might  be taken to Imply »hat magnesium 
might  have exer ted a posi t ive Inot rop ic  ef fect  in the presence of adrenal ine as 
no such Increase In s troke vo lume was seen In the phento lamlne group  despi te  
a lower  e f ter load.  There Is no ev idence that magnesium exerts a pos i t ive 
Inot rop ic  ef fect  In its own r ight,  and the on ly l ikely exp lanat ion  for  this Is that 
m a g n e s iu m  c o u ld  have e n h a n c e d  p -ago n ls t  b i n d in g  to  the  m y o c a r d iu m .  
Magnesium does augment p agon is t  recepto r  b ind ing In cer ta in  t issues (vide 
supra) , a l t hough this effect has not been studied In myocard J  t issue.
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This s tudy  has conf i rmed that magnesium has useful  a-ad rene rg ic  b lock ing 
proper t ies ,  s imi lar  to  those possessed by phento lamine a l though of  lesser 
m a g n i tu d e  at the dosages  used.  It seems un l ik e ly  to  p r o d u c e  d a n g e ro u s  
add i t ional  e f fects  In pat ients a l ready t reated wi th other a adrenerg ic  b lock ing 
d r u g s .  In a d d i t i o n  It has been s h o w n  th a t  m a g n e s iu m  can  e xe r t  usefu l  
an t l -ar rhy thmic  ef fects In the presence of catecholamlnee and It Is unl ike ly  to 
p r o d u c e  any  m y o c a r d ia l  d e p r e s s i o n  u nde r  the  c i r c u m s t a n c e s  of  ra ised 
adrenal ine levels. 7 ere Is a poss ib i l i t y  that  magnesium may have a pro tect ive 
ef fect  on the adre i .erg lca l ly -s t imulated heart.
6.8 In teractions with Beta-Adrenergic Blocking Drugs
The f inal  p iece of in format ion requi red to Indicate that  . . tagneslum sulphate 
would be safe to use In condi t ions  of catecholamine excess was the extent  of 
po ss ib 'e  In te rac t i on  with p -b lock lng  agents .  In the m anagem e n t  of these 
pa t i en ts ,  a -a d re n e rg lc  b lo c ka d e  is a lm os t  Inva r iab ly  the f i r s t - l in e  choice.  
A d m ln ' r t i a t l o n  of a p-adrenerglc  b locker  to a pat ient  wi th ca techo lamine excess 
Is l ike ly  to  be ext remely hazardous as the unopposed  a lpha ef fects  could 
p roduce  severe hyper tens ion and card iac fai lure (Hull , 1987; Edmondson & 
F lowers ,  1979; Buchanan et al . ,  1976). The on ly  c i r cu m s tanc e s  In which 
p -adrenerg ic  b lockers should be used to ' reat  ad renetp lc  over load should be
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In con junc t i o n  wi th the use of a-b leckade .  Therefore.  In order  to Invest igate 
the potent ia l  for  interact ion between magnesium and p b lockers  It wns dec ided 
to  use t h e  same e x p e r i m e n ta l  m ode l  as th a t  e m p l o y e d  In th e  p re v io u s  
expe r iments  descr ibed  In this chapter ,  but In addi t ion to  admin is te r  p b lockade 
subsequent  to the a-b lockade  In order  to restore near-normal  card iovascula r  
s tatus to the animal despite Ihe cont inu ing adrenal ine Infusion. Subsequent  
admin is t ra t ion of magnesium should thus unmask any potent ia l ly  dangerous  
Interact ion.  In par t icu lar  the danger  of myocard ia l  depress ion,  as Is known to 
occu r  wi th other  ca lc ium antagonis t  drugs in the p r e s e n t ^  or p -u 'ockade
6.9 METHODS
Six chacm a baboons were s tud ied using the same exper imenta l  des 'gn as has 
been prev ious ly  descr ibed,  with the same mon i tor ing devices,  and the same 
a n a e s t h e t i c  t e c h n i q u e .  As In the p r e v io u s  e x p e r im e n t s ,  an In fu s io n  of 
ad renal ins  was admin istered at a rate of 1M,g/kg/mln.  and con t inued th roughout  
the expe r im en t .  Phen to la m ine  was then  a d m in is te red  In t ravenously ,  wi th  
r e p e t i t i o n  of  al l  m e a s u r e m e n ts ,  f o l l o w e d  by the  a d m i n i s t r a t i o n  of 1 mg 
p r o p r a n o l o l  I n t ra v e n o u s ly ,  dt w h ic h  p o in t  al l  m e a s u r e m e n ts  we re  aga in  
repeated. M g3 0«  at a dose of 60mg/kg was then admin is tered and a f inal set 
of measurements made.
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6.10 RESULTS
Resul ts are presented as means _±. 1 S.E M. The main po in ts  f rom the resul ts
are summar ized In table 6.2.
6.10.1 Serum  M agnesium : Serum magnesium levels were Increased f rom a 
basel ine value of 0.68 _±_ 0.045 mmol/ l  to 3.26 _±_ 0.12 mmol / l  by the 
magnesium Infusion.
6.10.2 H eart Rate: As In the previous exper iment,  adrenal ine p roduced  an init ial  
t a c h y c a r d i a  f o l l o w e d  by a i t i t u rn  of  hear t  ra te  to  bas e l in e  va lues 
accompan ie d  by mul t i focal  ar rhythmias.  Phento lamine again abol ished 
the ar rhy thmias and produced a rapid Increase In heart  rate to  a mean 
of 187.17 _±_6.76 beats per min. Propranolo l  reduced th hear t  rate to 
a mean of 122.67 ±_ 3.27 which was not s ign i f i can t l y  di f ferent  f rom the 
basel ine value of 116.83 7.87 beats per mln. The admin is t ra t ion of 
MgS04  was accompan ied  by a fur ther  sl ight, not  s ign i f icant  dec l ine in 
heart  rate to 109.83 ± . 2 .5 5  beats per mln.
6.10.3 S ystem ic B lood  P ressure : As In the prev ious exper iment ,  the Infusion of 
ad rena l in e  Increased b lood  pressure s ign i f i can t l y  to  235.17 ±_ 19.4 
mmHg and the use of phento lamine reduced the b lood  pressure to  100.80 
±_ 11.04 mmHg,  which was not s ign i f icant ly  d i f ferent  f rom the basel ine 
value of 123.17 ± .  8.27 mmHg Nei ther  o rop rano lo l  nor magnesium 
caused any fur ther  s igni f icant change In blood pressure.
Diasto l ic  b lood pressure was simi lar ly af fected wi tn  adrenal ine causing 
a s ign i f icant  Increase above and phento lamine caus ing a s igni f icant  
reduc t ion below basel ine. Propranolo l  restored DBP to basel ine levels 
and magnesium produced no further s ign i f icant change.
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6.10 .4  C a rd ia c  O u tp u t: As in the p r e v io u s  e x p e r im e n ts ,  at s tea dy  s ta te  
c o n d i t i o n s  d u r in g  the a d ren a l in e  In fus ion CO was not  s ign i f i c an t l y  
d i f ferent  f rom basel ine. Phento lamine p roduced  a s ign i f icant  increase 
In h e a r t  r a t e  and  t h i s  w a s  r e s t o r e d  t o  b a s e  Ine l e v e l s  b y  th e  
a d m i n i s t r a t i o n  of the b e ta - b lo c k e r .  M a gn e s iu m  p r o d u c e d  a smal l  
Increase In card iac output ,  but th is did not reach stat ist ical  s igni f icance.
6.10.5 S troke  Volum e: There were no s igni f icant  d i f ferences for  the values of 
s t roke vo lume at the var ious stages of the exper iment .  However , when 
t h e  c h a n g e s  In s t r o k e  v o l u m e  f r o m  b a s e l i n e  w e r e  c o n s i d e r e d ,  
magnesium produced a s igni f icant  Increase In s troke vo lume ( f igure 
6 . 12 ).
SV (ml/beat)
MagnesiumPropranolol
I + S.E.M.
Figure 6.12 Changes in stroke volume from baseline at each stage of the experir tent. 
* - p < 0.05 for differences from baseline.
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6.10.6 P u lm onary A rte r ia l P ressure : As In the p rev ious  s tud ies adrena l ine  
caused a s ign i f icant  increase In both systo l ic  and d ias to l i c  pressures and 
phento lamine restored these values to  thei r basel ine levels. Nei ther  
proprano lo l  nor  magnesium produced any fur the r  s ign i f icant  changes.
6 .10 .7  C e n tra l Venous P ressu re : CVP was s ign i f i c an t l y  increased by the 
adrenal ine in fusion and this was restored to basel ine by phento lamine.  
N e i t h e r  p r o p r a n o lo l  no r  m agn es iu m  caused  any fu r th e r  s i g n i f i c a n t  
changes In CVP.
6 .10 .8  P u lm onary  C a p illa ry  W edge P ressu re : The changes  In PCWP were 
ident ica l  to those In CVP wi th  adrenal ine p roduc ing  a s ign i f icant  Increase 
In wedge pressure,  but no other resul t  b e l r j  s ign i f ican t ly  d i f ferent  f rom 
basel ine
Table 6.21 over
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TABLE 6.2
Base Adren Phent Prop M agnesium
HR 116.83 107.00 187.17* 122.67 109.83
b.p.m. (7.87) (14.01) '6.76) (3.56) (2.55)
SBP 123.17 235.17* 100.80 114.67 116.63
mmHg (8.27) (19.40) (11.04) (8.41) (6.95)
DBP 73.17 128.17* 38.33* 71.83 65.67
mmHg (7.14) (10.63) (2 24) (5.84) (4 07)
CO 3.63 3.41 6.27* 3.81 4.33
l/min (0.27) (02 1 ) (0.42) ( 0 4 1 ) (0.38)
SV 32.18 35.56 33 84 31.63 39.72
ml/beat (3.21) (5.15) (2.76) (4.04) (3.92)
Table 6.2. Pr inc iple card iovascular  changes found wi th magnesium In ject ion In 
adrenal ine t reated a- and p-b locked baboons.  Figures In parentheses Indicate 
one s tandard er ror of the mean.
Base - basel ine values
Adren - resul ts fo l low ing adrenal ine Infusion 
Rhent - resul ts fo l low ing phento lamine admin is t ra t ion 
Prop - resul ts fo l l ow ing propranolo l  admin is t ra t ion 
HH - heart  rate
S9P - systo l ic  arter ial  b lood pressure 
DBh - d iasto l i c  ar ter ial  b lood pressure 
CO - card iac  output  
SV - s troke vo lume
* - p < 0 . 0 *  for  d i f ferences from basel ine.
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6.11 DISCUSSION
As in th e  p re v io us  e x p e r im e n t ,  p h e n to la m ln e  reve rsed  the  hy pe r tens ive ,  
vasocons t r i c to r  and ar rhythmic  ef fects of adrenal ine,  a l low ing the unopposed 
beta ef fects  to p roduce s igni f icant  Increases In card iac ou tput  and hear t rate, 
but not s t roke volume.  The marked decrease In systemic vascu lar  res is tance 
was p robao ly  in par t due to ^ mediated vasod i la ta t ion as wel l  as to a b lock  je. 
The adm in is t ra t ion of proprano lo l  reversed these p-adrenerg ica l ly  mediated 
changes and restored all of the measured card iovascu la r  var iab les to basel ine 
va lues .  It Is reaso nab le  to  assume,  the re fo re ,  tha t  «- and  p-adrenerg ic  
b lockade,  at the doses  used, had total ly  reversed the ef fects of adrenal ine in 
these animals.  The fur ther add i t ion of magnesium to the preparat ion produced 
very l i t t le fur ther  change In card iovascular  parameters,  the only s igni f icant 
change being the increase In s t roxe vo lume from baseMne values.
On the bas is  of these  resu l ts  It wou ld  seem reasonab le  to  c o n c lu d e  that 
magnesium Is not l ike ly to exh ib i t  addi t ive ef fects with those of the ( j-b lockers 
In pat ients  wi th catecholamine excess. In par t icular ,  there was no evidence at 
al l  ' h a t  m ag n e s iu m  was l i k e l y  to  p ro d u c e  p o te n t ia l l y  ha za rd ou s  nega t i ve  
Inot rop ic  act ions In comb inat ion wi th p-antagonis ts  In such pat ients.  On the 
cont rary ,  the increase In s t roke vol rse might be In terpreted as an increased 
p.agonis t  effect, a l though  this In terpretat ion must be regarded wi th cau t ion as 
the com p lex  In ter re la t ionships between preload and af ter load in this model
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make hard conc lus ions  about  con t rac t i l i ty  very d i f f icu l t  t o  draw. By far  the most 
reasonable conc lus ion  Is that  magnesium Is un l ike ly to be dange rous  In the 
presence of p-b lockade  In pat ients  wi th adrenerg ic  ex ess
6.12 CONCLUSIONS
These exper iments  have demons trated for the f i rst t ime In the Intact  animal a 
n u m b e r  o f I n t e r e s t i n g ,  and  p o t e n t i a l l y  v a l u a b l e .  I n t e r a c t i o n s  b e tw e e n  
magnesium and adrenerg ica l ly  act ive agents.  In the f i rst  exper-ment  It was 
shown that  magnesium can exert ant i -adrenerg ic  e f fects of a magni tude  that 
would be l ike ly  to be useful  In the cl inical  s i tuat ion.  The second exper iment  
showed that  these act ions of magnesium were qua l i ta t ive ly  s imi lar  to those of 
p h e n t o l a m i n e ,  and t h a t  t h e r e  w e r e  no o b v i o u s  p o t e n t i a l l y  h a z a r d o u s  
In teract ions between magnesium and this a lpha-ad rene rg lc  o locker .  Final ly, It 
was shown that magnesium did not appear to have any apparen t ly  hazardous 
I n t e r a c t i o n s  w i th  b e t a - b lo c k e r s .  In p a r t i c u la r ,  the  t h e o r e t i c a l l y  p o s s ib le  
po tent ia t ion of the negat ive Ino t rop ic  ef fects of beta-adrenerg ic  b lockade did 
n o t  a p p e a r  t o  o c c u r .  C o m b l n r t l o n s  of  a lp h a  and  be ta  b hockade  w i t h  
m a g n e s iu m  seem, th e re fo re ,  un l i k e ly  to be d a n g e r o u s  In a p a t ie n t  w i th  
ca techo lamine excess.
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Magnesium does, therefore,  apoear  to have a cons iderab le number  of potent ia l  
a p p l i c a t i o n s  In c o n d i t i o n s  of  c a t e c h o l a m i n e  o v e r l o a d .  T h e  u s e f u l  
a lpha-adrene rg lc  antagonis t ic  ef fects of this agent  combined wi th It? capaci ty  
for  Inh ib i t ing the release of catecholamines could make magnesium uniquely  
benef icia l  In such cl inical  s i tuat ions.  There is also the In terest ing poss ibi l i ty  
tha t  m agnes ium  may p ro tec t  thv n v 'o ca rd iu m  f rom the adverse metabo l i c  
c o n s eq u e nc es  of ca techo la mine  dr ive.  Dem ons tra t i on  of the f ct that  the 
theore t ica l  poss ib i l i ty  that magnesium can Inhibi t  the release of ca techolamines 
is, In fact,  borne out  in the cl in ical  s i tuat ion Is the theme of the f inal chapters  
of th is thesis.
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7. Catecholamine Release at Endotracheal  
Intubation
It has been shown In preceding chapte rs  thet  magnesium has ant l -adrenerg ic  
proper t ies  which may be c l in ica l ly  useful  in cond i t i ons  of adrenerg ic  excess. 
Th e  u n i q u e  a d d i t i o n a l  a b i l i t y  o f  t h i s  a g e n t  t o  I n h i b i t  t h e  r e l e a s e  of  
catecho laminos f iom  adrenerg ic nerve terminals  and f rom the adrenal  gland in 
v i t r o  ( D o u g l a s  & Rubin ,  1963;  L i s h a j k o .  1970) ,  m ay  have m an y  c l i n i c a l  
apol icat ions ,  but 'his act ion has never been Invest igated In Intact  animais or 
imanc.
The commones t  s i tuat ion In which an anaesthet ist  faces a pred ic tab le  stress 
response In his pat ients  Is at the t ime of endo tracheal  in tubat ion.  It Is well  
known that  la ryngoscopy  and Intubat ion produce  marked Increases In heart rate 
and b lood  pressure (Sledleckl ,  1975), which carr ies wi th  It n rls of myocard ia l  
s t ra in .  The p r o b le m  has been e x te n s ive ly  re v ie w ed  by Ng (1985) .  This 
response Is assoc ia ted wi th the release of catecholamines In large amounts 
(Russel l  et al.. 1981; Derbyshi re et al.. 1983). There are var ious techniques  by 
which th is  In tubat ion-rela ted stress response can be at tenuated,  all of which
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depend on reduct ion  in Input s t imul i  by local  anaesthet ics  or cent raMy-act lng 
a na lg e s ic s ,  o r  the p e r ip h e ra l  b l o c k a d e  of a d r e n e r g i c  respon ses .  These 
m e thod s  In c lude  the use of l l g n o c a in e  bo th  to p i c a l l y  and by In t r avenou s  
I n j e c t i o n  ( S t o e l t i n g ,  1978) ;  t he  a d m i n i s t r a t i o n  of  be ta  b l o c k i n g  d r u g s  
(Sledlecki , 1975); tne use of d i rect -ac t ing  vasodi la tors  (Stoel t ing.  1979); and 
the use of large doses of opiates,  no tab ly  fentany l  and al fentani l  ( f  tanley et al., 
1980, Crawford & Fell. 1987). All of  these techniques have d isadvan tages 
related to  ei ther  card iovascular  or  resp i ra to ry  depress ion,  and none of them 
d i rec t ly  Inhibi ts the release of catecholamines.
As has been demons trated in prev ious chapters,  magnesium seems to have 
relat ively m inor  card iovascula r  s ide effects at modera te b lood levels,  despi te  
Its apparent ly  useful  ant i -adrenerg ic  propert ies .  Such card iovascula r  ef fects 
as do occur  are l ikely to be benef icia l  to a st ressed myocard ium  - reduc t ion In 
af ter load and a decrease In heart rate. The on ly  resp i ra tory  depressant  ef fect  
of this agent  Is related to Its wel l -known abi l i ty to  potent ia te  the act ion of the 
non-depola r i s ing neuromuscular  b lock ing  drugs (Ghonhelm & Long,  1970). The 
stress of endotracheal  in tubat ion therefore seemed an app ropr ia te  model  In 
w h ic h  to  I n v e s t ig a te  the a b i l i t y  o f  m a g n e s iu m  to c o n t r o l  c a r d i o v a s c u l a r  
d is turbances and to Inhibi t  the release of catecholamines under  re pe r ta b le  and 
con t ro l led s i tuat ions.
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7.2 METHODS
The study  was approved by the Ethics Commit tee of Hl l lbrow Hospi tal  and the
Univers i ty of Wl twatersrand and all pat ie gave nformed consent .
7.2.1 P a tien t s e le c tio n : Par t ic ipants  In the tr ial  were male ASA M l  pat ients
booked  fo r  e lec t i ve maxi l lo  fac ia l  su rg e ry  In w h ic h  the anaes th e t i c  
t e c h n i q u e  w o u ld  r e q u i r e  e n d o t r a c h e a l  I n t u b a t i o n .  P a t i e n t s  were  
randomly  a l located to  one of two Groups. Group A or Group 6. using 
tables of  random numbers.  There wore 15 pat ients  In each group.
7.2.2 A n a e s th r ic  Te rtm ique . All pat ients were premedicated  wi th d iazepam 10
mg p.u. 1 hour  preoperat lve lv.  Under  local  anaesthesia,  an Intravenous 
cannula was Inserted Into one forea-m for  Infusion of drugs, and a central  
venous l ine was p laced  via an a r t e c u b l t a l  vein fo r  b lood  samp l ing.  
Anaesthesia was Induced wi th  a sleep dose of th iopentone,  and Group  A 
pat ients then received an Infusion of MgSCU ROmg/kg l.v. over  1 minute. 
Group B subjects received an equivalent  vo lume of sal ine also over  1 
mlr.ute Dur ing these  In fus ions ,  50% n i t r ous  o x id e  in o x y g e n  was 
Inhaled. Subjects In ooth groups  then rece ived suxamethon ium 1mg/kg 
In t ravenous ly .  Tracheal  In tubat ion  was per fo rmed  60 sec. a f ter the 
admin is t ra t ion of suxamethonium. Based on the rap id i ty  of onset of the 
ant l -adranerg lc  ef fect of magnesium (see chapter  6), this t im ing ought  
to have al lowed for  the magnesium to exer t  Its ful l  ef fect.  The person 
p e r f o r m i n g  th e  I n t u b a t i o n  and  t h e  l a b o r a t o r y  s t a f f  p e r f o r m i n g  
catecholamine  est imat ion; ,  were bl ind as to the group  to which the 
pa t l rn t  belonged.
7.2.3 C atecho lam ine  Estim ations. Blood samples for  est imat ion of catechol -  
rm in e s  were taken by an assistant at the fol low g t imes: immediate ly
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pr ior  to Induct ion,  Immediately  r  lor to Intubat ion immediate ly  fo l lowing 
in tubat ion and at 2 and 5 minutes after in tubat ion. Tubes wi th b lood 
sa m p les  fo r  p lasma c a te c h o la m in e  m ea su re m en t  were  im m ed ia te ly  
p laced  on Ice. Sai ,,!es were cent r i fuged at 3 000 revo lut ions per minute 
for  10 mln at 4° C. A l iquots of the serum were sto ed at -70°C for  not 
longer  than 1 week. Fract ionated serum catecholamine  concentrat ions  
w e r e  d e t e r m i n e d  u s in g  r e v e r s e d  p h a s e  h i g h - p e r f o r m a n c e  l i q u i d  
ch rom a to g raphy  with e lect rochemica l  detect ion  and an internal  s tandard 
( K r s t u lo v l c ,  1982; Causen  & Car ru th e rs ,  1982) . The low e r  l im i t  of 
sens i t iv i ty  of this method is 10 pg/ml  (see Append ix  A).
Standard ECG leads w i r e  m on i to red  th ro u g h o u t  the p roced  nd b lood  
pressure was moni tored non- lnvas lve ly  using an auton at ic osc l l lo tonometr lc  
dev ice w h b h  recorded t h '  b lood pressure every 60 sec. Heart  rate was also 
recorded every 00 sec Stat ist ical  analysis was per formed us ing S tuden t ’s 
t - tes t  to  d e te c t  d i f fe rences  if any between  the g ro ups  S ig n i f i c an ce  was 
def ined as (p <0 .05) .
7.3 RESULTS
Results a n  repor ted ms means _t_ 1 S.F.M.
The mean th iopen tone  dose used In Group A was 304.6 ±_ 15.2 mg and 322 _j_
18.4 mg In Group  B. There was no s igni f icant d i f ference between the groups.
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7.3.1 Serum M agnesium : Basel ine serum magnes ium concen tra t i ons  were 0.85
i . o . 2 4  mmol / l  in Group  A and 0.81 0.31 mmol / l  in Group B. In Group
A serum magnesium levels increased to 2.95 i  0.56 mmol / l  fo l low ing 
in tubat ion and remained unchanged in Group B
7.3.2 C a rd io v a s c u la r S ys tem : I n d u c t i o n  of  anaes thes ia  p r o d u c e d  m in im a l
non-s ign, f ice, i i  changes  In heart rate and b lood pressure in bo th  groups.  
In the magnesium g roup the in jec t ion of magnesium produced  a r ise in 
neart rate o, 13 _±_ 3.9 beats per m inute from a p re- induct ion mean of
92.2 A . 2.9 b.p.m : in the con t ro l  g roup  there was no s ign i f icant  change  
in heart  rate f rom the basel ine evel of 90 '  .±. 2.5 b.p.m. Fol low ing  
in tubat ion heart rate increased to a maximum moan value of 120.9 i _ 5 . 8 
hears per minute at 2 minutes p o s t - l n tu ta t io n  in the con t ro l  g roup and 
in the magnesium g roup  heart  rate remained v i r tua l ly  unchanged from 
pos t -magnesium values at 107.3 i  3.9 beats per n ln u te .  The d i f ference  
between groups at 2 mln. post In tubat ion was signi f icant  at the 0.05 level
( f igure 7.1)
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Figure 7.1 The effect of either MgSO< or saline on heart rate at the time of endotracheal
Intubation.
* - p  <  0 .0 5
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Neither  magnesium nor sal ine produced s ign i f icant  changes In systol ic 
or  d iasto l ic  arter ial  b lood pressures. Systo l ic  b lood pressure pr ior  to 
In tubat ion was 108.4 _ t 3 . 2  m m H ^  In the magnesium group  and 105.5 ±_ 
2  0 mrr.Hg In the cont ro l  group.  At 2 minutes after Intubat ion systol ic  
b lood pressure had Increased to 128.1 ± . 5 . 3  mmHg In the magnesium 
g roup  and to  143.9 ±_ 4.8 mmHg In the con t ro l  g roup ( p < 0 .0 5 ,  f igure
7.2).
mmHo ________________ __ ___________________________ _
160 , —  -  *
MagnesiumControl
Figure 7.2 The effect of either MgSO* or saline on systolic blood pressuie at the time of 
endotracheal intubation.
* -p<0 .05
Dias to l i c  b lood  pressure Increased In the magnes ium g ro u p  f rom a 
pre- in tuba t ion value of 69.9 ±_ 13.0 mmHg to  a post - in tuba t ion value of 
82.5 ±_ 15.0 mmHg.  In the c o n t r o l  g ro u p  d ia s to l i c  b lood  p ressure  
Increased f rom 68.8 10.5 mmHg io  96.4 ± .  14.4 mmHg fo l lowing
Intubat ion.  The d i f ference between the groups was s igni f icant  at the
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7.3.2 C a techo la m in es : Noradrenal ine concen tra t ions  pr ior  to Induc t ion vere 
s imi lar  in the two groups: Group A 297.3 ± .  27.9 pg/ml  and Group  B
271.4 ±_ 35.5 pg/ml  and were not s ign i f ican t l y  changed by i n du c t ion  of 
a n a e s th e s ia .  F o l l o w i n g  In tu b a t i o n ,  n o r a d r e n a l i n e  c o n c e n t r a t i o n s  
Increased to 626.1 ±_ 59.4 pg/ml  In Group B and to 469 4 j L 3 1 . l  pg/m l  
in G ro u p  A ( p < 0 . 0 5 ) .  Two m inu tes  af ter  In tu b a t io n  n o r a d r e n a l i n e  
concen tra t ions  in Group  B increased to 944.6 ± .  68.7 pg/ml  whi ls t  in
G r o u p  A t h e  noradrenal ine value was 532.5 J L 30.1 pg/ml  ( p < 0 .0 1 ) .  Five
minutes af ter  Intubat ion noradrenal ine concen tra t i ons  were 7 9 0 . 7 ^ . 6 8 . 7  
pg/ml  In Group B and 462.7 ^ 4 0 . 0  pg/ml  In Grcup  A (p < 0 .01 .  f igure
7.3).
Ini t ial  adrenal ine levels were mi ldly elevated In both groups, p roba b ly  as 
a resu lt  of the stress of impending surgery,  despi te  the fact  that  the 
pat ients  were apparent ly  adequate ly  premedicated .  This ef fect  has been 
descr ibed  before (Derbyshi re et al. 1983). Adrenal ine values fel l  In both 
gr oups  fo l l ow ing  Induct ion of anaesthesia f rom 94.5 .±.16 9 pg /m l  to 68.3 
n . 2  in Group  A and from 113.9 19.5 pg /m l  to 7 4 . 9  i  14.2 pg /m l  in
Group  B. In group A adrenal ine concen tra t i ons  remained at basel ine 
leve ls  th ro u g h o u t  the s tudy. In Group  B, ad rena l ine  c o n c e n t r a t i o n s  
increased fo l lowing  intubat ion to 158.9 ±_ 19.7 pg/ml  (p < 0 .0 1 )  and to
279.6 ± .  92.3 pg/ml  ( p < 0  .05) tw o  minutes after in tubat ion.  At f ive 
m in u te s  af ter  in tuba t io n  ad rena l ine  c o n c e n t r a t i o n s  had r e tu rn e d  to 
post  Induct ion values and were not s ign i f ican t ly  di f ferent  f rom Group  A 
(F igure 7.4).
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Figure 7.3 The effect of either MgSOtor saline on noradrenaline levels at the time of endotracheal 
intubation.
* -p < 0 .0 5  + p<0.01
pg/ml 
40J p---------
300
200
100 Ml Mi
Pre-mducMon Poel-lnduetion P o tm tu b lto n
■ ■  Control N M K  Magnesium
Figure 7.4 The effect of either MgSO* or saline on adrenaline levels at the rime of endotracheal 
intubation.
* • p <0.05 + - p<0.01
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7.4 DISCUSSION
The abi l i ty  o l  magnesium Ions to Inhibi t  the release o l  ca techo lamines  I rom  both 
the adrenal  g land and I rom  per iphera l  adrenerg ic  nerve terminals  has been 
known l o r  over  twen ty- l i ve years (Douglas S Rubin,  1963). and Is now  wel l  
es tab l ished In laborato ry  exper iments  (L ishajko.  1970; Dandavlno  at at.. 1977; 
Kl rpekar  & Mlsu. 1967: George S Leach.  1971). but  the ac t ion  ol  Increased 
serum magnesium concen t ra t i ons on Ihe ou tput  ol  ca techolamines  In v 'v o  has 
been po o r l y  Investigated. A l though Lenz el al (1987) showed a small  Increase 
| „  noradrenal ine values al ter  magnesium Infusion, they  at t r i bu ted th is  rise lo 
re f lex  a c t i v a t i o n  o l  m e  s y m p a th e t i c  ne rv ous  sys tem  by re d u c e d  a r te r ia l  
pressure;  noradrena l ine levels In this s tudy  remained w i th in  normal  l imi ts.  The 
present  s tudy  has shown that magnesium can s ign i f icant ly  a t tenuate the output  
ol  ca techo lamines  at the t ime ol  endotracheal  Intubat ion and thus reduce the 
sever ity of card iovascula r  d is turbances.
Tne ca rd iovascula r  ef fects observed In this s tudy were par t icu la r ly  in terest ing.  
U might  be expected that magnesium would produce a s lowing of the atr ial  rate 
by Inh ib i t ing the ca lc ium mediated depo lar i z ing current  In pacemaker  t issue, 
and th is  effect has been demonstra ted  In Isolated anlma! hea r t :  (Tur lapaty  & 
Carr ier.  1973). However .  In the Intact animal  the ab i l i ty  of magnes ium to 
inhibi t  ;ne release of acety lchol ine f rom the vagus nerve may predominate 
(Somjen & Baskervi t le,  1968) and this could  explain the mi ld increase in heart
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rate seen In this ex,  er lment.  A l though  this resul t Is s l ight ly at var iance wi th  the 
earl ier s tud ies descr ibed In chap ter  5, this d i sc repancy  Is smal l ,  and spec ies 
d i f ferences  may account  l o r  it. Despi te this Init ial ,  smal l  Increase In heart rate, 
t h e r e  w a s  no  f u r t h e r  In c r e a s e  In hear t  ra te  f o l l o w i n g  I n t u b a t i o n  In the  
magnes ium group.  A l though  hear t rale In the cont ro l  g roup  was s ign i f icant ly  
tow er than that  In the magnesium g roup pr ior  to  In tubat ion,  the post - ln tuba t lon 
he a r t  ra te In th e  c o n t r o l  g r o u p  was s ig n i f i c a n t l y  h i g h e r  t h a n  th a t  In the 
m a g n e s iu m  g roup .  Th is  was p re su m a b ly  due  to  the  fac t  th a t  ad rena l ine  
concen tra t ions  In the magnesium group did not Increase above basel ine values 
whereas In the cont ro l  g roup there  was a s ign i f icant  Increase In adrenal ine
concen tra t ions.
The vasodi la to r  ef fects of magnesium have been wel l  descr ibed  (Ghonhelm & 
Long. 1970; Tur lapaty  & Carrier.  1973; Somjen & Baskervl l le.  1968. Al tura & 
A l t u r a .  1 978a ;  K e l l y  et a l ,  I 9 6 0 ;  F a r m e r  & C a m p b e l l .  1 9 6 7 ) .  and are 
character ized by a mild and t rans ient  fall In b lood  pressure which Is assoc iated 
w i th  pe r iphe ra l  vas od i la ta t i on  and a c o ns is ten t  Increase in ca rd ia c  index 
(Mroczek et al. 1977; Chapter 5. v ide supra).  Magnesium has a lso been shown 
to reduce the responsiveness of vascular smooth muscle to  noradrenal ine 
s t imulat ion (Farmer 4 Campbel l .  1967). In the present  study, increases in both 
sys to l ic  and d iasto l ic  b lood pressure were less in the magnes ium group than 
t h o s e  seen  In the  c o n t r o l  g r o u p  In n e i t h e r  g r o u p  was t h e  re lease  of 
noradrenal ine  to ta l ly  prevented but the noradrenal ine levels in the magnesium
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group  were s ign i f icant ly  lower  than those seen In the cont ro l  group.  The 
improved con t ro l  of b lood pressure In the magnesium g roup  was probably  
therefore due to a comb ina t ion of the vasod l la to ry  ef fects  of the Ion and the 
inh ib i t ion of catecholamine  release.
This s tudy  thus provides the f i rst  ev idence that  elevated serum magnesium 
concen t ,a t i ons  can Inhibi t the release of catecholamines dur ing per iods 01 
stress. This response is a lmost cer ta in ly  due to  d i rect  ca lc ium antagonism at 
adrenerg ic  nerve terminals and In the adrenal  gland. It m ight  be argued that 
magnesium Is produc ing Its effect by a cent ral  sedat ive mechanism but this is 
un l ike ly  as magnesium crosses the b lood-b ra in  t err ier  wi th d i f f icul ty,  and has 
l i t t le or no central  sedat ive effect even at much higher  serum levels than those 
usod In the present  s tudy (Somjon et al, 1966).
These a c t i o n s  of m agnes ium  In p r o te c t i n g  aga ins t  the harmfu l  e f fects  of 
endot racheal  Intubat ion are probably  not super ior  to  the ef fects of the poten i  
s ho r t -ac t ing  op ia te  agents,  fentany l  and al fentan l l .  A l fentan i l  In "a r t i cu la r  
shows cons iderab le  promise In this regard (Crawford & Fell, 1987). However , 
the use of op ia tes has been assoc ia ted with muscle r ig id i ty ,  bradycard ias,  
hypo tens ion,  and respi ratory  depress ion and in those c i r cumstances In which 
th e s e  c o m p l i c a t i o n s  may  be u n d e s i r a b le  m a g n e s iu m  c o u l d  be a usefu l  
a l ternat ive In the case of patients wi th pregnancy-assoc ia ted  hyper tens ion,  
a l though the use of Intravenous op iates has been advocated to a t tenuate the
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potent ia l ly  l i fe- threaten ing hyper tens ive response to Intubat ion ?t the t ime of 
caesarean sect ion,  the use of such drugs carr ies obv ious  hazards In terms of 
foetal depress ion.  A sc '- im magnesium level of 2-4 mmol / l  at the t ime of 
e n d o t ra c h e a l  I n tuba t io n  may be p a r t i c u la r l y  va lu a b le  In the hype r te ns ive  
pregnant pat ient.  In a study, this possib le protect ive  ef fect  of magnesium 
in pat ients  wi th pregnancy associa ted hyper tens ion was conf i rmed  (Cork et al, 
1984).  w i t h  no a p p a re n t  d e t r im e n ta l  e f fe c ts  on the fo e tus .  Even where  
magnesium has been used to cont ro l  the convuls ive risk In these pat ients.  It 
would seem sensible to conf i rm the serum concen trat ion of magnesium pr ior  to 
the induct ion of anaesthesia,  as s tandard doses of M g S 0 4 f requen t ly  fal l  to 
p roduced this des i rable  therapeut ic  level. A fur ther  In tr igu ing poss ib i l i t y  Is that 
c o m b i n a t i o n s  of  s h o r t - a c t i n g  o p i a t e s  and  m a g n e s i u m  m a y  o f f e r  g o o d  
card iovascular  cont ro l  at lower  doses of both agents  and therefore wi th fewer 
side ef fects.  This poss ibi l i ty  remains to be evaluated.
Magnesium has also been shown to reduce fasc icu la t ions (De Vore 4 Asraml . 
1980) and potass ium release (Aldrete et al. 1970; James et al. 1986) fo l l owing 
suxamethon ium and these act ions combined wi th the ca rd iovascula r  cont ro l  
that can be achieved by the use of magnesium may be of value. First ly,  the 
reduct ion In fasc icu la t ions should reduce the post operat ive muscle d is comfor t  
which com m on ly  accompanies the use of depola r iz ing relaxants. Secondly,  by 
reduc ing the Inc idence and sever ity of the fasc icu la t ions,  magnesium might 
p r o t e c t  a g a i n s t  the  In c re a s e  In I n t r a o c u l a r  p r e s s u r e  w h i c h  f r e q u e n t l y
■ . . . « h  1 .  - - . i - r  r
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accom panies  tha onset of suxamethonium para lysis  and this would obv ia te the 
n e e d  f o r  t h e  p o t e n t i a l l y  d a n g e r o u s  use o f  a p r e t r e a t m e n t  d o s e  o f  a 
n o n -d e p o la r i z i n g  re laxant  In pa t i en ts  wi th  open  eye In jur ies.  Th i rd ly ,  by 
prevent ing the release of potass ium at the t ime of depola r izat ion,  magnesium 
should of fer  pro tec t ion  In pat ients  wi th e lect ro ly te  d is turbances.  None of these 
possib i l i t ies  have been studied at the present  t ime.
This s tudy has, therefore, conf i rmed the in v itro  work which demonstrated that 
excess magnaslum can Inhibi t  the release of catecholamines,  probab ly  by 
ca lc ium antagon ism at adrenerg ic  nerve terminals  and the adrenal  gland. It has 
a l so shown tha t  th is  e f fect  o c c u r s  at c l i n i c a l l y  adequa te  and safe serum 
concen trat ions  of magnesium, s imi lar  to those advocated for the management  
of pre e c la m p t i c  toxaemia ,  and It has d e m o n s t ra te d  tha t  th is  e f fec t  Is of 
suf f ic ient  magni tude as to be of use in c l in ica l  si tuat ions.  This Inh ib i t ion of 
c a t e c h o l a m i n e  re lease  c o u p le d  w i th  the a n t i - a d r e n e r g i c  e f fe c ts  a l r e a d y  
demonstra ted make magnesium a potent ia l ly  very valuable agent In cond i t ions 
of  c a te c h o l a m i n e  excess ,  but  Its role in such  c o n d i t i o n s  rem a in s  to  be 
evaluated.
0
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8. MAGNESIUM AND THE MANAGEMENT OF 
SEVERE TETANUS
Very severe te tanus is character ized by ca rd iovascula r  ins tab i l i ty  and other  
signs of au tonomic  nervous system d is tu rbances.  These d is turbances have 
been shown to be due main ly  to  over  ac t iv i ty  of the sympa thet ic  nervous system 
and are associate • wi th elevated c i rcu la t ing ca techo la mine  levels (Kerr et al, 
1968; Kei l ty et il, 1968). Prys-Rober ts  and others  (Prys-Rober ts et al, 1969) 
used prop rano lo l  to con t ro l  the charac ter is t ic  tachycard ias  and hyper tens ion,  
and this app roach has become standard pract ice (Kerr, 1978). Addi t ion  of 
vasod i la to r  drugs inc lud ing  phen to lamine (Al f rey & Rauscher , 1979; Goldman 
ei al, 1979), bethanid ine (Kanarek et al, 1973) and phenoxybenzam ine (Furste, 
1980) has been recommended .  More recent ly,  labetalol  has been used for  its 
added a -  b lock ing proper t ies  (Dundee & Mor row,  1979; Omar et al, 1979; 
Connor  et al, 1979). Very heavy sedat ion has been c la imed to reduce the 
i n c id ' n c e  of au tonomic  dys func t ion  (Cole & Youngman,  1969; Edmondson  & 
Flowers, 1979) but ca rd iovascula r  instabi l i ty  and elevated catecholamine levels 
may persist  in severely in tox icated pat ients  (Kerr et a l . . 1968; Buchanan et al, 
1979) and the use of ad rene rg ic  b lock ing drugs to cont ro l  the peaks of pulse 
rate and b lood  pressure is recommended  in add i t i on to seda t ion (Kanarek et al,
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1973; Edmondson,  It is now wide ly  accepted p rac t ice to ut i l ize deep
sedat ion,  coupled  wi th muscle relaxants and posi t ive pressure vent i la t ion as the 
mainstay of t rea tment  H  an at tempt  to minimize input  s t imul i  wh ich may resul t 
in excessive au tonomic  act iv i ty.  In some pat ients,  however ,  these d is tu rbances  
persist,  despi te  very heavy sedat ion to the point  of v i r tual  anaesthes ia.  In this 
group  of pat ients the mor ta l i ty  has been quoted as being in excess of 50%, even 
wi th  the add i t ion of ad renerg ic  b lock ing drugs (Wesley et al, 1983) and It has 
been suggested that p -ad iene rg ic  b lockade may have con t r ib u ted  to the fatal 
ou tcome in some of these pat ients.  The use of p-ad rena rg lc  b lock ing drugs is 
no t  w i t h o u t  hazard,  as the hear t  may depend  on p -ad re ne rg ic  ac t i v i ty  to 
maintain adequate t issue perfus ion (Kerr, 1979), The co m m c ne s t  cause of 
death in these c i rcum stances  is sudden, unexpected ca rd iac  arrest  (Kanarek et 
al, 1973; Kerr, 1979; Tru j i l l o  et al, 1980) and this has been assoc ia ted wi th the 
use of p-b lockers (Edmondson  & Flowers,  1979; Buchanan et al, 1978). Where 
adrenerg ic  b lockers are used, It Is not uncom mon to be faced  with the prob lem 
of a relat ive overdose of these agents  when the spasm of adrenerg ic  d ischa rge 
a b r u p t l y  t e r m i n a t e s .  If i t  w e r e  p o s s i b l e  t o  p r e v e n t  t h e  r e l e a s e  of  
catecho lamines,  this wou ld  be an at t ract ive al ternat ive to t ry ing to b lock thei r  
a c t i o n s  The  a n t i - a d r e n e r g i c  a c t i v i t y  o f  m a g n e s i u m  w h i c h  has b e e n  
d e m o n s t r a te d  In p re v io u s  c hap te rs  as be i i .y  p o te n t i a l l y  usefu l  in c l in i ca l  
s i tuat ions suggests  that  this agent may have a role in the management  of the 
ca rd iovascu la r  d is tu rbances  assoc ia ted with severe tetanus. If, in add i t ion,  
magnesium also inhib i ted the release of adrenal ine and no radrenal ine f rom the 
adrenal  g land and f rom per iphera l  adrenerg ic  nerve terminals ,  this would  add
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s ign i f icant ly  to  tha ease wi th  which the ca rd iovascu la r  d i s tu rbances  could be 
managed a .d £ uuid decrease both morb id i t y  and mor ta l i ty .  Fur thermore,  .he 
we l l - known nvu ro  luscular  b lock ing proper t ies  of this agent  (Engbaek, 1952; 
Del Cast i l lo  & Engbaek, 1952, Je nk i r s on  & Engbaek,  1954; Jenkinson,  1957) 
c o u l d  be of  va lue  in c o n t r o l l i n g  spasm s.  It t h e r e f o r e  seemed w o r t h y  of 
inves t iga t ion as a potent ial  therapeu t ic  agent  in very severe tetanus.
8.1 METHODS
All pat ients admi t ted to the intensive care unit w i th  a d iagnos is  of severe te tanus 
were t reated by 3ta dard methods based on neuromuscu la r  b lockade and deep 
sedat ion,  but omi t t ing the use of p-b lockers.  Sedat ion was gradual ly  increased 
as Ind icated by the pat ient 's  condi t ion up to a pre set maximum. The d rugs and 
dcsage  schedules used are i l lustrated in table 8.1.
Tab le  8.1
Drug In i t i a l  Dosage M a x im u m  Dosage
Diazepam lOmg every 2 h 20mg every hour
Morph ine 5mg every 2 h lOmy every hour
Ch lo rp rom az ine  50mg every 12 h 10Omg every 6 h
Rhenobarb i tone  50mg every 12 h lOOmg every 6 h
Table 8.1 Sequence and dosage In which sedat ive drugs were admin is tered 
t c  adul t  pat ients  wi th severe tetanus Dosages were appropr ia te ly  scaled 
dow n  for  ch l ld 'en .
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Muscle re laxat ion was mainta ined wi th 10 mg of a lcuron lum i.v as necessary  
to con t ro l  pers istent  spasms. This form of therapy  was fo l lowed  for at least  7 
days.
At the end of seven days, the pat ient 's  response to therapy was assessed 
Cri ter ia fo r  judg ing current  the rapy  as unsat is fac to ry  were aro i t rar i ly  de f ined  as 
fol lows:  f luc tuat ions of sys to l i c  arter ial  b lood p r e s c i r e  of more than 40 mmHg 
per day, f luc tua t ions  of pulse rate of more than 40 beats per minute In a 24 hour  
per iod and f requency of spasms of more than one per hour. If all these cr i ter ia  
were met, the pat ient was then admi t ted to the trial.
At the t im e  of admiss ion to the trial, all pat iunts had an ar ter ial  l ine p laced,  
usual ly In the radial  ar tery,  using a 22G tef lon cannula. This was to fac i l i ta te  
b lood pressure moni tor ing,  and to prov ide easy access for  the f requent  b lood 
samples that  the s tudy require i  Where poss ible ,  a f low-d i rected the rm od i lu t i on  
pu lmonary  ar tery catheter  (Edwards 93A-131-7F)  was Inserted at the same t ime.
M a g n e s i u m  su lp h a te  I n f u s io n s  have a c h ie v e d  an a c c e p t e d  p lace  in the 
managem ent  of pre ec lampt ic  toxaemia (Pr i tchard & Pr i tchard.  1975; Cavenagh 
& Knuppel ,  1981) and it wr.s dec ide. '  to use therapeu t ic  regimes bor rowed  f rom 
standard obs tet r i c  p iac t l ce  as the basis for  the use of magnesium in tetanus. 
Acco rd in g ly  each pat ient  was given a lead ing dose of 70mg/Kg of magnesium 
sulphate as an infus ion over  5 minutes. This was fo l lowed by an in fus ion at 
whatever  rate was requi red to maintain a s teady s u t e  b lood level of between
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2.5 and 4 mmol / l i t re .  Serum magnesium levels were moni to red every 4 hours,  
us in g  a t o m i c  a b s o r p t i o n  s p e c t r o p h o t o m e t r y ,  and s e ru m  c a l c i u m  le v e ls  
m on i to red  on a da i ly  bas is a long  w i th  all the rout ine da i ly  inves t iga t io ns.  
Card iac ou tpu t  was est imated by the rmod i lu t ion using 10 ml of iced 5% dex t rose 
as an Ind icato r  and a Hewlet t  Packard card iec  ou tpu t  com pu te r  (HP 78231C). 
Measurements were made pr ior  to the start  of magnesium therapy,  and then 
tv/ice da i ly  for  t. e next two days. Measurements were made at the sarr t ime of 
day, and at least two hours af tor  any d is tu rb ing  p rocedure such as t racheal  
suct ion or  phys io the rapy ,  in order  to ensure that  measurements were rela t ively  
c o r  oarable.  Readings of centra l  venous and pu lm onary ar tery  wedge pressures 
were also made, and a value for  per iphera l  vascular  resis tance ca lcu la ted.  In 
all pat ients,  b lood  pressure record ings were made on an hour ly  basis, but peaks 
of pulse rate and b lood pressure occur r ing  between these Intervals were also 
n o t e d  t h r o u g h o u t  the  c o u r s e  of  th e  I l l n e s s .  To m i n i m i z e  the  r i s k s  of 
cathe ter - re la ted  sepsis, the pu lmonary  ar tery cathe te r  was removed af ter  two 
days, but  the arter ial  pressure mon i tor ing mainta ined con t inuous ly  over  the 
next two weeks using mul t ip le  sites Fol low ing the Inst i tut ion of magnesium 
therapy,  o the r  forms of sedat ion were gradual ly  decreased as the pa t ient ' s  
cond i t ion  a l lowed,  com m enc ing  with t i .e pheno th iaz ines and benzod iazepines.  
If the pat ient  fai led to respond to magnesium therapy,  prov is ion was mar < In 
the p ro to co l  for  addi t ional  doses of sedat ives as wel l  as a l l owance  being made 
for  the add i t i on  of a-ad renerg lc  b lockers In ext reme cases. The magnes ium 
Infusion was gradual ly  reduced after two weeks, or earl ier If ♦' pat ient ' s
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condi t ion permi t ted,  but if ca rd iovascula r  ins tab i l i ty  recurred,  the infus ion was 
increased again.
8.2 RESULTS
Out of a to ta l  of twanty-one pat ients wi th te tanus admi t ted  to the intensive care 
unit of the Paryrenyatwa Hospi tal  Harare,  Z imbabwe,  over  a two year per iod 
f rom 1981 to  1983, ten pat ients qual i f ied for  admiss ion to ’ he tr ial There were 
two ch i ldren  in the group,  both under  six years of age. Neonates were not 
cons ide red  for  admiss ion to the tr ial.  Of the ten pat ients,  eight  survived The 
cause of death In one pat ient was overw he lm ing sepsis and In the ether  severe 
pu lmonary Infect ion wh ich predated her admiss ion to the unit. Of the non- tr ial  
group,  three pat ients died,  two of whom had sympathe t ic  over load,  but died 
before the seven day point  One of these pat ients,  a 70 year-old male, died 
suddenly ,  fo l lowing  a sudden fall In b lood pressure,  nnd a myocard ial  in fa rc t ion 
was suspected  The other  two both had aspi ra t ion  pneumonia on admiss ion,  
and this was the probable  cause of death in these cases. In the pretr ial  per iod,  
therefore,  there was a total  of 12 pat ients  with sympa i t i c  over load,  four  of 
whom died, two wi thou t  receiving magnesium. The mor ta l i ty  in the pret r ia l  
g roup v/as 3 out of 11, whi lst  in the pos t - t r ia l  group, 2 pat ients  died out of 10. 
Of the 5 dea ths  over  this period,  four  of these were due to in fect ions wi th 
organisms resistant to the l imi ted range of an t ib io t ics  avai lable in Z imbabw e at
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the t ime One of the deaths  in the pretr ial  g roup  was probab ly  the resul t  of 
sympa thet ic  overact iv i ty .  The surviving 8 pat ients  in the non -s tudy  g roup were 
a'l easi ly cont ro l led at re lat ively low levels of sedat ion and were not s tud ied 
further.
The magnes ium infus ion was maintained for a mean of 22 days wi th a range of 
9 to 31 days.  In every surv iv ing case, it was poss ib le  to s top all sedat ion excep t  
for morphine  for  the last few days, and to con ta in  st i f fness and spasms wi th 
magnesium alone. This al lowed for  a comfor tab le ,  awake and co operat ive  
pat ient.
In al l but  one  case,  s a t i s f a c t o r y  c o n t r o l  of c a r d i o v a s c u l a r  f u n c t i o n  was 
achieved. The one case in whom contro l  of the card iovascu la r  system could 
not be estab l ished was the one who died of severe sepsis. Since this p a t ian t ’ s 
prob lems were related to sepsis, addi t ional  card iova 'u 'u lar  agents were not 
used in th is  case, a l though deep sedat ion was maintained No other case 
requi red mod i f icat ion of the protocol .  Typical  records are i l lustrated in f igures
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Figure 8.1 Hourly heart rate and blood pressure recordings in a patient with severe 
cardiovascular disturbances at Day 7 prior to admission to tne trial
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Figure 8.2 The same patient as in figure 8 1 at Day 9, two days after the commencement of 
magnesium therapy.
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Figure8.3 Cardiovascular disturbances in another patient on Day 12, the day of commencement 
of magnesium therapy. Between 23:00 and 24:00 the infusion was interrupted due to 
a blocked line. Note the re-appearance of instability at this time, and the drop in serum 
magnesium to below therapeutic levels.
24 HOUR OBSERVATION
240
220 -
200
180 -
160
140
120
100
80
07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 01 02 03 04 05 06
HR — t— BP
Figure 8.4 The some patient as in figure 8.3 at Day 13.
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The range of b lood pressure and pulse rate encoun te red  before and dur ing  
magnesium the rapy  is i l lust rated In table 8.2 The maximum pulse rate was 
reduced In all but the one case, and the d i f ference In max imum heart rate before 
and d u r i n g  the m ag n e s iu m  in fus ion  was h ig h ly  s ig n i f i can t .  There  was no 
s ign i f icant  change in the min imum rate. The maximum systo l ic  b lood  pressure 
was also reduced in 9 cases, the d i f ference again being signi f icant .
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Table 8.2
P re -m a gne s iu m
SBP/D BP SBP/DBP Hear t Rate
Max Min Max Min
160/110 60/40 165 60
240/1 10 90/40 160 68
160/70 110/60 130 82
150/100 90/60 160 110
160/90 80/40 150 104
170/120 130/100 164 80
176/130 60/20 140 64
142/102 80/45 152 94
150/70 90/50 150 80
130/60 60/30 146 74
Means 163.8.1.28 85_±_21 151.7.1.10 8 2 j J 6
Post m a g n e s iu m
SBP/DBP SBP/DBP Hear t  Rate
Max Min Max Min
98/58 86/47 118 110
120/50 90/40 100 60
150/90 80/50 170 100
130/70 100/40 128 102
120/70 90/50 118 100
110/70 100/60 108 84
130/80 110/70 120 90
124/90 100/72 144 92
140/60 80/50 104 72
100/6" 84/40 104 72
Means 122±_16* 9 1 4 U 5 121 _1_20* 92.9.1.9
Table 8.2 Pulse rates and b lood  pressures before and af ter magnesium therapy.  
Pre-magnesium values represent  the greatest  f l uc tua t i on  In a 24 hour  per iod for 
the 2 day s  p r io r  to  t rea tm en t .  The p o s t -m a g n e s iu m  values rep resen t  the 
greatest  f luc tua t ions  dur ing the first week af ter  s ta r t ing t reatment .
* - p «- 0.05
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Pulmonary aMery catheter iss t ion  was achieved In six cases It was dec ided not 
to a t tempt  It In the case of overwhelm ing sepsis, due to the r isks of bacter ia l  
endocard i t is ,  nor was it a t tempted in the two ch i ld ren In one other  case, 
cathete r isat ion was imposs ib le  for  technica l  reasons The values for  card iac  
indices obta ined  are i l lust ra ted in tab le 8.3.
Tab le  8.3
P re -M a g n e s iu m  P o s t - M a g n e s iu m
HR Cl SVI SVR HR Cl SVI SVR
130 4.12 31 4 970 116 2. ) 37.9 860
106 4.46 47.4 1123 90 2.79 52.1 732
120 4.72 40.3 869 80 4.00 50.0 695
124 5.51 44.9 1067 76 5 23 68.9 636
110 5.34 48.5 1109 N 7.08 68.0 745
168 7.00 41.7 1008 72 4. : 'A 49.9 868
Means 126 5.19 42.4 1025.3 82.3* 4.68 54.5* 757.3
SEM 9.1 0.4 2.5 44.7 7.8 0 6 4 9 37.5
Table 8.3 Card iovascu lar  ind ices in six pat ients pr ior  to the start of magnesium 
therapy,  and two days af ter  magnesium therapy had been inst i tuted.
HR - heart rate in beats per  minute 
Cl - card iac Index in l /m in /m 2 body sur face area 
SVI - s t roke vo lume index in m l /bea t /m 2 body sur face area 
SVR - systemic vascular  resis tance In dyne s .c m '5 
* - p <0 .0 5  
+ - p <  0 01
Not  surpr is ingly ,  all pat ients exhibi ted an e levated card iac  index which was not 
markedly  reduced by the magnesium Infusion. In these pat ients  pulse rate at 
the t ime of do ing  the readings  was reduced in every case and the d i f ference in 
mean pulse rate between the pre-magnesium and pos t -magnesium values was
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s ta t i s t i ca l l y  s ign i f i can t  ( p < 0 . 0 5 ) .  There was a para l le l  i nc rease In s t roke  
vo lume In all pat ients (p < 0 05 for  the d i f ference in means between pre- and 
p o s t - m a g n e s iu m  g ro u p s )  p r o b a b l y  due  to a r e d u c t i o n  in a f t e i l o a d .  The 
systemic vascular  res is tance was rela t ively  low pr ior  to the use of magnesium, 
p resumably  as a result  of the ch lo rp romaz ine and barb i tu rate inc luded in the 
sedat ive regime. Fur ther  s ign i f icant  reduc t ions  o l lowed the use of magnesium 
( p <0 .01) .  Pulmonary cap i l lary  wedge  pres ure was w i th in  the normal  range 
(5-12 mmHg) In all cases both before and af ter  the com m encem en t  of the 
magnesium Infusion, and appeared to be unaf fected by It. Central  venous 
pressure was simi lar ly unchanged  by magnesium in all cases.
In order  to mainta in a s teady  level of serum magnesium of between 2.5 and 4 
mmol /L,  an infus ion rate of between 1 and 3 gm per hour  was requi red. However,  
there was wide Individual  var ia t ion and also cons iderab le  day - to-day var ia t ion 
within each individual.  No f irm guide- l ines could be dete rmined  for the in fusion 
rate, and f requent  est imat ion  of the serum magnesium was the only safe way to 
keep con t ro l  of the magnesium level. In two cases the serum magnesium rose 
to over  6 mmol / l  on one occas ion In each pat ient.  These pat ients  both exh ib i ted 
p ro longa t ion  of the PR Interval  with runs of noda: rhythm The arrhythmias 
responded prompt ly  to the infus ion of ca lc ium g lucona te  and reduct ion in the 
Infusion rate of the magnesium sulphate,  and did not recur  No other  ser ious 
cardiac d i s turbances  were noted In the series.
The com m ones t  b iochemica l  comp l ica t ion  was a fall  In serum calc ium.  This Is 
not surpr is ing,  as magnesium inhibi ts the release of pa ra thy ro id  ho rmone (Ebel
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& Gunther,  1980). Calc ium supplements  were needed f requent ly  in o rder  to 
maintain the serum calc ium level wi thin the no rma1 range. In no pat ient  was the 
serum ca lc ium level a l lowed to fal l  be low 1.7mmol / l .
F o u r  p a t i e n t s  s h o w e d  s i g n s  of  h i g h  o u t p u t  ren a l  f a i l u r e  p r i o r  t o  the  
c o m m e n c e m e n t  of m a gne s ium  su lpha te  therapy ,  wi th  e leva t i ons  of serum 
creat in ine and urea and a fall  In creat in ine c learance,  despi te  adequate ur ine 
ou tput  in three of the four  cases. One pat ient  in this group  died, this being the 
pat ient  wi th  severe sepsis,  this pat ient u l t imate ly  deve lop ing  o l igu r ic  renal 
fai lure as par t of his sep t icaemlc  state.
The levels of serum magnes ium used In this study (2.5-4 mmol / l )  produced  
p io fo i .nd  neu rom uscu la r  b lock  in all  pat ien ts .  As a resul t ,  the am oun t  of 
a lcuron ium requi red was drast ica l ly  reduced from a general  range of 250 - 
300mg per  day (approx imate ly  one dose every 45 to 60 min.) to eround IPOmg 
per day (approxl .  . , ly  2 to 3 hours between doses) .
8.4 DISCUSSION
This is not  the f irst t ime that a role for magnesium in the management  of te tanus 
has been suggested .  B lake (1906) d es c r ibe d  two cases of severe te tanus  
treated w i th  intrathecal  magnesium sulphate.  One pat ient wi th a very heavy 
bacteraemia  died t w ' ' v e  hours after the in ject ion,  but the other  rece ived 5
H H H H H H V  ^M H M M m m h h h h b h h m
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Int rathecal  In ject ions of 12 5% magnesium sulphate over  a ten day per iod and 
made a ful l recovery. In the same year, Mel tzer  descr ibed the use of magnesium 
by Int ravenous, int raspinal  and subcu taneous  routes and co nc luded  that no 
other  agent then avai lable was as as ef fect ive In cont ro l  of sym p tom s  as was 
magnesium (Meltzer,  1906b). More recent ly,  Natu and his co l l eagues  descr ibed  
hypomagnesaemia  in a series of 36 pat ients and corre la ted the level of serum 
magnesium wi th the sever i ty  of the disease (Natu i t al, 1980). They suggested 
a role for magnesium Infus ions In the management  of the cond i t ion ,  at least in 
t h o s e  p a t ie n t s  In w h o m  the se rum  m a g n e s iu m  was low .  The f i n d i n g  of 
hypomagnesaemia  was not, however , con f i rmed in the present  study.
Al though it is Imposs ible to make any f irm s tatement  about  mor ta l i t y  in a small  
si  ies l ike this one, the fact  that no pat ients died from causes at t r ibu tab le  to 
the i r  te tanus was pleasing, par t icu lar ly  in v iew of the fact that  four  pat ients  had 
ep isodes of high output  renal fai lure, and on ly one of these d ied Seedat  et al. 
(1981) found that thei r pat ients wi th this comp l i ca t ion  of te tanus had a 65% 
morta l i ty .  The two deaths were both related to In fect ions (one pu lmonary,  the 
other  sept icaemia of unknown source)  wi th organism that were resistant  to the 
avai lable an t ib io t ics  It is possible  that, wi th a wider  spec t rum of an t ib io t i cs  to 
cal l  upon, these pat ients  could also have been saved.
The cont ro l  of the card iovascu lar  ef fects of severe tetanus dem ons tra ted  in this 
s tudy are most  encouraging.  At the t ime of per form ing this s tudy,  fac i l i t ies  for 
the  d i re c t  m ea s u re m e n t  of  c a te c h o la m in e  leve ls  were not  ava i lab le ,  and 
therefore the mode of ac t ion of magnesium in these cases remains con jec tu ra l .
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The reduc t i on  in per iphera l  resistance that occu r red  could  be mediated by a 
d i rect e f fect  on the b looa vessels (Kel ly et al, 1960; Farmer  & Campbel l ,  1967; 
Overbeck  et al, 1969; George & Leach, 19 /1 ;  A ltura & Altura, 1981 a, b & c, chap 
5). However ,  In vivo, the hypo tens ion  produced  by raised serum magnes ium Is 
genera l ly  found t c  be evanescent (Pr i tchard & Pr i tchard,  1975; Maxwel l  et al, 
1965; Dandav lno et al, 1977; Mroczek et al, 1977). One of ♦he features of this 
study was the cons is tent  reduct ion  in sys to l i c  b lood pressure,  and the con t ro l  
obta ined over  the paroxysmal  episodes of hyper tens ion.  A l though the dai ly 
range c f  b lood  pressure f luc tuat ion  sti l l  exceeded the admiss ion cr i ter ia for  the 
trial, the range of b lood pressure was reduced In 8 of the 10 sub jects  and 
u n c h a n g e d  In one.  The on ly  case In w h ic h  the range in b lood  p res s u re  
de te r iorated was In the pat ient  wi th severe progress ive sept icaemia It It, 
unl ikely,  therefore,  that the cont ro l  of b lood  pressure achieved was due solely 
to the d i rec t  vasodi la tor  ef fects  of magnesium The reduct ion in heart ra t '1 that 
occu rred  is also unl ikely to be due to a d i rec t  ac t ion  of magnesium The act ion 
of m agnes ium is to produce a mild s low ing of hear t rate in the isolated heart 
(Somjen & Baskervi l le,  1968), and this has also been shown . 0  occu r  in the 
In tact  a n im a l  (see chap te r  5), How ever ,  It has a lso been de s c r ib e d  that  
Inhib i t ion of ace ty lcho l ine release at the vagal  terminals  may predomina te  
resul t ing In a mild increase in heart rate in humans  (Garb, 1951; see chap te r  7). 
The observed reduct ion in heart rate was very much greater  than that seen in 
the an imal  exper lme i ts  at simi lar  magnesium levels, and opposi te  to the change  
se en  in h e a l t h y  h u m a n  s u b j e c t s  w h e r e  m a g n e s i u m  was used  p r i o r  to 
e n d o t r a c h e a l  I n tu b a t i o n  ( c h a p te r  7). Thus ,  It seems p r o b a b le  t h a t  thiv.
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reduct ion in heart rate was, at least in part ,  due to a lessening of sym pathe t i c  
tone. The range of heart ra le f luc tuat ion  was also reduced in every case excep t  
the pat ient wi th sept icaemia.  It Is most  l ikely,  the re fo re  that the Improvemen t  
in ca rd iovascu la r  func t ion In these subjects  was due In some degree to  a 
reduc t ion  in the level of c i r cu la t ing  catecholamines .  However , a l though  it has 
been shown that magnesium infus ion can inh ib i t  the release of catecho lamines,  
this s tudy does not al low the assumpt ion that  the benef icia l  ef fects seen were 
ent i re ly due to  this act ion of magnesium. Whi lst  there is a st rong c i rcum stant ia l  
case to be made for this possibi l i ty ,  fur ther  ev idence is requi red before this 
c la im can be made wi th conf idence.
Contra ry  to the popular  v iew (see chapter  2), magnes ium is not an anaesthet ic  
nor  even a major  centra: nervous system depressan t ,  unless appl ied d i r ec t l y  to 
the nervous t issue via the cerebrospina l  f luid (Mordes  & Wacker,  1978). Somjen 
e l  at (1966 )  s h o w e d  th a t ,  p r o v i d e d  v e n t i l a t i o n  was  m a in ta in e d ,  s e r u m  
magnes ium levels of up to 8 mmol /L  had no sedat ive ef fect  in humans.  A ldrete 
et al (1968) found that s imi lar  levels of magnes ium p roduced a sleep l ike state 
in dogs, but not anaesthesia.  They at t r ibuted the dec l ine in c o n s d c  level  to 
Impai red ca rd iovascu la r  ’ unct ion The fai lure of In travenously admin is te red 
magnesium to produce ana,. ?'h,.sia is large ly  due to the fact that the b lood-  
brain barr ier  is relat ively Impervious to magnes ium and even in long s tand ing 
del iberate hypermegnesaemia,  only small  Increases In CSF magnesium leve s 
w e re  fo u n d  ( P r i t c h a r d ,  1955) .  C en t ra l  a c t i o n s  of  m a gne s iu m ,  t h e r e fo r e ,  
p robably  d id  not cont r ibu te  s igni f icant ly  to the observed resul .s of this s tudy
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The ca lc ium antagonis t ic  ef fects  of magnesium might  be expec ted to produce  
a reduct ion  in myocard ia l  con t ract i l i ty ,  and a fal l In card iac  output .  However ,  It 
has been show n  tha t ,  p r o v id e d  h y p o c a l c a e m i a  is a v o i d e d ,  the neg a t i ve  
inot rop ic  ef fects of magnes ium are minimal  (Garb, 1951; Kovacs & O'Donnel l ,  
1?7 5). The p r e s e r v a t io n  of  c a rd ia c  o u tp u t  at e l e ' a t e d  leve ls  is a lso  not 
surpr is ing,  as magnesium increases the cardiac output  in baboons (chap ter  5), 
par t icu lar ly  in the presence of catecholamines (chapter  6). It has also been 
shown tha t  magnes ium  can increase the ca rd ia c  o u tp u t  in normal  human 
subjects (Mroczek et al, 1977). A l though magnesium d im in ishes  the ou tput  of 
ca techolamines,  It Is un l lke 'y  that total  Inh ibi t ion of ca techolamine reioase can 
be achieved In the cl inical  s i tuat ion.  The hazards of p -b lockade in the face of 
a adrenerg ic  d ischarge have al ready been descr ibed,  and magnesium may offer 
a safer means of con t ro l l i ng  the tachycard ias.  Not only does magnesium not 
depress myocard ia l  con t rac t i l i ty ,  but the ab i l i ty  of the heart  to respond to 
ad renerg ic  s t imulat ion is preserved (Paddle & Haugaard,  1971; Levin «t al, 
1976) Indeed, It has been shown that magnesium Is essent ia l  for the Inot rop ic  
act ion of adrenal ine (Vincent ,  1982). It has been suggested that the toxic 
myocard i t i s  occas iona l l y  descr ibed  in tetanus may be mere ly  a manifestat ion 
of catecholamine excess (Kerr et al, 1968), s ince the h is to log ica l  changes  are 
s imi lar to those descr ibed in myocardia l  damage assoc ia ted with p ro longed 
adrenerg ic  s t imulat ion (Raab, 1963). The fai lure of magnesium to b lock the 
Ir c re a s e s  In c a r d ia c  o u t p u t  caused  by a d r e n e r g i c  s t i m u l a t i o n  m ig h t  be 
cons idered a d i sadvan tage However , It has been shown that,  a l though the 
c o n t ra c t i l e  response  Is p rese 'v ,  d < magnes ium, the harmfu l  b iochem ic a l
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ef fects of a d iene rg ic  dr ive such as g lycogenc lys is ,  lac ta te p roduc t ion ,  and ATP 
degrada t ion are inh ibi ted (Paddle & Haugaard,  1971; Levin el a!, 1976). It is 
tempt ing to speculate, therefore,  that magnesium may not on ly protect  the 
card iovascu la r  system by l imi t ing the f luc tuat ions in ca techo lamine levels, but 
a lso may protect  the myoca rd ium  f rom the adverse b iochemica l  ef fects of 
excess adrenerg ic  dr ive when it occurs.
In view of the fact that magnesium has been given in t ramuscular ly  to obste t r ic  
patients in whom only l imi ted mon i to r ing  was used, it might  be cons idered that 
it could be used in the conserva t i ve management  of tetanus. However ,  in this 
study,  magnesium sulphate infus ions exer ted a I. more p ro found ef fect  on 
neuromuscu la r  t ransmiss ion than would have been expected f rom exper ience 
gained wi th  simi lar serum levels In obstet r ics .  Serum magnesium levels of less 
t h a n  5 m m o l / l  are g e n e r a l l y  r e g a r d e d  as h a v i n g  no  m o r e  th a n  m i l d  
n e u r o m u s c u la r  b lo c k in g  p ro p e r t i e s ,  but  in pa t i en ts  in th is  ser ies marked  
neu rom vscu la r  block occur red  at levels between 2.5 - 4 mmol / l .  This could,  
perhaps have been an t ic ipa ted as te tanus tox in  Is known to exh ib i t  a botu l inus-  
l ike act ion at the moto r  end plate (Kaeser & Saner, 1970; Mel lanby & Green, 
1981), p roduc ing  a simi lar  type of neur i  muscular  b lock  to that p roduced  by 
magnes ium alone, and therefore leading to an addi t ive effect.  Whatever  the 
mechanism of this enhanced neu romuscu la r  block produced  by magnesium, the 
m arked  n e u r o m u s c u la r  b l o c k a d e  that  was found  in pa t ients  in th is s tu dy  
prec ludes recommending  the agent for  use outside the intens ive care uni t at 
the present  t ime.
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In c o n c lu s io n ,  m a gne s iu m  s u lp h a te  i n f u s io n s  have been shown to be of 
p o te n t i a l  bene f i t  in a s s i s t i n g  the c o n t r o l  of c a r d io v a s c u la r  d i s t u r b a n c e s  
assoc ia ted  wi th severe tetanus.  Further  s tud ies into the use of this agent  are, 
t h e r e fo r e  j u s t i f i e d  in o r d e r  to  a ns w e r  s om e  of  the re m a in in g  q u e s t i o n s ,  
p a r t i c u l a r l y  t h o s e  p e r t a i n i n g  to  the use of  m a g n e s iu m  in less  s e v e r e l y  
in tox ica ted pat ients than those s tud ied in th is tr ial .  It is also necessary  to 
demonst ra te  that  catecholamine  concen tra t i ons  can, indeed,  be reduced  by 
in fus ions of magnesium.
8.5 MAGNESIUM AND C ATEC H O LAM IN E  RELEASE IN TETANUS
A recent  case of vary severe te tanus presented the oppor tun i ty  for  s tudy ing the 
h y p o t h e s i s  tha t  m agn e s iu m  s u lp h a te  I n f u s io n s  c o u ld  r e d u c e  c i r c u l a t i n g  
ca techolamine levels and thus improve ca rd iovascu la r  funct ion.
8.6 CASE REPORT
The pa t i em was a 29 year old black male, prev ious ly  in good heal th,  who  was 
t ransfer red from another hospi ta l  wi th a d iagnosis  of severe te tanus The focus  
for  his Clostr id i um te tan ii In fect ion was a sept ic  com pound  f racture of the r ight  
radius which he had sustained dur ing an assaul t  one week prev ious ly.  There
Tetanus 142
was no reco rd  of his ever oeing vacc inated against  te tanus and the phase of 
onset of the d isease was on ly  48 hours At the t ime of his transfer , he was 
ha v in g  f r a n k  t e t a n i c  s p a s m s ,  w i t h  o p i s t h o t o n o s ,  r i s u s  s a r d o n l c u s  and 
a b d o m in a l  r i g i d i t y  fo r  w h i c h  he had rece ived  20m g of d ia z epa m  and 11 
ampoulas of human ant i - tetanus g lobul in  (10 ampou les  IMI, and 1 am poule 
int ra thecal ly ) .  Approp r ia te  an t ib io t ic  t he rapy in the fo rm of penici l l in G 2 mi l l ion 
units 2 hou r ly  IVI had been inst i tuted.
Physical examinat ion f ind ings  were normal and his pulse was 130/min, b lood 
pressure 150/100 and his perfus ion good.  However , the most minor  s t imulat ion 
p r o v o k e d  g e n e r a l i s e d  m u s c u la r  spasm s .  The p a t i e n t  was se d a te d  w i th  
diazepam, para lysed with a lcuronlum, intubated and vent i lated. Tetanus toxo id  
was admin is tered ,  and a tho rough  deb r idement  of the arm wound per formed.  
A t racheos tom y was subsequent ly  per formed on day  3. 'nl t ial ly,  the pat ient  was 
cont ro l led on int ravenous Infusions of a lcuron lum ( I0r, ig /hr ) ,  and d iazepam 
(5mg/hr) .  As his I l lness progressed these doses became to ta l ly  inadequate  as 
muscle spasms,  tachycard ia  and severe hyper tens ive episodes assoc ia ted  wi th 
profuse sweat ing and oro-nnsai  secret ions con t inued unabated.  His muscle 
spasms were  eventual ly  cont ro l led on a lcuronlum, at a dose of 17,5mg/hr  hut 
his b lood pressure remained extremely  labi le
Various com b in a t ion s  of d iazepam, morphine and ch lorpromazine,  bo th  as 
con t inuous Infusions and hour ly boluses, were t r ied.  At his most  unstable ,  he 
was r e c e i v i n g  a d ia z e p a m  In fus ion  of  8 0 m g /h r  and b o lu s e s  of 40rr ,y /hr ,  
m orph ine  bo luses  of 30mg app rox im a te ly  every 4 hr., and ch lo rp ro m a z in e
Tetanus 143
20mg/hr.  On one occas ion,  day 15, he was given 175mg of d iazepam, plus 
10mg of m orph ine  in one hour; 195mg of d iazepam in the next hour  and 1 15mg 
of d iazepam wi th 25 mg of ch lorprom az ine n the 3rd hour ; the average hour ly  
s e d a t io n  f o r  th is  day  was 120 mg d ia zepa m ,  5 mg m o r p h in e  and 10 mg 
ch lo rprom az ine .  The instabi l i ty  of  the pa t i en t ’ s b lood  pressure on day 18 can 
be seen in f igure 8.5, a l though greater  f luc tua t ions  In card iovascula r  s tatus 
actua l ly  occu r red  than can be shown on this per iod ic  char t.
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Figure 8.5 Hourly heart rate and b lo o d , assure chart on day 18. The patient was receiving an 
average of 120mg diazepam and 7 5mg morphine each hour plus chlorpromazine 60 
mg 6 hourly
On day 19, It was dec ided to t ry to stabi l ize the pat ient  using large doses  of 
magnes ium sulphate p!v«r. cc a cont inuous  Infusion. The pat ient was being 
paralysed w ' th  a icu ronium 17,5 mg per hour  and the sedat ives that  were be ing 
used at tha t  t ime are shown in f igure 8.6.
Tetanus 144
A loading dose of 4g magnesium sulphate IVI over  20 minutes was admin is tered ,  
fo l lowed by a cont inuous infus ion of I g / h r  (see f igure 8.6) Serum ca lc ium and 
m a g n e s iu m  leve ls  were measu red  eve ry  4 hrs,  c a l c iu m  s u p p le m e n te d  as 
requi red,  and the rate of magnesium in fusion ad justed to keep the serum 
magnesium level between 2 and 4 mmol / l  (see f igures 8.5, 8.6, 8.7) T i l s  
requi red high Infusion rates and as a result  adequa te magnesium levels were 
not ach ieved unti l  18.00 hrs on day 20.
Fol lowing the inst i tut ion of magnesium therapy,  a d is t inc t  downward trend in 
systol ic  and d iasto l ic  pressures, mean b lood pressure and pulse rate w e r j  
noted; and smal ler  doses of seuat ives were requi red.  Once the rate of MgS04 
was Increased to above 2gm/hour ,  no systo l ic  b lood pressure of grea ter  than 
170 mmHg was recorded despi te  the fact  that ca techo lamine levels were sti l l  
elevated at this t ime F luctuat ions in b lood  pressure were also less marked.  This 
is in con t ras t  to the state pr ior to the advent  of magnesium therapy when 
systo l ic pressures of over  200 mmHg were c om m on  wi th a range o* systo l ic  
pressure of 140 mmHg. Catecho lamine levels were recorded before and dur ing 
the admin is t ra t ion  of magnesium (see Append ix  B). These levels are recorded 
In table 8.4 Once magnesium levels above 2 mmol / l  were establ ished (18.00 
hr. day 20) catecholamine levels returned to normal ,  w i th  the excep t ion  of 
dopamine which remained marg ina l ly  elevated.
Tetanus 145
24 HOUR OBSERVATION
240
220
200
180
160 J
140 -
120 -
100 -
80
60
SeMg (mmol/1)
-i 1 i t
1.49 1.7
HR BP
Figure 8.6 Hourly heart rate and blood pressure changes on day 19 during the introduction of 
magnesium. Diazepam dosage averaged lOOmg/hr until IB.OOhr. and 80mg/hr 
thereafter. Morphine dosage averaged 2.5mgmr. No chlorpromazine was used.
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Figure 8.7 Hourly heart rate and blood pressure changes on day 20. Diazepam dosage 
averaged BOmg/hr and morphine dosage averaged 5mg every 4 hours. No 
chlorpromazine was used
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Figure B.8 Hourly heart rate and blood pressure changes on day 21. No morphine or 
chlorpromazine was needed., and the diazepam infusion rate was BOmg/hr
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Figure 8.9 Hourly heart rate and blood pressure changes following the withdrawal of all sedation 
on day 22. Sedation was re-introduced at a rate of BOmg diazepam per hour at 18:00 
hours
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TABLE 8.4
DATE TIME NORADRENALINE ADRENALINE DOPAMINE
06/03/96 09h00 918,59 54,70 47,71
(Day 18) 13h40 747,68 78,71 22,81
16h50 820,92 57,13 40,98
07/03/86 08h30 734,53 59,85 15,78
(Day 19) 09h45 1160,72 118,90 50,34
15h30 1602,64 115,24 98,13
16h15 1916,56 109,62 164,39
1 7h30 983,95 58,10 38,30
08/03/86 
(Day 20)
10h15 429,4 62,48 18,98
09/03/86 
(Day 21)
12h00 178,98 21,6C 22,80
Table 8 4 Catecholamine levels dur ing the Ini t iat ion of magnesium therapy. 
Mg star ted at 12h00 on 07/03/86.
Al l  a b o v e  v a l u e s  In p l c o g r a m s  p e r  ml . N o r m a l  ( p l c o g r a m s  p e r  ml )  : 
Noradrenal ine 250 - 400; Adrenal ine 10 - 50; Dopamine 0 - 20.
On the morn ing o '  day 22. the pat ient  seemed very stable, and the d iazepam 
I n f u s i o n  w a s  s t o p p e d .  T h i s  h o w e v e r  p r e c i p i t a t e d  a r e c u r r e n c e  of  
haemodynamlc  Instabi l i ty,  a l though this was less marked than pr ior  to the 
Inst i tut ion of magnesium therapy ( f igure 8.9). Catecholamine levels could not 
be obta ined at this t ime. The pat ient became Increasingly  unstable on MgSO* 
a lone ,  and d i a z e p a m  b o lu s e s  were re I n t r o d u c e d  a f te r  11 hou rs ,  w h ich  
re-estab l ished good cont rol .  The total  sedat ion now received by the pat ient 
was 80 my /hou r  In addi t ion to a magnesium Infusion of 2 gm/hour .  No morphine 
or ch lorprom az ine was needed. This part ial  recurrence of Instabi l i ty s trongly  
a rgues  aga ins t  the p o s s ib i l i t y  that  the changes  seen above  were due to 
spontaneous remission of the disease.
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The pat ient  was con t inued on magnesium and d iazepam, and the subsequent  
cou rse of  the pat ient  ove r  the f o l l o w in g  2 weeks was that  of p rog ress ive  
improvement  enabl ing gradual  weaning of all sedat ives.
8.7 DISCUSSIG.
It is apparen t  f rom this case repor t  that even massive doses of sedat ive drugs 
may be unable to prevent  the release of catecho lamines  in large amounts . 
Magnesium has been shown in  v itro  to inhibi t  the release of adrenal ine and 
noradrenal ine f rom both the adrenal  gland and from per iphera l  nerve terminals,  
as wel l  as reduc ing  the sen s i t i v i t y  of the « -ad rene rg lc  recep to rs  to these 
neurot ransmi t ters  ugias & Rubin, 1963; Ki rpekar  & Misu, 1967; Lishajko, 
1970; George & Leach, 1971; Von Euler & Lishajko, 1973). It was shown !n 
chapter  7 that  this act ion of magnesium could be conf i rmed  in normal  human 
subjects subml . ted to t h ^ s tress of endotracheal  in tuba t ion This case, however  
represents the first dem ons tra t i on  of the abi l i ty of magnesium to reduce the 
level of c i rcu la t ing adrena l ine  and noradrenal ine In the presence or elevatod 
c i rcu la t ing catecholamine concent ra t ions .  It is of interest  that magnesium 
sulphate a lone was unable to cont ro l  the autonomic d is tu rbances  In this pat ient  
once the other  sedat ives were s topped.  Unfor tunate ly ,  catecho lamine  levels 
were not obta inable at this t ime, but It seems l ikely that magnesium would have 
cont inued to Inhibit ca techo lam ine  release from the adrenal  gland. The most
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l ikely exp lanat ion  for the recurrence of card iovascula r  Instab i l i ty  at this t ime is 
that magnes ium is a poor  central  sedat ive (Somjen et al, 1966), and that  the 
l i g h t e n i n g  leve l  of c o n s c i o u s n e s s  of  the p a t i e n t  led to  an In c re a s e  in 
sympa thet ic  tone. It has a l ready been shown (chapter  7) that magnesium 
a pp ea rs  to  be more e f f e c t i v e  In b l o c k in g  the re lease of a d ren a l in e  than 
noradrenal ine.  Possibly,  sympa thet ic  nerve terminals,  which  operate at much 
lower  leve ls  of no rad rena l ine  than those  needed to  exer t  sys tem ic  ef fects  
(Cryer, 1980), are less suscept ib le  to the effects of increased serum magnesium 
levels than are the cel ls of the adrenal  medul la.  Whatever  the explanat ion,  it is 
c lear that,  whi lst  magnesium may be a very useful  ad junc t  In the management  
of the ca rd iovascula r  d is tu rbances  of tetanus,  It Is Inadequate as a sole agent 
and should be used in add i t ion to adequate sedat ion.
These tw o  s tu d ie s  have d e m o n s t r a t e d  tha t  m a g n e s iu m  can im p r o v e  the 
ca rd iovascula r  s tab i l i ty  in pat ients wi th very severe te tanus It seems l ike ly  that 
the mechanism by which it achieves this act ion Is a dual  one invo lv ing both the 
ant i -adrenerg ic  act ions of magnesium, end In addi t ion,  b lock ing  the release of 
catecho lamines from the adrenal  meduua Less sedat ion Is requi red when 
magnesium Is con com i tan t l y  Infused Magnesium Is the re fo re  a useful  ad junct  
to sedat ion in the management  of the card iovascular  d is tu rbances r f  tetanus.
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9. Magnesium and Anaesthesia for 
Phaeochromocytoma
The a n a e s t h e t i c  m a n a g e m e n t  o f  a p h a e o c h r o m o c y t o m a  p r o v i d e s  a 
cons iderab le chal lenge to the anaesthet ist  and Involves careful  cont ro l  of every 
phase of the procedure. A l though there are no cont ro l led tr ials on the subject , 
It Is gene ra l l y  a ccep ted  tha t  adequate p reope ra t iv e  a d ren e rg ic  b lockade ,  
pa r t i cu lar ly  of a- receptors,  has enhanced pat ient safety and Improved ou tcome 
Preoperat ive preparat ion,  therefore,  usual ly entai ls the the use of a adrenerg ic 
b lo c k e r s  such  as ph e n o x y b e n z a m ln e ,  wi th  the a d d i t i o n  of  Q-adrenerg lc  
blockers,  If necessary,  to cont ro l  tachycard ias (Hul l ,  1986). Int raoperat ively,  
the prob lem Is approached on two f ronts.  Deep anaesthesia,  usual ly wi th the 
generous use of opiate agonists,  Is employed to min imize input  st imul i  which 
may t r igge r  neurogenica l ly  mediated catecholamine release. Control  of the 
effects of excess catecholamine release is usual ly mainta ined by the use of 
a d re n e rg ic  b lo c k in g  d rugs  such as p h e n to la m in e  and p r o p ra n o lo l  and /o r  
vasod i la to rs  such as sodium n i t ropruss lde; fo l low ing tumour  devascular lzat lon,  
vasoconst r ic to rs  may prove necessary (Hull , 1986; Rolzen, 1986). Despi te all 
of  th ese  th e r a p e u t i c  manoouvers ,  the to ta l  e l im in a t io n  of c a rd io v a s c u la r  
d i s tu rb a n c e s 's  seldom achieved and some f luc tuat ion In arter ial  pressure often
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o c c u r s ,  and a r r h y th m ia s  are c o m m o n  (Roizen,  1986) ,  du e  to  su rges  of 
catecholamine  release In response to minimal  st imul i .  None of the agents in 
common use has the abi l i ty to prevent or reduce the release of catecholamines 
other  than by reduc ing nox ious st imul i  which may cause hormone  release 
through s t imulat ion  of the autonomic nervous system. Magnesium, as has been 
shown In the prevlc js chapters,  can Inhibi t  the release of catecholamines f rom 
both ;he adrenal  medul la and per ipheral  adrenerg ic  nerve terminals,  as wel l  as 
b lock ing  catecholamine receptors  di rect ly.  In addi t ion,  magnesium has, as has 
been d iscussed In prev ious chapters,  a d i rect  d i la tor  effect on vessel  wal ls. It 
therefore appeared wor thy  of a tr ial In phaeoch romocy toma as an ad junct  to 
convent ional  therapy.
9.1 PATIENTS AND METHODS
Over a per iod of 5 years, magnesium sulphate has been used as an a d ju re !  to 
the anaesthet ic management of 16 pat ients on 17 occas ions.  In the first of 
these cases, MgS04 was used, based on the onale oresented In previous 
chapters,  In response to a s i tuat ion i ,i which c 1 nt ional  therapy appeared to 
be Inadequate to meet the problems presenteo ‘ *• ♦he patient. Tne success 
achieved In the m anag jm en t  of this case prompted  t i t  study of the remainder  
of the cases presented In this series Relevant Individual  pat ients  detai ls are 
presented In the appendix,  but the overal l  f ind ings of this series, the general
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approach to preoperat ive preparat ion,  and the basic anaesthet ic  approach
adopted,  wi th relevant I l lust rat ions frorr selected cases Is out l ined below,
9.1.1 P a tien ts : The ape ,ange i f  the pat ients was from 14 years to  55 years. 
There wore 5 mains and 11 females l r  the series. Two of the pat ients  
were pregnant at the t ime of presentat ion.  One of these was del ivered 
by Caesarean  sec t ion  and had her  t um our  resec ted  on a separate 
occas ion (cace ) The other  had a mal ignant  phaeo chrom ocy tom a for 
which she hac had hree prev ious excis ions (case 7). In th is case, an 
elect ive caesarean sect ion was per formed,  and she was subsequent ly  
managed wi th radioact ive meta- lodobenzy lguane th id ine (MIBG). Of the 
remainder,  two hcd tumours th * t  were loca l1 1 Invasive, one involv ing the 
r ight  d iaphragm and the other  Invading the left renal vein and infer ior  
vena cava. The f i rst of these pat ients had pre-ex is t ing ch ron ic  renal 
d y s fu nc t io n  (p reoperat ive crea t in ine  c learance 42 ml /hr ) Two other  
pat ients had ev idence of target organ damage In the form of a strain 
pattern on the ECO with Inverted T-waves and depressed ST segments 
In one case, and left vent r icu lar  hyper t rophy In the other. The remaining 
9 pat ients all had uncompl icated tumours.  Tumour  size var ied between 
3cm and 12 cm.
9.1 P P re o p e ra tiv e  p re p a ra tio n :  Th is  c o n s i s t e d  p r i m a r i l y  of  a-adrenerglc  
b lockade  wi th ei ther phenoxybenzamlne (8 cases) or  prazos in (8 cases) 
In Increasing dosage unti l  adequate con t ro l  of s ym ptom ato logy  had been 
achieved.  Beta b lockade was added as Indicated by the occur rence  of 
t a c h y c a r d i a s  and  f l u i d  r e p l a c e m e n t  p e r f o r m e d  as I n d i c a t e d  by 
card iovascula r  measurements.  In one case In whlcn the author  was
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involved In an adv isory  capaci ty  on the morn ing of surgery,  the pat ient  
had been prepared pr imar i ly  wi th 8 b lockade (atenolol  tOOmg b.d.) and 
a smal l  dose (40mg/day)  of phenoxyber .zamine (case 9). Fi tness for  
surgery was judged In accordance wi th cr i ter ia laid down by Rolzei, 
(1986), but In case 9 these cr i ter ia were not met and surgery probab ly  
should have been postponed.  One case was not prepared preoperat lvely  
as the d iagnosis  was made at laparotomy.
\
O
Premedicat ion was general ly ach ieved with a combinat ion of d iazepam lOmg 
and promethaz ine 25mg administered oral ly the night before surgery and again 
on the morn ing of operat ion. Despi te this aggressive and apparent ly  adequate 
preoperat ive preparat ion,  several of the pat ients ar r ived In the operat ing room 
w i th  e le v a te d  a r t e r i a l  p r e s s u re s  but  m in im a l  o th e r  c l i n i c a l  e v id e n c e  of 
catecholamine  excess such as sweat ing and anxiety.  This was regarded as a 
m a n i f e s t a t i o n  of  t h e  s t re s s  of  Im p e n d in g  s u r g e r y ,  and no t  t a k e n  as a 
c o n t r a  i n d i c a t i o n  t o  th e  p r o c e d u r e .  A s u m m a r y  of  p a t i e n t  d a t a  and 
preoperat ive presentat ion Is presented In table 9.1.
O
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Table 9.1
Case Age Sex Preparat ion Diagnosis Comments
1 14 F Phen, prop Large RA Hyper tens ive In Theatre
2 45 F Phen, prop Small RA Hyper tensive In Theatre
3 54 Phen, prop V. large RA Penal disease, Dlaphrag
4 26 F Praz, aten Small RA Pregnant , poor  cont ro l
4 26 F Praz, aten Small RA
5 48 Phen Large LA Renal vein, IVC Involved
6 22 F Praz, aten Small RA
7 24 F Phen, aten Mul tiple Mal ignant,  pregnant
8 26 F Phen, aten Small RA
9 42 Aten, phen Small LA Inadequate ly prepared
10 34 F Phen Small LA
11 32 F Praz, aten Small RA
12 51 F Praz, aten Large LA Hyper tensive In Theatre
13 39 F Praz, aten Large RA Hypertensive in Theatre
14 28 e Praz, aten
15 55 F Nil PA Diagnosed l n f a - o p .
16 14 M Praz, aten Large PA
Table 9.1 Summary of pat ient detai ls
Phen - Phenoxybenzamlne 
Praz - Prazosin 
Aten - atenolol
RA/LA - Right / lef t  adrenal  tumour  
Diaphragm - d iaphragm involved 
IVC - in fer ior  vena cava Involved 
PA - Para aor t ic tumour
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.3 A naes the tic  techn iqu e : In most cases, pat ients were given a moderate
dose of 3-5 ^.g/kg of fentanyl  pr ior  to induct ion of anaesthesia,  fol lowed 
by an int ravenous infusion of magnesium sulphate (MgSCU) 40mg/kg If 
the arr ival  systo l ic  blood pressure (SBP) was wi th in  20mm/Hg of the 
preoper&t lve basel ine, or 60 mg/kg If the arr ival  SBP was above this 
range. The two pregnant pat ients received magnesium but no opiate. In 
tw o  o the r  cases who arr ived In theat re  wel l  c on t ro l le d ,  magnesium 
sulphate was withheld unti l  af ter induct ion of anaesthes ia in order  to 
al low an invest igat ion of the separate ef fects of anaesthesia and MgS04 
on catecholamine levels. In all pat ients, arter ial  and cent ral  venous 
pressure mon i tor ing  l ines were Inserted under  local  anaesthet ic  pr ior  to 
Induct ion of anaesthesia. Anaesthesia was Induced wi th th iopen tone  
and muscle relaxat ion achieved with a lcuronlum excep t  In the pregnant 
pat ients In whom suxamethonium was used. Whi lst  Individual  var iat ions 
occurred,  the scheme by which MgS04 was admin is tered was as fol lows. 
It the arter ial  pressure remained e le /a ted after induc t ion  of anaesthesia,  
a f c i t h e r  bo lus  of 40 m g /k g  MgS04 was ad m in is te re d  fo l lo w ed  by 
endotracheal  intubat ion.  Anaesthesia was maintained t h r o u r ' i o u t  with 
ni t rous oxide,  oxygen and enf lurane In all but the f i rst  case In which 
ha lothane was used as it was the only agent  avai lable at the t ime. A 
con t inuous Infusion of MgSO< at between 1-2 gm/h r  was star ted and 
mainta ined th rougho u t  the p rocedure  The rate of th's Inh alon was 
adjusted accord ing  to the pat ients response. Card iovascula r  cont rol  
was aimed at keeping the systol ic blood pressure w i th in  a range 30mmHg 
e i ,her side of the preoperat ive basel ine Peaks of arter ial  pressure weie 
managed Ini t ial ly wi th up to three fur ther  boluses In ject ions of MgS04, 
20 mg/Kg on each occas ion,  but If this proveo Insuf f ic ient to restore SBP 
io wi thin the stated l imits, sodium n l t ropruss lde was added.  If SBP was 
cont ro l led wi thin the stated range by magnesium alone cont ro l  was 
des ignated as good;  If adequate cont ro l  could be establ ished by the
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9.1.3 A naes the tic  techn ique : In most cases, pat ients were given a moderate
dose of 3-5 ^g / k g  of fentanyl  pr ior  to Induct ion of anaesthes ia,  fo l lowed 
by an Int ravenous Infusion of magnesium sulphate (MgSO*) 40mg/kg If 
the arr ival  systol ic  b lood pressure (SBR) was wi th in  20mm/Hg of the 
preopera t ive basel ine, or  60 mg/kg If the arr ival  SBP was above this 
range. The two pregnant pat ients received magnes ium but no opiate.  In 
tw o  o the r  cases  who ar r ived  in thea t re  wel l  co n t ro l l e d ,  magnes ium 
s u lp h i t e  was withheld unt i l  af ter Induct ion of anaesthes ia In order  to 
a l low an invest igat ion of the separate ef fects of anaesthes ia and MgS04 
on catecholamine levels. In all pat ients,  ar ter ia l  and cent ral  venous 
pressure mon i tor ing l ines were Inserted under  loca l  anaesthet ic  pr ior  to 
induct ion of anaesthesia.  Anaesthesia was induced  with th iopen tone  
and muscle relaxat ion achieved wi th a lcuron lum excep t  In the pregnant 
pat ients In whom suxametuonlum was used. Whi lst  Individual  var ia t ions 
occur red ,  the scheme by which MgSO* was admin is te red was as fo l lows 
If the arter ial  pressure remained elevated af ter  Induc t ion of anaesthesia,  
a f u r t h e r  bo lus  of 40 mg kg MgSC>4 was a d m in i s t e r e d  fo l low ed  by 
endot racheal  Intubat ion. Anaesthesia was mainta ined th roughou t  wi th 
n i t rous oxide, oxygen and ent lurane In all but the f irst  case In which 
halo thane was used as it was the only agent ava i lab le  at the t ime. A 
con t inuous Infusion of MgSO# at between 1-2 gm /h r  was star ted and 
m ainta ined th roughou t  the p rocedu re  The rate of this Infus ion was 
ad justed acco rd ing  to the pat ients response Card iovascular  cont ro l  
was aimed at keeping the systol ic b lood pressure wi th in  a range 30mmHg 
e i ther  side of the preoperat ive basel ine. Peaks of a rU r ia l  pressure were 
managed ini t ial ly with up to three fur ther  boluses. In ject ions of MgS04,  
20 mg/Kg on each occasion, but If this proved Insuf f ic ient  to restore SBP 
to wi thin  the stated l imi ts,  sodium n ' t ropruss lde was added. If SBP was 
con t ro l led wi th in the stated range by magnes ium alone cont ro l  was 
des ignated as good; if adequate cont ro l  cou ld  be estab l ished by the
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add it ion  of e ither n i tropruss ide  or phento lam ine or both, con tro l  was 
des igna ted  as fair and if adequate con tro l cou ld  not be ach ieved by any 
com b ina t ion , con tro l was designa ted as poor. Once the tum our had 
been devascu la rized, magnesium was d iscon tinued , and at the  end of 
su rgery  neurom uscu lar b lockade was reversed in the normal manner. 
Adequate  reversal of neurom uscu la r b lockade was dem onstra ted  by the 
use of a periphera l nerve s t im u la to r p r io r  to ex tubat ion . B lood samples 
fo r  serum magnesium were taken after the Initial load ing  doses, and at 
r e g u la r  In te r v a ls  t h r o u g h o u t  th e  p r o c e d u r e .  S e ru m  m a g n e s iu m  
c o n c e n t r a t i o n s  w e re  m e a s u r e d  b y  a t o m ic  a b s o r p t i o n  
spec tropho tom e try .  Blood gases were sampled using heparln lsed 2ml 
syr inges at regular Intervals th roughou t all p rocedures  and analysed 
w i th o u t  te m p e ra tu re  c o r r e c t io n  on an ABL4 a u to m a t ic  b lo o d  gas 
analyzer.
9.1.4 C a techo la m in es : Catecho lam ine concen tra t ions  were measured using a 
rad io - im m une assay techn ique, as descr ibed  In chap te r 7, in f ive of the 
las ' s ix cases, in case 11, catecholar. i l , ie  concen tra t ions  were measured 
p r io r  to  induction , fo l low ing  tracheal in tuba tion , and dur ing  periods of 
tu m o u r  handling. In cases 12 and 14, ca techo lam ines were estimated 
p reopera t lve ly  fo l low ing  the in it ia l dose of MgSCU, after induc t ion  of 
anaes thes ia  and a fte r trachea l In tuba t ion , as we ll as d u r in g  tum our 
hand ling . MgSO* was w ithhe ld  until a fter Induct ion  of anaesthesia and 
a d m in is te re d  jus t  p r io r  to  in tu b a t io n  In cases 13 and 16. In these 
p a t ie n ts ,  c a te c h o la m in e  c o n c e n t r a t io n s  w e re  m e a s u re d  p r io r  to  
Induct ion , fo l low ing  Induction , after MgS04, a fte r tracheal In tubation, 
and dur ing  tum our handling.
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9.2 RESULTS
In the f irs t  case of th is  series, m agnes ium  prov ided  rem arkab le  c o n tro l  of 
ca rd iovascu la r  func t ion  p r io r  to  Induc t ion  of anaesthesia when conven t io na l 
m e thods  had fa iled ( f ig u re  9 .1). E xce l len t  c o n tro l  was m a in ta ined  d u r in g  
induc t ion  of anaesthesia and In tuba t ion  (f igure 9.2). The su rp r is ing  fea tu re  of 
ih is  case, was the rem arkab ly  good co n tro l  of c a rd io /a s c u la r  fun c t io n  which 
was m a in ta ined th rougho u t surgery , even during pe r iods  of tum ou r  hand ling  
(f igure 9.3), and It was th is  result w h ich  encouraged the co n t in u a t io n  of the
study.
INFUSIONMgS04
PR 122PR 149
Figure y  l  Initial cardiovascular changes in response 'eco.cte.
during the Initial intuslon olMgSO.. C 0
represents 50 seconds. The figures on the y-axis are in mmHg.
Phaeochromocytoma 155
MgS04 
INFUSION 
(2.5 Gm) 
h
INDUCTION
i -  1 1 ' -i
INTUBATION
I
200J
0  i
speed is 0. ■ ■mlsec and one large square represents 50 seconds The figures on 
the v-exis are in mmHg.
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Figure 9.3 Cardiovascular responses and MgSO* administration during tumour handling. Chart 
speed is 0. Immlsec and one large square represents 50 seconds. The figures on
the y-axis are in mmHg.
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In all but one of the remaining cases, magnesium prov ided sa t is fac to ry  contro l 
of arteria l b lood  pressure and heart rate up to  the t im e of tum our handling. 
Where patients arrived In the opera t ing  room w ith  e levated arteria l pressures, 
the com b ina t ion  of magnesium and fentanyl sa t is fac to r i ly  con tro l led  the arter. il 
pressure In all but one patient. The only fa i lu re  was the f irs t of the pregnant 
p a t ie n ts  (c t  e 4, f i r s t  a n a e s th e t ic ) .  Only one o the r  pa t ien t  e x h ib i te d  an 
Increase In arter ia l pressure at In tubation, and th is was the second patient 
undergo ing  Caesarean section (case 7) In whom  opiates were not adm in is tered 
p r io r  to  in tubation . This Increase was small (20 mmHg). In 11 of the 17 
anaesthetics, MgS04 alone prov ided good ca rd iovascu la r  con tro l th roughou t 
the procedure . The case record of the worst con tro l led  pat 'en t In th is  group is 
shown In f igure  9.4.
mmHg
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  Systolic BP —  Magnesium Infusion
Figure 9.4 Systulic blood pressure in case 8 in whom control was designated as good. Events 
1 - induction; 2 - intubation; 3 - incision; 4 - tumour handling; 5 - tumour removal.
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In four of the remainin',- six patients, two w ith  loca l ly  Invasive tum ours, and two 
others w ith  very large tumours, in fus ions of n i t rop russ ide  were required in 
add it ion  to  the MgSOa In o rder to  con tro l Increases In arter ia l pressure at the 
t im e of tum our handling. The case record of the w ors t con tro l led  patient in 
tM s g roup  is shown In f igure  9.5. In tw o of these cases (Cases 12 & 13), 
ca techo lam ine  levels were measured dur ing  tum our hand ling  and found to  be 
ex trem ely  high.
mmHg
300
=0 4 5 Events
250
200
150
100
i.a
3.91Joe
250200150100
Time (mlns)
 Systolic BP —  Magnesium Infusion
Figure 9.5 Systolic blood pressure In case 12 in whom control was designated as fair. Events: 
1 - Induction; 2 - intubation; 3 - incision; 4 - tumour handling; 5 ■ tumour removal.
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In ,he f irs t o l the p regnan t patients. M gSO. was w ithou t apparen t bene l i l  at any 
stage, but It was subsequen tly  tound  that she had been gross ly  m agnes ium  
dep le ted, and the rapeu t ic  levels o l magnesium were not approached. The 
h ighest serum  m agnes ium  level a tta ined In th is  patient was 1.3 m m ol/ l ( l l g u r ,  
9.6). In her subsequent anaesthetic  to r removal o l  her tum our she was well 
s iab l l lsed  pre -opera tlve ty . the rapeu tic  levels o l  magnesium were es tab lished 
and exce l len t con tro l was mainta ined (f igure 9.7). The lac t  that she was no 
lo n g e r  p r e g n a n t  w o u ld  a ls o  nave  c o n t r ib u t e d  to  h e ,  g r e a te r  e a s e  o l
management.
mmHg
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Na Nilroprusside infusion (ug/nln) 
Magnesium infusion (2gn/Hf) 
Magnesium Boluses
100 110 120
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F/'gu.e 9.6 SBP changes during caesarean section in case 4 
Fvents: I - induction; 2 - incision; 3 - delivery.
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Figure 9.7 SBP changes in case 4 during tumour removal.
Events: 1 - induction; 2 - incision; 3 - incision; 4 - tumour handling; 5 - tumour removal.
In the other pregnant patient, no resection of the tum our was con tem pla ted  as 
the  l u m o :  ' w as  a m a l ig n a n t  one  w i th  s e c o n d a r ie s .  In th is  c a s r ,  a f te r  
p re -opera t ive  con tro l had been established In the u s u l I manner, a routine 
C aesa rean  s e c t io n  a n a e s th e t ic  was p e r fo rm e d ,  w ith  the  so le  a d d i t io n  of 
m agnes ium  p r io r  to in d u c t io n  and co n t in u o u s ly  th ro u g h o u t  the p rocedure . 
G o o d  c a r d io v a s c u la r  c o n t r o l  was m a in ta in e d  t h r o u g h o u t  th e  s u rg e ry .  
W ithdrawal of magnesium after the p rocedure had ben com ple ted  resulted in a 
ra p id  and severe  Increase In b lood  p ressure  to  250/140 m m Hg fo r  w h ich  
In travenous phenoxybenzam lne had to be admin istered.
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In me remainder, serum m agnesium levels in the presumed the rapeu t ic  range 
of between 2-4 mmol/l were achieved and mainta ined. During tum our hand ling, 
all pa t ien ts  required supp lem enta l doses of M gSO, to  con tro l Increases in 
arte r ia l pressure, and the tota l dose adm in is te red  was In the range of 8-16 gm 
w ith  a su rg ica l d u ra t io n  rang ing  be tw een  60 and 150 min. be fo re  tu m o u r  
devasc i i la r iza t lon .  No arrhy thm ias  occu rred  In any o ‘ the patients stud ied. 
These results  are summarized in Table 9.2. In case 16, the card iovascu la r 
s tab i l i ty  wh ich  was mainta ined dur ing  tum our hand ling was such that it led to 
th e  e r r o n e o u s  a s s u m p t io n  th a t  th e  t u m o u r  nad b e e n  d e v a s c u la r iz e d .  
M agnesium  was there fore  w ithdrawn p r io r  to t u m o r  removal, and this was 
fo l low ed  by an Immediate, steep increase in SBR w h ich  responded p rom ptly  to 
tv/o fu r the r  bolus In jec tions  of MgSO« (f igure  9 8)
mmHg
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100 Mg SO 4 
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Se Mg383228
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SRP Magnes. tm Infusion
Figure 9 8 SBP changes during anaesthesia and surgery in case 16. Events: 1 - induction, ?
- intubation; 3 - incision; 4 - tumour handling, 5 - MgSO* withdrawn; 6 - tumour removal
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In case 15, the d iagnos is  was made as a result of severe hypertens ion  and 
m u lt ifoca l arrhy thm ias  exh ib ited during  exp lo ra t ion  of a para aort ic  abdom ina l 
mass. On th is  occas ion, the adm in is tra t ion  of d 4gn. bo lus of MgSO* resulteu 
In Im m ed ia te , bu t short l ived, re d u c t io n  of b lood  p ressure  and c o n tro l  of 
a r rh y th m ia s .  Two fu r th e r  4gm bo luses  and one of 2gm were, req u ire d  to 
estab lish good card iovascu la r contro l,  and tum our removal then proceeded 
uneventfu lly  ( f igure  9.9).
mmHg
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Hguro 9.9 SBP changes in case 15 where the diagnosis was made irt'aooerativeY Events: i 
■ i  ideation; 2 - intubation; 3 - incision, 4 -tumour handling; 5 - tumour removal
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Case SBP1 SBP2
Table  9.2 
IO Range S ta b i l i t y O th e r  A gen ts
1 195 135 120-140 Good Nil
2 220 115 110-140 Good Nil
3 215 145 95-180 Fair SNP
4a 220 150 85-220 Poor SNP. PH
4b 130 110 100-140 Good Nil
5 195 115 110-190 Fair SNP
6 130 100 100-150 Good Nil
7 170 150 120-150 Good Nil
8 186 130 105-150 Good Nil
9 205 100 100-140 Good Nil
10 140 95 95-135 Good Nil
11 150 100 95-140 Good Nil
12 240 120 100-250 Fa'r SNP
13 120 105 100-185 Fair SNP
14 130 100 90-145 Good Nil
15 150 175 70-260 Nil
16 130 95 90-200 Good Nil
Table 9.2. In tra-operative  con tro l of card iovascu la r events.
SNP - sodium  n ltropruss lde  used In add it ion  to MgS04 
PH - phento lam lne used.
10 Range - In traopera tive systo lic  blood pressure range.
SBP1 - Systo l ic  b lood pressure on arrival In the opera t ing  theatre.
SBP2 - Systo lic  pressure after MgS04 and Induction  of anaesthesia
Note that case 16 is designated Good desp ite  one episode of very high b lood 
pressure as this was associated with Inappropria te  w ithdrawal of magnesium 
(see text and figure 9 8).
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Two patien ’ s In th is series required post-opera t ive  ven t i la t ion . The f irs t was a 
54 yr. old male with a tum our invading the d iaphragm , and pre-ex is t ing  renal 
dys func t ion . In view of his renal disease, pers is tence of high levels of serum 
m agnes ium  was a n t ic ip a te d ,  but the  natu e of the su rg e ry  m ade e lec t ive  
post opera tive  ven ti la t ion  the method of choice. N eurom uscu la r transm iss ion 
rem ained depressed  fo r  12 hours pos tope ra t lve ly .  In the  o ther, adequate  
neurom uscu la r func t ion  was restored at the end of the p rocedure , but in view 
of her obes ity , and the fact that a ib -costa l Inc is ion had been perform ed, it 
was dec ided to  Institu te elective post opera tive  ven t i la t ion  for the f irs t  12 hours 
p o s to p e ra t lv e ly .  In all of the o the r  pa t ien ts , n e u rom uscu la r  b lockade  was 
reversed w ithou t d i f f icu lty ,  despite a mean serum magnesium  level et the time 
of reve sal of 1.9 mmol/l. In the first 3 cases, ig m  ca lc ium  g lucona te  was 
rou t ine ly  adm in is te red  pr io r to reversal of neurom uscu la r b lockade, but th is 
appeared unnecessary and was d iscon t inued  In the la te r cases. Good blood 
gases were mainta ined In all cases, w ith no acid-base d is tu rbances  seen.
Greatly increased adrenaline and noradrena line concen tra t ions  were found on 
arrival In the opera ting theatre In the 5 patients m whom they were measured. 
N oradrena line  levels ranged from 1900 - 6650 pg/ml (no-mal range 100-600 
pg/m l) and adrenaline levels from 120-390 pg/m l (normal range 10-80 pg/m l). 
D o p a m in e  leve ls  w ere  norm al. N o ra d re n a l in e  and a d re n a l in e  leve ls  were 
reduced fo l low ing  magnesium In all 5 cases, a lthougn the effect was greater on 
a d re n a l in e  t h - n  on n o ra d re n a l in e  A d re n a l in e  e ve ls  w e re  re d u c e d  by
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magnesium to w ith in  the norma' range In all 5 cases, but noradrena line  levels, 
a lthough  reduced, remained marked ly  elevated. In the two patients In whom 
a n a e s th e s ia  w as  In d u c e d  p r io r  to  th a  a d m ln ls t r a . i o n  o f m a g n e s iu m ,  
noradrena line  and adrenaline levels Increased fo l low ing  Induction , and returned 
to  p re - lnduc t lon  values fo l low ing  magnesium. Nc Increase In catecho lam ine  
levels occurred  fo l low ing  In tubation. During tum our handling MgSC>4 appeared 
to  be ine ffec tive  In b lock ing  the release of ca techo lam ines. In tw o  cases, 
noradrena line  levels were very high and sodium n ltrop russ ide  was requ ired In 
add it ion  to  magnesium to  con tro l a rte r ia l pressure during  tum our handling. In 
the o the r three magnesium alone prov ided  adequate con tro l,  desp ite  the fact 
that adrena line  levels were s im ilar In all 5 cases. The changes In ca techo lam ine 
levels are I l lustra ted In f igures 9.10 and 9.11.
Tumour HandledMag/lnd
Case 11 WM  Case 12 Case 14 S Case 13 # #  Ceu, 16
Figure 9.10 Changes in adrenaline concentrations in 5 patients. Mglind - induction of 
anaesthesia in cases 13 & 16; administration of MgSO* in the other 3 cases Ind/mag 
- administration of MgSO* in cases 13 & 16; Induction of anaesthesia In the other 3 
cases.
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Figure 9.11 Changes in noradrenaline concentrations in 5 patients. Mglind - induction of 
anaesthesia in cases 13 & 16; administration of MgSO* in the other 1 cases. Indlmag 
■ administration of MgSO* in cases 13 & 16; induction of anaesthesia in the other 3 
cases.
C o m p lica tl :ns : One pa t ien t deve loped severe hypotens ion  fo l low ing  tum our 
removal and In assoc ia t ion  w ith  massive b lood  loss. B lood t rans fus ion  and 
v a s o c o n s t r ic to r s  fa i le d  to  Im p rove  the a r te r ia l  p ressu re ,  and m y o c a rd ia l  
d e p re ss io n  appeared to  be c o n t r ib u t in g  to  the poo r a rte r ia l p ressu re .  An 
adrenaline infusion was requ ired to mainta in  sa t is fac to ry  arteria l p ressures 
dur ing  the remainder of the surgery and fo r 24 hours pos to p e ra t ive ! / .  This 
patient (case 9) had been inadequate ly  prepared for surgery, and his prob lem  
appeared to  ba p r inc ipa l ly  due to  an excess of B-blockade pe rs is t ing  after 
tum our excis ion. As he con t inued  to requ ire  adrenaline long a fter his serum 
magnesium levels had re tu rned  to  normal. It seems most un l ike ly  that his 
ca rd iovascu la r problem was due to  the magnesium, a lthough th is  poss ib i l i ty
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cannot be ruled cut com p le te ly .  The on ly  o ther co m p lica t ion  was the well known 
unp leasan t b u rn in g  s e n sa t io n  p ro d u ce d  by m agnes ium  in fus ion . The only 
patient to com p la in  of th is  was the second of the Caesarean section  patients  in 
whom MgSO- was g iven w ithou t the pr io r adm in is tra t ion  of any ana lges ic  or 
sedative drugs. The o the r pregnant patient did not com p la in  of th is, hut as she 
was In labour at the t im e th is  may account fo r her absence of sym ptom s. The 
concom itan t use of fen tany l appeared to prevent com p la in t  of th is  prob lem  in
the other patients.
9.3 DISCUSSION
The rationale fo r  the use of MgSO* Infusions In the anaesthe t ic  managem ent of 
phaeoch rom ocy tcm a  is based on the ab il i ty  of magnesium to  Inh ib it the release 
of ca techo lam ines from  the adrenal medulla as well as Its vasod i la to r  and 
an t i-adrenerg ic  p rope rt ies  which have been d iscussed in p reced ing  chapters. 
The ab il i ty  of magnesium  in fus ions to con tro l ca techo lam ine - induced  crises 
assoclax d w ith  severe te tanus, and reduction  of ca techo lam ine  concen tra t io ns  
fo l low ing  in fus ions of m agnesium  In a patient with th is  cond it ion  have been 
d e s c r ib e d  In the p re v io u s  c h a p te r .  The sa fe ty  of M g S 0 4  at th e  s e ru m  
concen tra t ions  used in th is  series is well established by the use of s im ila r serum 
m a g n e s iu m  c o n c e n t r a t i o n s  in th e  m a n a g e m e n t  o f  p r e g n a n c y - in d u c e d  
hypertens ion  (P r itchard  & Pritchard , 1975; Pritchard el al, 1984)
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In the  f ive  p a t ie n ts  In w hom  c a techo la m in e  c o n c e n tra t io n s  were s tud ied , 
magnesium reduced ad.ena llne  concentra tions  to  w ith in  the normal range and 
also reduced noradrena line  concentra tions, a lthough not to  levels approach ing  
normal values. The greater effect on adrenaline cou ld  s im p ly  be due to  Its 
shorter half- l ife , and there fore  a more rapid c learance fo l low ing  the Inh ib it ion  
of release from  the tumour. A lthough the stress of In tuba t ion  is known to 
release ca techo lam ines (Russell et al, 1981; Derbyshire  et al, 1983), th. e was 
no In c re a s e  In c a te c h o la m in e  c o n c e n t ra t io n s  fo l lo w in g  In tu b a t io n .  No 
comm ent can be made on the effect uf magnesium on ca techo lam ine  release 
dur ing  tum our handling, as no com parisons were made w ith  patients treated 
w i th o u t  m agnes ium . It Is poss ib le  tha t  m agnes ium  m ay have had some 
In h ib ito ry  e ffect on catecho lam ine release at th 's  time, but this poss ib i l i ty  
r e q u i r e s  fu r t h e r  s tu d y .  The m e c h a n is m  by  w h ic h  m a g n e s iu m  b lo c k s  
ca techo lam ine  release Is by com petit ion  with ca lc ium  for membrane channels 
as has been ou tl ined previously, and It seems unlike ly  that th is  action would  be 
Im portant du r ing  physical s t im ula tion  of the tumour.
In add it ion  to Its ac tion  In b lock ing  catecho lam ine release, magnesium exerts 
cons iderab le  ca rd iovascu la r effects of Its own (chapter 5), all of w h ich  could 
be e x p e c t e d  to  be o f  b e n e f i t  d u r i n g  a n a e s th e s ia  In p a t ie n t s  w i th  
phaeochrom ocytom as. The dlrec asod ila t lng  p ropert ies  of the agent are well 
es tablished and as has been shown In chapter 6, magnesium  Infusions can
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antagon ize the adverse affects of high concen tra t ions  of c ircu la t ing  adrenaline 
In Intact animals.
The re s u l ts  o f th is  p re s e n t  s tu d y  are In a p p a re n t  c o n f l i c t  w i th  the well 
e s ta b l is h e d  ro le  of m agnes ium  In o b s te t r ic  p ra c t ic e  In w h ic h  m agnes ium  
appears to  produce on ly  mild hypotension, a lthough p ro found hypotension 
fo l low ing  magnesium  therapy In assoc ia tion  with a b lood  vo lum e defic it  has 
been descr ibed  (Bourgeo is  et al. 1986). There are several poss ib le  explanations 
fo r  th is d isc repancy . F lrs t ’ y, the dosages of magnesium genera lly  used In 
obs te tr ic  p rac t ice  frequen tly  fail to  produce the des ired serum concen lra . ions  
of m agnesium (Slbal et al, 1981). In the present s tudy, very arge doses of 
m a g n e s iu m  s u lp h a te  w e re  n e e d e d  to  m a in ta in  th e  s e ru m  m a g n e s iu m  
c o n c e n t ra t io n s  w i th in  <he 'e q u ire d  range. S e co n d ly ,  the  m ild  degree  of 
hypo tens ion  p roduced by magnesium In obs te tr ics  Is genera lly  regarded as 
Ind ica ting  l i t t le  card iovascu la r effect. However, magnesium has been shown to 
p ro d u ce  m arked  v a s o d i la ta t io n  In bo th  exp e r im e n ta l an im a ls  and humans 
accom pan ied  by an Increase In card iac ou tpu t (M roczok et al, 1S77; Lee et al, 
1984; see chap te r  b). vh lch la rge ly  o ffse ts  the hyp o te n s ive  e ffect of the 
vasod ila ta t ion . In the presence of excess catecho lam ines, the  reduction  in 
periphera l res is tance produced by magnesium appears to be g reater than that 
p r o d u c e d  by  m a g n e s iu m  u n d e r  c o n d i t i o n s  In w h ic h  c a t e c h o la m in e  
concen tra t io ns  a r t  not elevated (chapter 6), p robab ly  because of the a -b lock lng  
p r o p e r t i e s  o f m a g n e s iu m .  F u r th e r ,  th e  r e d u c t io n  o f  c a te c h o la m in e
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concen tra t ions  in patients w ith phaeochrom ocy tom a will not on ly enhance the 
vasod ila to r e ffect but wil l prevent the usual card iac  ou tpu t, as was seen In the 
s tudy  on pa t ien ts  with severe te tanus (chapter 8). It Is not surp r is ing  therefore 
tha t the card iovascu la r e ffects of MgSOa Infus ion should be far m ote  profound 
In phaeoch rvm ocy tom a patients than In obs te tr ic  patients.
Magnesium is a potent an ti-a rrhy thm ic  agent (Enselberg et al, 1950; Ghanl & 
R a b a h ,  19 7 7 ;  Is e r l  et a l,  1983) p a r t i c u l a r l y  In th e  H.e s e n c e  o f h ig h  
concen tra t io ns  of ca techo lam ines (chapter 6) and no patien t In th is series 
d e v e lo p e d  in t r a - o p e r a t l v e  a r r h y th m ia s ,  even  w hen  th e re  w as  m ass ive  
ca techo lam ine  release. This was Impressive, as a lmost all o ther agents used 
are a sso c ia te d  w ith  a h igh  rate of t ra n s ie n t  Intra o p e ra t iv e  d y s rh y th m ia s  
(Rolzen, .986). Where arrhythm ias occurred  pr io r to  the  use of magnesium 
these were reversed, as In the unprepared patient, whose arrhy thm ias  were 
com p le te ly  con tro l led  by the magnesium In jections.
The rarity of phaeochrom ocytom as makes con tro l led  tr ia ls  in th is  cond it ion  
extrem ely  d if f icu lt .  Consequently , reports  of the management of th is  cond it ion  
tend to be co l lec t ions  of case reports, and the present series is no exception. 
As th is series of patients was co l lec ted  over a cons iderab le  period of time and 
the  pa t ien ts  were re fe rred  by many d if fe re n t  p ra c t i t io n e rs ,  us ing  d i f fe ren t 
m ethods of In itia l patient preparation, a con tro l led  tr ia l of m agnesium was not
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feasible. Nevertheless, the ease of management of these cases, part icu la r ly  
during the Induction  and early surg ica l phases of the procedure , was In marked 
c o n t r a s t  to  th e  a u th o r 's  p e r s o n a l  e x p e r ie n c e  o f 10 p r e v io u s  p h a e o -  
ch rom ocy tom as  handled by conventiona l means. The au tho r ’s experience with 
the use of magnesium In the cases presented here was so super io r  to  o ther 
m oda lit ies  of therapy that It was fe lt that a con tro l led  tr ia l w ou ld  be d i f f icu l t  to 
jus t i fy  on eth ical grounds. Whilst o ther an t l-adrenerg ic  and vasod ila to ry  agents 
are more potent than magnesium, the unique capac ity  of magnosium to Inhibit 
the release of catecho lam ines pr io r to  tum our handling Is p robab ly  the pr inc ipa l 
reason fo r  the good card iovascu la r con tro l obta ined In th is series.
The anaesthetic  management of pregnant patients w ith phaeochrom ocy iom as 
p resen ts  a m a jo r  anaes the t ic  p io b le m  and va r ious  te c h n iq u e s  have been 
suggested. As In o ther cases, a -adrenerg lc  b lockade has been the m ainstay of 
periopera tive  b lood pressure con tro l (Burgess, 1978), but Is often Inadequate 
on Its own dur ing  the stresses of surgery  (Fox et al, l9 6 9 ;G r i f f l th  et al. 1974) 
and may be accom panied by severe hypotens ion at the time of de l ivery  (Galletly 
et al, 1983; Burgess et al, 1978). The use of sodium  n lt rop russ ldc  in pregnant 
p a t ie n ts  Is c o n t r o v e r s ia l  ( W i l lo u g h b y .  1984) as a c ld o  is and c y a n id e  
accum u la t ion  occurs  to a greater degree In foetal lambs than In the mother; the 
foetus may also have Immature mechanism for cyan ide m etabo lism  (Naulty  et 
al, 1977). In add it ion  the drug may reduce uterine b lood flow  (Lleb et al, 1981). 
Regional b lockade has been said to be contra Ind icated (Schenker & Granat,
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1982), a l th o u g h  the re  have been repo rts  of success fu l  m anagem en t w ith  
epidural a laesthes la  (Davies & Navaratnara jah, 1984; Stoneham I  Wakefie ld,
1983). It Is worth  noting that In the f irs t of the two pregnant patien ts  in th is 
series ep idura l analgesia was to ta l ly  Ineffective In am elio ra ting  ca rd iovascu la r  
d is tu rbances. In v iew of these con fl ic ts  and d if f icu lt ies  In m anaging these rare 
but h igh ly  cha lleng ing  cases an agent w ith  an a lready estab lished place In 
obs te tr ic  prac t ice  such as magnesium sulphate may offer the anaesthetis t a 
unique add it iona l too l for the safe management of the oatient. It is a lso worth  
noting that bo ’ h of the pregnant patients in th is series showed magnesium 
defic iency . This Is not surp r is ing  in view of the fact that p regnancy Itself Is 
often associated with magnesium defic iency  (Seellg, 1980), and ca techo lam ine  
s t im ula tion  may prevent the Influx of magnesium to  tha In trace l lu la r  space 
(Maguire & Erdos, 1980; Erdos & Maguire, 1983). Such de f ic iency  should always 
be looked for and corrected.
Magnesium appears to  be a useful add it ion  to  the armam entar ium  availab le  for 
the anaesthetic  management of patient.? w ith phaeochrom ocytom as. It appears 
to  be of p a r t ic u la r  va lue  in c o n t ro l l in g  c a rd io v a s c u la r  d is tu rb a n c e s  and 
ca techo lam ine  release at the t imes of Induction  and In tubation, but can also be 
of use, In con junc t io n  with o ther agents, In con tro l l ing  a rrhythm ias and b lood 
pressure d is tu rbances during  tum our handling.
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10. Conclusions
The review of the b iochem is try , phys io logy  and pharm aco logy  of magnesium 
Invited specu la tion  that magnesium In.uslons may have cons ide rab le  benefits 
to o ffe r In various c ircum stances perta in ing to  ana ts thes la .  On rev iew ing the 
l i t e ra tu r e  ’ t a p p e a re d  th a t  th e re  w ere  c o n s ld e ia b le  d e f ic ie n c ie s  In the 
know ledge perta in ing  to  the ca id lovasc iHar ac t ions  of th is  Ion.
10.1 Cardiovascular  E t ie c ts
Invest iga t ions  of the card iovascu la r effects of Infusions of m agnesium  sulphate 
In Intact baboons genera lly  confirm ed ex is t ing  In form ation availab le  regard ing 
the effects of the Ion on b lood pressur. In add it ion . It con f irm ed some of the 
human s tud ies  w h ich  have sugges ted  tha t the  re la t ive ly  m ild hypo tens ive  
effects that resulted from  Infusions of magnesium were the consequence of a 
com b ina t ion  of vasod ila ta t ion  wHh an Increased card iac  ou tpu t re ther than 
ev idence of wr j k  card iovascu la r e ffects This study also dem onstra ted , for the 
f i r s t  t im e ,  th a t  the  e f fe c t iv e  range  of se rum  m a g n e s iu m  c o n c e n t ra t io n s
Conclusion* 176
appeared to  be between 2 and Smmols per l itre  and that on ly at 'evels greater 
than Smmols per l i tre  were s ign if icant fa lls In b lood pressure and heart rate 
l ike ly  to  occur. Even at very high levels of serum m agnesium the absence of 
s ign if ican t m yocard ia l depress ion w a . one of the most Im portan t f ind ings of
th is  study
10.2 A n t i  a d re n e rg ic  E ffec ts
It was a lso confirm ed .hat the in  v itro  f ind ings that m agne* ’ m could b lock 
a d re n e rg ic  a c t iv . ty  at the a lpha  recep to r  cou ld  be d e m e n t  J In Intact 
animals rece iv ing an adrenaline f u s io n .  The m agnitude of th is  effect appeared 
to be suCii as to  be of ell leal value. It was also dem onstra ted , fo r  the f irs t t ime, 
that m agnesium  exerts Important anti-a rrhythm ic effects In the pres« nee of high 
levels of ca techo lam ines F ina lly  It was dem onstra ted that magnesium did not 
appear to  exert potentia l ly  hazardous In teractions w ith  e ither alpha or beta 
adrenerg ic  b lo cxa d t  In an,mats treated w ith  high levels of adrenaline
The conc lus ions  drawn from the animal experim enta tion  section of th is thesis 
were tha t magnesium exerted s ign if icant and po ten t ia l ly  useful vasod ila to r 
e f fe c ts  w h i le  at the  sam e t im e  m a in ta in in g  at le a s t  n o rm a l m y o c a rd ia l  
con trac t i l i ty ,  and, In add it ion , that magnes'um exerted c l in ica l ly  useful and 
apparen tly  safe anti adrenerg ic  effects In animals trea ted w ith  high doses of 
adrena line . These animal s tud ies the re fo re  jus t i f ied  tr ia ls  of this agent In
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c lin ica l cond it ions  In which ca techo lam ine excess presented a therapeu tic  
problem.
t o .3 Clinical  Studies
In the c l in ica l studies section c l th is thes is  it was shown that magnesium not 
on ly  use fu l ly  an tagon ized  excess ad renerg ic  a c t iv i ty  but a lso  appeared  to 
Inh ib it the release of ca techo lam ines from  adrenerg ic  nerve term ina ls . This 
con firm ed the f ind ings of in v itro  experiments In which 'h is  ac t ion  of excess 
magnesium Ions had been dem onstrated. It can be conc luded, there fore , that 
In cond it ion s  of ca techo lam ine  excess, Infusions of magnesium sulphate, and 
probab ly  of other salts of magnesium, may well provide c l in ic ians  w ith  an 
add it iona l tco l  to enable them to manage d if f icu lt  c l in ica l s itua t ions  with a 
greater degree j f  patient safety.
10.4 Unanswered Quest ions
There are, however, a number of questions which remain unanswered.
10 4.1 M agnes ium  and  In o tro p y . One of the In t r ig u in g  o b s e rv a t io n s  that 
emerged from  both the animal work and from  the c l in ica l stud ies In 
te tanus, was thv increase In card iac stroke vo lume that was cons is ten t ly
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d e s c r ib e d .  This Increased s troke  vo lum e  Is, at least su p e r f ic ia l ly ,  
d i f f icu l t  to  expla in In view of the fact that magnesium is theo re t ica l ly  a 
c a lc iu m  a n ta g o n is t  and, th e re fo re ,  shou ld  have nega t ive  In o t ro p ic  
e ffects and that such effects have been descr ibed  In iso la ted tissue 
experim ents. There are a number of Im portant cons ide ra t ions  to be 
borne In mind when cons ider ing  th is ra ther surp ris ing  find ing. Central 
to these arguments Is the concep t that magnesium Is essentia l fo r energy 
m etabo lism  and Is p robab ly  essential fo r  the ac t ion  of beta adrenerg ic  
s t im ulants  on the con trac t i le  state of the m yocard ium . In all of the 
experim ents In which an increased s troke volume was found, Increased 
adrenerg ic  ac tiv ity  was l ike ly  to be present. Increased p-agon ls t b ind ing 
has been d e s c r ib e d  as one of the  a c t io n s  of m a gnes ium  and It Is 
t h e r e fo r e  p o s s ib le  th a t  th is  Is an e x p la n a t io n  fo r  th e  a c t io n s  of 
magnesium In these s ituations. It is a lso possib le , a lthough less likely, 
that the experimenta l animals and the human sub jec ts  were marg ina lly  
magnesium defic ien t at the start of the experiments. If th is  were the 
case, then the f ind ing of an Increased stroke vo lum e would  be less 
surp r is ing  because catecho lam ines require magnesium  to exert their 
Ino trop ic  effects. It Is also possib le  that these results were merely 
ch ance  f in d in g s  as the re  Is some ev idence , a l th o u g h  none of It In 
essentia l ly  Intact animal models such as those used fo r  the present 
experiments, that magnesium may have negative In o t ro p h  effects In the 
In tac t  an im al. In genera l, these resu lts  were found  In ex tens ive ly  
Instrumented animals In wh ich rather deep anaesthesia wou ld  have been 
requ ired, and the Influancw of th is is unclear. It seems a safe conc lus ion  
to  d ra w  tha t m agnes ium  Is not a nega t ive  In o t ro p e  at the c l in ica l  
concen tra t ions  used but It Is d if f icu lt  at th is stage to  be sure about what 
o ther effects It may have on con trac t i l i ty .
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10.4.2 C a techo lam ines and tum our hand lin g . It ..as not been Investigated 
w hether magnesium Infusions had any effect at all on the ou tpu t of 
ca techo lam ines during tu m o u ' handling In patien ts  undergo ing  surgery 
fo r  the removal of a phaechrom ocytom a. One of the surpris ing  features 
of the phaechrom ocytom a studies was that. In the m a jo r ity  of patients, 
ca rd iovascu la r d is turbance could be well con tro l led  even during  the 
p e r io d s  o f tu m o u r  h a n d l in g .  O n ly  a c o m p a ra t iv e  s tu d y  b e tw een  
magnesium and other forms of ca rd iovascu la r con tro l could Indicate 
whether or not magnesium was, In fact, Inh ib it ing  ca techo lam ine release 
at th is  time. Unfortunate ly  th is au thor found the ca rd iovascu la r contro l 
so Impressive as to make magnesium the drug  of choice. Ethically, 
there fore , It would require someone else, less conv inced of the benefits 
to  do such a con tro lled  study. This does, however, remain an in tr igu ing  
poss ib i l i ty  and worthy  of fu rther research. Whether or not th is  Is the 
case the evidence presented here does suggest that magnesium may 
prov ide  an extremely useful add it ion  to the arm am entarium  of drugs 
availab le  to  the anaesthetis t fo r the management of th is  problem.
10.4.3 P re -ec lam p tlc  toxaem ia . The role of magnesium In the management ut 
p re  e c la m p t ic  to x a e m ia  rem a ins  a c o n t ro v e rs ia l  s u b je c t .  C l in ic a l  
experience would appear to Indicate that magnesium both prevents and 
con tro ls  convu ls ions In th is po ten t ia l ly  l i fe - th rea ten ing  cond it ion . The 
mechanism by which It does so are, however, obscure  in v iew of the 
apparen t Inability  of magnesium Infusions to  produce s ign if ican t CNS 
d e p re s s io n .  It seem s m os t l ik e ly  th a t  m a g n e s iu m  Is e x e r t in g  Its 
an tl-convu isan t effects secondari ly  to Its ac t ion  on the card iovascu la r 
s y s te m  a n d  th e  m o s t  I l k e i y  m e c h a n is m  o f a c t i o n  Is c e r e b r a l  
va s o d i la ta t io n  and Im proved cerebra l oxygena t ion . This poss ib i l i ty .
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however, remains en tire ly  speculative and the subject fo r  much fu rther 
research. An a lternative poss ib i l i ty  Is that p re-eclampsia produces local 
areas of brain In jury w hich act as ep i lep t ic  foc i. As such foc i would be 
l i k e l y  to  have  d is r u p te d  b lo o d  b ra in  b a r r ie r s  it is p o s s ib le  th a t  
magnesium cou ld  penetrate such areas loca l ly  and exert anti convu lsan t 
e ffects w ithout a lte r ing CSF magnesium to any great extent.
10.5 F u r th e r  s tu d ie s
A fu r th e r  p o te n t ia l ly  f r u i t fu l  area fo r  m agnes ium  resea rch  Is the  ro le  of 
magnesium Infusions In the p ro tec t ion  of the stressed m yocard ium  pa rt icu la r ly  
during  periods  of actual or potentia l co ronary  Ischaemla. The poss ib i l i ty  exists 
that magnesium in fus ions may offer part icu la r benefit In anaesthesia in cases 
where co ronary  perfus ion may be at risk.
In a to ta l ly  d iffe rent d irec t ion , it appears that the In teraction  of magnesium with 
m usc le  re laxan ts  has been inadeq ua te ly  eva luated. There are p o te n t ia l ly  
exc it ing  poss ib i l i t ies  in the observation  that magnesium appears to  reduce the 
in c idence  in sever ity  of suxam e thon lum - lnduced  fa sc lc u la t lo n s  and tha t it 
appea rs  to  Inh ib i t  the  re lease  of p o tass ium , at leas t  In n c m a l  s u b je c ts ,  
fo l low ing  the use of th is  relaxant. If these observa tions  are con f irm ed, It may 
imply a role for magnesium In reduc ing some of the hazards assoc ia ted w ith  the
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use of depo la r is ing  muscle relaxants. It may pro tec t a a lnst Increases In In tra­
ocu lar pressure and thus make emergency anaesthesia In the patient w ith an 
open eye In jury cons lde rao ly  safer. Inh ib it ion  of potassium  release may also 
enable the use of depo la ris ing  re laxants In s itua tions such as burns where the 
rap id , co m p le te ,  and sho r t  d u ra t io n  p a ra lys is  p ro d u ce d  Is of bene f i t  but 
cu rren t ly  prevented by the hazards of potassium  Induced arrhythm ias.
An even m ore In t r ig u in g  p o s s ib i l i ty  l ies In the  recen t c o n f i rm a t io n  of o ld 
observations that magnesium may reduce bronch ia l tone. Given the apparen tly  
b e n e f ic ia l  In te ra c t io n s  be tw een  m a g n e s iu m  and a d re n a l in e  w h ic h  were  
dem onstra ted In th is thesis, part icu la r ly  the a -b lockade and ant i-a rrhy thm ic  
p ropert ies of magnesium, the poss ib i l i ty  exists that com b ina t ions  of magnesium 
and a d re n a l in e  or Indeed, o the r  p -s t lm u la n ts  may no t o n ly  Im p rove  the 
e ff ic iency  of b ronchod lla ta t lon  but may also Increase the safety of p -agonists 
by suppress ing the arrhy thm ic  response. Furthermore, the poss ib i l i ty  which 
has been suggested that magnesium may pro tec t against the adverse m etabolic  
effects of ca techo lam ine  stim ula tion  on the m yocard ium  fu rther Increases the 
po ten t ia l  bene fit  tha t  cou ld  be ga ined  from  th is  In te ra c t io n .  One fu r the r  
In te re s t in g  p o s s ib i l i t y  Is tha t  If the  enhancem ent of p -agon is t  b ind ing  by 
magnesium can be demonstra ted In bronchia l muscle It Is l ike ly  that magnesium 
would have a synerg is t ic  action In asthma with the p agon is t s tim ulants
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It Is also poss ib le  tha t com binations of magnesium and adrena line  may exert 
other benefic ia l effects. There Is curren tly  a resurgence of in terest in the use 
of adrenaline In a w ide variety of c l in ica l cond it ions  lim ited p redom inan tly  by 
the  a r rh y th m ic  r isk  posed by in fu s io n s  of th is  ag e n t.  C o m b in a t io n s  o! 
a d re n a l in e  and m a g n e s iu m  m ay w e ll  a l lo w  fu r th e r  m a n ip u la t io n s  o f the 
card iovascu la r system w ithout the arrhy thm ic  risk. In add it ion , m agnesium Is 
known to  d ila te  rena' b lood vessels and n a y  have a d iu re t ic  ac tion . It is 
possib le that magnesium may antagonise the adverse effects of adrena line  on 
renal b lood  f low  and urine output. The studies reported in th is  thesis have 
sh o w n  th a t  m a g n e s iu m  m ay have  b e n e f ic ia l  e f f e c t s  In c o n d i t i o n s  of 
ca techo lam ine  excess. The poss ib i l i ty  exists that these s tud ies are on ly  the 
beg inn ing of a w ide range of fu ture Investigations in to  the c l in ica l s ign,nuance 
of magnesium as a therapeu tic  agent.
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Appendix A
Cardiac Output Eetlmatlon by Thermodiiution
The th^rmodilution technique for determining cardiac output utilizes the Stewart-Hamilton 
Indicator dilution equation as modified for thermal indicator. The following equation Is 'he lesult:
C O. -
Where:
C O .  =
1.08 =
CT
60
V|
tB
T|
1.22
f
1.22
1.08 (60) CT V, (Tb - T|)
1.22 J  ATg( t )d t
Cardiac output In litres/minute 
p Cp (5 percent dextrose)
p Cp (Blood)
Th j i alio of the density 
times the specific heat of 
5 percent dextrose to the density 
times the specific heat of blood.
*■ Correction factor for the Injectate temperature rise through the catheter.
-  Seconds/minute
-  Volume of Injectate In litres
-  Initial blood temperature in °C
-  Initial injectate temperature in 0
A Tg (t) dt -  Area u. -oer the time temperature thermodilution curve In °C - sec 
■ Tlme to 30% of curve peak amplitude from START
-  Compensation for area lost due to 30% termination
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Basis for Modified Equation
One aspec t  of heat theory relates the change of heat in a s u b s ta n c e to  i ts mass 
a.id spec i f ic  heat for  a given change in temperature.  In a stat ic s i tuat ion,  it two 
sub r tances  at di f ferent  temperatures are mixed, the resul t ing temperature of 
the mix ture wil l  fal l  between the or iginal  temperatures.  If one of the masses is 
unknown,  It can be determined by equat ing,  at equi l ibr ium,  the change In heat 
of the two substances and ca lcu la t ing the unknown mass f rom the resul t ing 
equat ion.  When appl ied to a system of cont inuous f low, as In the heart  and 
vasculatu ie ,  a smal l  amount  of cold ind icator  can be in t roduced Into and mixed 
wi th the  f low ing  substance (b lood )  to determine a t lme- tempera tu re  curve 
d o w n s t r e a m .  T h e  a rea  u n d e r  t h i s  c u r v e  r e p r e s e n t s  t h e  sum  o f  the  
Instantaneous mixture temperature at the sensing point .  When appl ied to thu 
Stuwar t -Haml l ton equat ion,  the unknown f low of mass per unit t ime can be 
de termined much as mass alone Is determined in the s tat ic case.
The f i r s t  f o u r  t e r m s  of  th e  m o d i f i e d  e q u a t i o n  ( ( 1 .0 8 )  C r  (60 )  Vi ] are  
pre determined by the volume and physical  proper t ies  of the injectate and the 
characte r is t ics  of the catheter . They can, therefore, be grouped  and entered 
Into the computer  as a preset cons tant  cal led th= Compu ta t ion  Constant".  The 
c o m p o n e n ts  of the f i f th  term (TB - Tl) are c o n t in u o u s ly  measured by the 
the rm is to r  probe on the catheter , and the injectate tempera ture sensor f rom the 
computer .  The compute r  e lec t ron ica l ly  determines the d i f ference between TB 
and Tl and mul t ipl ies  the d i f ference by the computat ion con i tant .  The resul t ing 
v a lu e  is  I n t e r n a l l y  he ld  f o r  l a t e r  p r o c e s s i n g  The t e m p e r a t u r e  of  the
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Ind ica tor -b lood mixture Is sensed by a thermis tor  In the catheter . The resul t ing 
t lme- tempera ture curve is ampl i f ied and Integrated In the computer .  Integrat ion 
Is automat i ca l ly  terminated when the curve returns to  30 percent  of Its peak. 
The rat io of the f inal value shown In the prev ious paragraph t 0 this Integrated 
value Is the measured card iac output.  The area lost by cut t ing off  the c u m  on 
the downs lope at 30 percent  of Its peak ampl i tude amounts  to approx imate ly  22 
percent of the remaining area. Compensat ion for this lost e ea Is accompl ished  
by ampl i fy ing the d i lu t ion signal  presented to the in tegru ior  by 22 percent . The 
value of 30 percent  Is chosen as the cut -of f  - iolnt b e c iu s e  of documen ted 
c l inical  studies which relate this point  to minimal var iabi l i ty. (Ref :  Edwards 
Laborator ies Cardiac Output  Compute r  Manual,  1930)
Thermodi lu t ion  techniques have the advantage over  o ther  methods that the 
technique Is nontox lc  and readi ly repeatable.  The values obta ined by this 
method corre late  wel l  wi th those obtained by other  techniques such as the Pick 
m e th o d  o r  the use of  I n d i c a to r  d i l u t i o n  curves  (Kee fer  & Barash,  1985). 
Po ten t ia l  sou rces  of e r ro r  Inc lude In jectate tempera ure changes  p r lu '1 to 
In ject ion and along the catheter ;  Incomplete mixing In low card iac  output  
states, and variat ions In pu lmonary  ar tery tempera ture wi th changes In the 
v e n t i l a t o r y  c y c le  (Sykes  el  al,  1981) In th is  th e s is ,  al l  c a r d ia c  o u tp u t  
measurements  were made us ing co ld dext rose .  The In jectate,  tub ing  and 
syr inges were kept In a water  bath for  at least an hour  pr ior  to use, and unti l  
the moment  of Inject ion The Injectate temperature probe f rom the compu te r  
was p laced In the water  bath which wa f requent ly st i rred to ensure an even
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temperature d i s t r ibu t ion th roughou t  the container.  Syr inge handl ing was kept 
to a minimum by the use of insulated syr inges. AM in jec t ions  were made by the 
author  to min imise var iat ion Induced by di f ferent  in ject ion styles. All readings 
were on animals or pat ients  on cont ro l led  vent i lat ion,  and dur ing  readings 
vent i la t ion was d i scon t inued  to minl  nise er rors due to f luc tua t ions In ai rway 
temperature.
C a r d io v a s c u la r  M e as u rem e n ts
In the card iovascular  invest igat ions repor ted in chapters  5, 6 & 8 of this thesis, 
the fo l low ing d i rect  measurements were made:
Systol ic,  d iastol ic  and mean systemic arter ial  b lood  pressure f rom the 
radial  ar tery
Central  venous pressure f rom the proximal por t of the PA catheter  
Systol ic,  d la s to l i ;  and mean pu lmonary  arter ial  pressure f rom the distal  
por t of the PA catheter
Pulmonary capi l lary  wedge pressure from the distal  por t  w ith the bal loon 
inf lated
Heart Rate f rom the rate coun te r  of the ECG 
Cardiac output
Mean systemic 'MAP) and pu lm onary (PAP) arterial  pressures were determined 
by the moni to r ing  apparatus by in tegra t ion of tho area under  the curve of the 
a r te r ia l  p re s s u re  wave.  C e n t ra l  v e n o u s  and p u l m o n a r y  c a p i l l a r y  w e a g e
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pressures were read f rom the recorded t race at end of exp i ra t ion
Fiom these measurements the fo l low ing values were der ived:
St roke vo lum e  =•
Cardiac O r 'nu t  
Heart Raie
i . i l /beat
Systemic Vascular  Resistance dy n e .s e c .cm '5Card iac Outpu:
Pulmonary Vascular Resistance - .(PAP • CYP) X BJ dyne s e c .c m '5
7 Cardiac Outpu t  7
Left Ventr icu lar  St roke Work = SV X (MAP - PCWP) X 0.0136 gm m/beat  
Righ- Ven tr i cu la r  Stroke Work = SV X (PAP - CVP) X 0.0136 gm.n. /beat
in the te tanus study, body sur 'ace area (BSA) w ar  dete rm ined  for each pat ient  
using a nom ogram  relat ing height  and weigh t  to BSA and then card iac index, 
s troke v o lum e  index and st roke work index der ived by d iv id ing t h j  app ropr ia te  
values by the body surface area. In th *  bauoon s tudies this technique was not 
used s ince the ani als were of reasonably  cons is tent  size and weight ,  and 
rel iable BSA tables for baboons were not avai lable
B i o c h e m i c a l  assays  for  m a g n e s iu m  and c a lc iu m
The var ious methods which can be used for the es t imat ion of the magnesium 
content  of  body  f luids have been rev iewed extens ive ly  by Wacker  (1980) and 
Aikawa (1981) . Earl ier techniques involved th_ use of co lo r im e t r ic  methods
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i n c lu d in g  T i tan  y e l low  and ei lo c h r o m e  b leck ,  but  a l th oug h  bo th  of these  
methods  are simple,  *!iey are genera l ly  not regarded as suf f ic ient ly  accu ra te  or 
rep roduc lb la  for  research purposes.  In 1955, Walsh deve loped a hol low ca thode 
d ischa rge  lamp,  using magnesium metal  as the ho l low cathode When exci ted 
by an e lec t r ic  current ,  such a lamp emi ts a stable, high- inte,  si ty l ight  at the 
wave length spec i f ic  for  the metal. This l ight  beam is focused through  a f lame 
which con ta in s  the unknown concen trat ion of magnesium atoms at ground 
state. Abso rp t ion  of the l ight  ' jeam occurs in the ' lame in propor t i on  to the 
c o n c e n t r a t i o n  of m agnes ium in the so lu t ion.  S ince the mid-1960s a to m ic  
absorp t ion  spec t ropho tom e try  has been avai lable in commerc ia l  dev ices and 
has becom e the standard method for magnesium ana1 as this technique 
c ons ide rab ly  improves the prec is ion and accuracy  of the determinat ion.  In all 
of ‘ he s tud ies  conta ined in this series atomic  abso rp t ion spec t ropho tom e try  
was the  m e th o d  a d o p te d  The p r i n c ip a l  p ro b le m  w i th  this t e c h n i q u e  Is 
In ter ference , ;um phosphate,  a l though this Is a relat ively  minor  prob lem wi th 
b lood samples  and only becomes a s igni f icant  fac tor  when CSF magnes ium Is 
est imated,  h. , .der to minimise this Inter ference, the serum specimens studied 
were d i lu ted 1 5 0  In 0.75% e thy lened iam lne te t ra -ace ; . j  ac id (fcDTA). The EDTA 
hat. a h igh a t t i n l t /  for  cal r lmr.  snd magnesium and all of (he ca lc ium and 
mngnes ium In the spec imen is comp lexeo,  prevent ing the loss of magnes ium 
phosphate f rom the est imat ion.  The so lu t ion is then assayed for ca lc ium and 
magnes ium conten t  using atomic  abso rp t ion using lanthanum as an Internal  
s t a n d a r d .  As c a l c i u m  and m a g n e s i u m  have v e r y  d i f f e r e n t  a b s o r p t i o n  
charac te r is t i cs ,  the two substances are readi ly d is t ingu ished.  Qual i ty  cont ro l
Appendix A 240
was mainta ined using standard com m erc ia l ly  avai lable  s tock so lu t ion d i lu ted to 
yield s tandard magnesium concen tra t i ons f rom 0.25 to 1.75 mmol / l  in 0.25 
m r r o l / l  i n c r e m e n ts  and f rom 5 to  20 m m o l / l  c o n c c n t r a t l c n s  in 5 m m o l / l  
r< nents. Similar s tandards were prepared us ing ca lc ium standards  wi th 
■ntration of 1 to 4 mmol, i wi th inc remen ts of 0.5 mmol / l .  The accu racy  of 
method  is to within 0.0 r rmol / l ,  and the between run prec is ion  of the 
method is -t- 5%.
C a t e c h o l a m i n e  A ssay*
Ca techo lamine  assays repor ted In this thes is were performed by Dr. Jan Esser 
uf t h i  depar tmen t  of Nuclear  Medicine,  Univers i ty  of the Wi twetersrand.
T u b e s  w i t h  b lo o d  s a m p le s  for  se rum  c a t e c h o l a m i n e  m e a s u r e m e n t  were 
immediate l y  placed on Ice Samples were cent r i fuged at 3 000 revo lut ions per 
minute for  ' 0  mln at 4°C. A l iquots  of the serum were stored at -70°C for  not 
l o n g e r  than  one week. C a tech o la m in e  e x t r a c t io n  was pe r fo rm ed  us ing  a 
c o m m e r c i a l l y  a v a i l a b l e  k i t  ( C a t - A - K i t ,  U p j o h n  P h a r m a c e u t i c a l s )  and 
f r a c t i o n a t e d  serum c a te c h o la m in e  c o n c e n t r a t i o n s  were d e te rm in e d  us ing 
reversed phase h igh-per formance l iquid c h rom atog raphy  wi th e lect rochemica l  
de tec t ion  using a Waters ECO machine The lower  l imi t of sens i t iv i ty  of the 
de tec to r  Is 0.5 nanoamps, and the lowest accurate  readings are 10 pg/ml .  An
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Internal s tandard DHBA was used for every estim ation and the ca techo lam ine  
concen tra t io n  ca lcu la ted Is related to  the recovery  of DHBA.
The In terassay variation is as fo l lows:
1%
2% 
4.7% 
<  1%
Noradrena line
Adrenaline
DHBA
Dopamine
The mean peak height and standard dev ia t ion  of each estimate ca lcu la teu  by 
the in teg ra to r  In mm for each substance  a re as fo llows:
N oradrena line  36.921 _±_ 0.126
Adrenaline 17.501 _±_C 358
DHBA 39.690 _±. 0.909
Dopamine 12.083 0 052
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APPENDIX B
CASE REPORTS.
Case 1. A 16 year o ld g ir l p resen ted  w ith  pe r iphe ra l gang rene  and lab i le  
h y p e r te n s io n .  A d ia g n o s is  o f  p h a e o c h r o m o c y to m a  w as  c o n f i r m e d  by 
ang iog raphy  and by f ind ing elevated urinary van ilm ande lic  acid levels. An 
Initial dose  of phenoxybenzamlne 50mg l.v. was Infused over 2 hours fo l lowed 
by 20mg ora lly  6 hourly  for five days days with carefu l l.v. f lu id  rep lacement 
m o n i to r e d  by c e n t ra l  v enous  p re s s u re  m o n i to r in g .  The f i r s t  d o s e s  of 
phenoxybenzam ine produced hypotens ion  with tachycard ia  w h ich responded 
well to  l.v. f lu id therapy. Over the next few days good ca rd iovascu la r s tab il i ty  
was ach ieved w ithou t the need for p -adrenerg ic  b lockers. During th is time, the 
supine a rte r ia l b lood pressure remained w ith in  the range 11d/60 - 130/80 mmHg 
and on s tano lng  this decreased to between 100/60 and 90/40 mmHg. There were 
no hypertensive episodes. The heart rate renmlned below 100 b p m at all 
times, and there were no a rrhythm ias detected or ECG abnorm alit ies  noted.
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After a fu r the r three days the patient was then judged ready for surgery in 
accordance with the cr ite r ia  laid down by Rolzen (1987).
She was p rem ed ica ted  w ith  ch lo rp rom az ine  50mg, papavere tum  I5m g  and 
scopo lam ine  0 4mg as well as being given lOmg phenoxybenzam ine ora lly. On 
arr ival  In the anaesthetic  room, her arterial b lood pressure was 190/120 mmHg 
and her hpart rate was 170 b.p.m. She was fu rthe r sedated with ,00p.g fentanyl 
and  lO m g  d r o p e r id o l  l .v .  w i th o u t  b e n e f i t  to  her c a r d io v a s c u la r  s ta tu s  
Venti la t ion  was gently assisted and 50% n itrous oxide In oxygen Inhaled. The 
patient was now well sedated, but the severe tachycard ia  and hypertens ion 
pers is ted, a lthough the patient was periphera lly  warm and vasodila ted. As the 
tachycard ia  appeared to  be th3 major problem, and In view of the fact that 
seve ra l a -a d re n e rg ic  b lo c k e rs  had a lre a d y  been g iven , p o p ra n o lo l  was 
adm in is te red  In 2rng Increments w ith con t inuous ECG m on ito r ing , and blood 
p re ssu re  re c o rd in g  us ing  an a u to m a t ic  d o p p le r  da v ice  A fte r  10 mg of 
p ro p ra n o lo l ,  l i t t le  Im provem ent had been ach ieved and her a rte r ia l b lood 
p ressu re  was 180/120m mHg and her heart rate 149 b.p m. At th is  po in t, 
abandonm ent of the p rocedure  was contem pla ted, but In view of her excellent 
p reopera t ive  status, It was felt that this was an acute response to  the stress cf 
com ing  to  the operating theatre. It was, therefore, dec ided  to make one fu rther 
a ttem pt to  con tro l the ca rd iovascu la r d is tu rbances at th is  time and a tr ia l of 
m agnesium  therapy was Initiated.
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The patient was transferred to the opera t ing  theatre, an arteria l line inserted 
Into the left radial a rte ry  under local anaesthesia, and a m agnesium  sulphate 
In fusion com menced at a rate of 2 gm per minute. After 1.5 mln the arterial 
b lood pressure had reduced to 130/90 mmHg, and the heart rate had decreased 
to 122 b.p m. (Flgu e 9.1). As the centra l venous line had becom e d isp laced 
pr io r to  the patient com ing  to theatre, a right subclav ian ca the te r was Inserted 
under local anaesthesia pr io r to Induction  of anaesthesia. This produced a 
mild increase In arteria l b lood pressure which responded well to  In fus ion of an 
add it iona l 2.5 gm magnesium sulphate. As eye lash and pharyngeal reflexes 
were stil l present, anaesthesia was then Induced with 150 mg th iopen tone  i.v., 
paralys is  w ith 15 mg a lcuron lum  I.v., and the trachea then in tubated. There was 
no card iovascu la r response to endotracheal In tubation and no change in heart 
rate ( f igure 9.2).
Surgery proceeded uneventfu lly  under halothane, n itrous ox ide and oxygen 
with con tro l led  ven t i la t ion  until m ob il iza t ion  of the tum our was attem pted . The 
tum our was t igh t ly  adherent to the In fer ior vena cava, and l iga t ion  of the venous 
dra inage p.-cved to  be Impossible. As It was obv ious that extensive tumour 
hand ling would be necessary to remove the mass, severe d is tu rbances of 
card iovascu la r func t ion  were an t ic ipated. As expected, arteria l b lood pressure 
and heart rate began to  Increase, and before resort ing  to phento lam ine  and 
sodium n ltropruss ide  as had been planned, a fu rther Infusion of magnesium 
sulphate was admin istered. A 2 gm Infusion term inated the upward trend and 
a fu rther 2 gm restored the arterial pressure and heart rate to  normal levels,
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desp ite  the  fact that tum our handling was con tinu ing  th roughou t.  Despite 
fu r th e r  m a n ip u la tio n  o f the  mass, the re  were no fu r th e r  c a ro lo v a s c u la r  
d is tu rbance s  (F igure 9.3). Fo llow ing tum our removal, m l'd hypo tens ion  and 
b radyca rd ia  occurred  (arterial b lood pressure 80/60mmHg and heart rate 64 
i ! m ) but th is  responded adequate ly  to  i.v. f lu id therapy alone, and Ino trop ic  
i-port was not required, a lthough 1 gm calc ium  g lucona te  was given to 
coun te rac t any remaining magnesium effects. This produced no s ign if icant 
change in card iovascu la r status Neurom uscula r b lockade was reversed with 
2 5 mg neostigm ine  and 1 2mg atrop ine, fo l low ing  which good muscle tone was 
read ily  res to red  and sa t is factory  spontaneous ven ti la t ion  estab lished. The post 
operative course was uneventful
Case 2 . A 45 year old black fern ,ie presented In it ia l ly  w ith  long-s tand ing  
hypertens ion  and was d iagnosed as having a phaeochrom ocy tom a s ituated In 
the r igh t adrena l g land. P reopera tive  p repa ra t ion  cons is ted  of Increas ing 
doses of phenoxybenzam lne up to  a maximum dosage of 180mg per day and 
propn-. io lo l 40mg per day. She was judged as fit fo r anaesthesia acco rd ing  to 
the c r ite r ia  laid down by Rolzen. P rem edication cons is ted of lOmg of d iazepam 
and 25mg of phenergan both admin istered orally, 90 m inutes preopera t ive ly
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On arrival In lha opera t ing  theatre  the patient was m ild ly  hypertens ive but 
during  p lacement of centra l venous and arteria l m on ito r ing  lines under local 
anaesthesia she became severely hypertensive w ith a sys to l ic  b lood  pressure 
of 2«.0mmHg. Fentanyl 200p.g was adm in is tered l.v. fo l low ed  by an Infusion of 
4gm MgS04. The b lood pressure rap id ly  fell to  120mmHg and then anaesthesia 
was induced with th iopen tone  JOOmg and muscle re laxa tion  obta ined w ith  15mg 
a lcuron lum . Endotracheal Intubation was perform ed 3 mln. after Induct ion  and 
produced no Increase In blood pressure or heart rate. During the p rocedure  a 
con t inuous  Infusion of MqSO< was adm in is tered at a rate of 2gm per hour and 
anaesthesia mainta ined with 50% nitrous oxide In oxygen and 1-3% enflurane. 
Excellent ca rd iovascu la r contro l was estab lished and mainta ined th roughou t 
the p rocedure  with 3 fu r the r boluses of MgS04 each of 2gm being adm in is tered 
during  tum our handling. At the end of the procedure  Ig m  of ca lc ium  g iuconate  
was glvan In travenously fo llowed by reversal of the neurom uscu la r b lock with 
2.5<np n- os t lgm ine  and 1 2mg atrop ine Good neurom uscu la r transm iss ion  was 
rap id ly  estab lished and the patient made an uneven..u l recovery.
Case 3. This patient was a 54 year old adult male who had until recent ly  been 
an underground mmeworker. He had mild res tr ic t ive  lung disease as a result 
o f  o ld  t u b e r c u l c s l s  and  h a d  b e e n  d ia g n o s e d  as h a v in g  a la rg e  
phaeochrom ocy tom a aris ing  from the right adrenal gland as a result of recent 
onse t h yp e r te n s io n  The pa t ien t a lso  had reduced  rena l fu n c t io n  w ith  a 
c re a t in in e  c le a ra n c e  o f 42m l/h r .  P re o p e ra t iv e  p re p a ra t io n  c o n s is te d  of
Appendix B 247
increas ing doses of phenoxybenzam lne to a maximum of lOOmg per day and 
proprano lo l 60mg per day Koliowlng routine oral p rem ed ica t ion  w ith d iazepam 
and phenergan the patient arrived in the opera t ing  theatre w ith  a sys to l ic  blood 
pressure of 215mmHg and a heart rate of 100 beats per minute. After the 
a d m in is t r a t io n  o f 200p.g fe n t  n a r te r ia l  a n d  c e n t ra l  v e n o u s  p re s s u re  
m on ito r ing  lines were placed and an in fus ion of 4gm Mg5C>4 adm in istered. 
Svsto l ic  b lood pressure reduced to 145mmHg and heart rate fe ll to 80 bents per 
minute. Induct ion  of anaesthesia with th iopen tone  and muscle re laxation  with 
a lcu ron ium  20mg did not alter the pa tien t 's  haem odynam lc status and there was 
no Increase In b lood pressure or heart rate fo l low ing  In tubation. At laparo tom y 
th e  tu m o u r  was fo u n d  to  be e x t re m e ly  la rg e  and a t ta c h e d  to  th e  r ig h t  
d iaphragm . Extensive tum cur handling and open ing  of the d iaphragm  were 
necessary. During th is time an Infusion of sodium n ltrop russ ide  was necessary 
to  con tro l  sys to lic  b lood pressure In add it ion  to a con tinuous Infusion of MgS04 
at a rate of 2gm per hour and four 2gm boluses Inhala tional anaesthesia 
cons is ted  of 50% nitrous oxide In oxygen with 1-3% enflurane. At the end of 
the p rocedure  the patient was transferred to  a high care ward and e lectlve ly  
ven t i la ted  for the next 24 hours Serum magnesium levels of 3.7mm ol/ l were 
achieved In traopera tlve ly  and serum levels of greater than 2mmof/l persisted 
fo r s ix  hours  p os tope ra t lve ly ,  w ith ev idenced of depressed neurom uscu la r 
t ransm iss ion  pers is t ing  for the next six hours. Thereafter the pat'ent made an 
uneventfu l recovery.
Appendix B 246
Case 4 . Th is pa t ien t was a 26-year o ld p regnan t b lack  w om an who was 
invest igated for secondary hypertension at a periphera l hospita l. An elevated 
ur inary vani l ly l  mandelic acid (VMA) level was found and she was trans fe rn id  to 
-i < entral  hospita l. She had had two previous uncom plica ted  pregnancies, the
last In 1982.
P r o m in e n t  s y m p to m s  on p re s e n ta t io n  In c lu d e d  s w e a t in g ,  p a lp i ta t io n s ,  
headache,  dizziness and backache, which had occurred  In te rm itten tly  during  
the preceding 15 months. Examination of the patient revealed a pregnancy of 
38 weeks d u ra t io n  In a ss o c ia t io n  w ith  a lab i le  b lo o d  p ressu re  (BP). No 
h y p e r te n s iv e  ta rg e t  o rgan  dam age  was no ted . An e leva ted  u r in a ry  VMA 
excre tion  was confirm ed at 121 (tmol/24 hours (normal < 6 0  p.mol/24 hours). 
The p lasm a adrenaUne level was 2 pg /m l but the no rad ren a l ine  level was 
markedly elevated at 1164 pg/ml. Other b iochem ica l measurements weie  w ith in  
normal l im its .
She was treated with prazosin 4 mg tw ice da ily  and a teno lo l 50 mg dally. After 
an Init ial hypotens ive  reaction, which responded to bed rest and Intravenous 
f lu id adm in is tra t ion , her biood pressure s tab il ized at 150/100 mmHg from an 
adm iss ion level of 180/120 mmHg over the next five days, and her symptoms 
related to  her catecholam ine excess subsided. Foetal m atur ity  was confirm ed 
with u ltrasound examination and It was dec ided to proceed with Delivery
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Vag ina l d e l iv e ry  under e p id u ra l anaes thes ia  was chosen  as the mode of 
de llve iy .  The estab lishment of arteria l, centra l venous and periphera l lines 
under loca l anaesthesia p roduced a marked hypertensive response (BP 220/110 
mmHg), and an Infusion of phento lamir.e at a rate of 3 m g/hour was Institu ted 
w ith  som e im provem en t In the  b lood  pressure . An ep idu ra l c a 'h e 'e r  was 
Inserted and 10 ml 0.5% bup iv ica ine  In jected fo l low ing  a test dose, with no 
Improvem ent In card iovascu la r con tro l.  Membranes were ruptured to Induce 
la b o u r  These manoeuvres also produced a marked hypertens ive  response, 
which necessita ted an Increase In the rate of the phento lam ine Infusion to 10 
m g/hour. Short ly  after labour had bagun, foata l b radycard ia  occurred  which 
made Immediate operative de livery Imperative.
Prior to Induction  of anaesthesia, a 4 gm bolus of MgSCU was adm in istered 
In travenously  over 15 minutes, fo l low ed  by a con t inuous In fus ion of 1 5gm /hour 
This p roduced  l i t t le  Improvement In the con tro l of b lood pressure A sodium 
n i t r o p ru s s ld e  In fu s io n  was co m m e n c e d  at 0 .27  p g /K g /m in  w h ich  a lm ost 
Imm edia te ly  reduced the BP to 102/60 mmHg. This Infusion was mainta ined 
th rougho u t the Induction sequence. Follow ing p re-oxygenation , l ignoca ine  60 
mg was Infused Intrave tous ly  p r io r  to  Induction . A standard rapid sequence 
In d u c t io n  a r d In tuba t ion  was then  perfo rm ed  using th io p e n to n e  sod ium  4 
m g /K g  and s u x a m e th o n iu m  1 m g /kg  w h ile  c r ic o id  p ressu re  was app l ied ,  
fo l lowed by a further 2 mg/Kg th iopen tone  just p r io r to  In tubation. In tubation  
p roduced  a d ram atic  rise In BP to  265/165 mmHg which pers is ted fo r  about 4 
m inutes, requ ir ing  an Increase In n itropruss lde  Infusion rate to 0 8 ug/Kg/m in.
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A healthy 2730 gm baby ,« l lvered rapid ly. Im mediate ly  a fter de livery, there 
was a p rec ip itous  fall In BP to  90 mmHg sys to l ic  which lasted for approx im ate ly  
5 minutes. This responded to  temporary d iscon t inua t ion  of the n i tropruss ide  
and in travenous f lu ids Thereafter she mainta ined a SBP In the range 180-230 
mmHg fo r the rest of the p rocedure  (Figure 9 6).
P os tope ra t lve ly ,  the  pa t ien t requ ired  c o n t in u a t io n  of sod ium  n it rop russ ide  
In fus ion fo r  the c o n tro l  of her pers is ten t hypertens ion , unti l  ora l prazos in  
therapy cou ld  be re-estab lished. It was subsequently  found that her serum Mg 
level p r io r  to  the Induction of anaesthesia was 0.5 mm ol/l and desp ite  the fair ly 
large doses of MgSO* the maximum seium Mg level achieved was 1.4 mmol/l.
Prazosin and a tenolo l were recommenced postopera t lve ly  In the same dosages 
as before delivery, and she was mainta ined on these drugs for 5 weeks while 
tu m o u r  l o c a l i z in g  p r o c e d u r e s  w e re  b e in g  p e r fo r m e d .  She re m a in e d  
asym ptom atic  and her BP was well con tro l led  at 130/90 mmHg A r igh t adrenal 
t u m o u r  w a s  fo u n d  on  CT s c a n  w h ic h  had  a p o s i t i v e  u p ta k e  o f  131l 
meta Io d o b e n z y lg u a n id in e  (M IBG), and the pa t ien t agreed  to  s u rge ry  fo r 
removal of the tumour.
The n ight p r io r  to surgery, the patient was sedated with d iazepam 7.5 mg orally, 
and on the morn ing of surgery she received 5 mg prazosin ora lly , 100 mg 
atenolo l ora lly , a no 15 mg papaveretum l.m. In the opera t ing  theatre  she was 
reasonab ly well sedated but placement of centra l venous and radial arterial
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l ines unde? local ar'o iesihctic produced a m oderate p ressor response with the 
BP rising to  160/100 r- nHg.
Anaesthesia was Induced with 150 »ig fentanyl fo l lowed by 250 mg th iopen tone 
and a bo lus of 4 gm MgSOe given over 5 minutes. This p roduced a reduction 
In b ood pressure to  110/70 mmHg. Muscular re laxation  was achieved with 20 
mg a lcuron lum  and llgnoca ine 80 mg was given pr io r  to  In tubation. Fo llow ing 
Ir ju c t io n ,  BP fell to  100 mmHg systo lic , and returned to 120/80 mmHg fo llow ing  
In tubation. A con t inuous  in fusion of 1 gm /hour MgSO* was started. Inc is ion 
produced an Increase In blood pressure to 140 mmHg sys to l ic  w h ich responded 
well to a fu rther bo lus of 2 gm M gSO v During tum our handling, three sim ilar 
mild increases In BP occurred, and on each occas ion these responded well to 
MgSO* bo luses Throughout the procedure , anaesthesia was mainta ined with 
50% n itrous oxide In oxygen and 1-1.5% enflurane. No o ther anti-hypertens ive  
m e d ic a t io n  was re q u ire d .  F o l lo w in g  tu m o u r  e x c is io n ,  the  M g S O * w as  
d iscon t inued  and at the end of the procedure, muscu lar re laxation wa-.. easily 
reversed w ith  5 mg neostigm ine preceded by 0.4 mg g lycopy rro la te  (F igure 9 7). 
There were no post operative com p lica t ions . A tota l of 16 gm of MgSO* had 
been adm in is tered over a 2-hour period, and the pa t ien t 's  In traopera tive  serum 
Mg levels were found to have been In the range of 2.6-3.9 mmol/ l,  w ith the 
maximum level just p r io r  to tum our devascu la riza tion . At the time of reversal, 
one hour later, the serum Mg level was 2.5 mmol/l.
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Case 5 . A 24 year old white woman was transferred from  a periphera l hospita l 
because of u n c o n tro l la b le  b lood  pressure du r ing  p regnancy . She gave a 
h is to ry  of having had an abdomina l phaeochrom ocytom a removed In 1979 and 
three opera t ions  for recurrences fn her neck In 1980, 1981 and 1983. She had 
had a normal vaginal de livery  In 1982, and a m iscarr iage at 4 weeks In 1904. 
She had been w e ll  c o n t ro l le d  m e d ic a l ly  u n t i l  her p re g n a n c y .  She now 
c o m p la in e d  o f h e a d a ch e ,  v is u a l  d is tu rb a n c e s  and fe e l in g  f lu s h e d .  On 
adm iss ion her arteria l b lood pressure was 170/110 mmHg and her heart rate 116 
beats per minute. Foetal m atur ity  v/as estimated at 32 weeks and confirm ed on 
u l t ra s o u n d  e xa m in a t io n .  S ig n i f ic a n t  la b o ra to ry  f in d in g s  Inc luded  a VMA 
excre tion  of 205 p.irol/24 hours and metadrena line 42.5 gmol/24 hours (normal 
< 5.5pm ol/24  hours).
She was con tro l led  on phenoxybenzamine 20mg a hour ly  and tenorm in  50 mg 
da lly . A fte r an Initia l hypotens ive  ep isode th is  reg ime prov ided  excellent 
con tro l,  Her progress was uneventful for the next 4 weeks, but It Is of Interest 
thr.t her serum Mg level which was in it ia l ly  0.83 mmol/l fell to  0.57 mmol/l during 
th is period. On oral supp lem entation  it improved but remained below normal 
at 0.71 mmol/l.
A fte r 4 weeks of m ed ica l m anagement, very  poor foe ta l g row th  p rom pted  
conce rn .  Adequa te  fe ta l m a tu r i ty  was es tab l ished  and It was d e c id e d  to 
proceed w ith  de livery  by elective caescrean section under general anaesthesia. 
Preoperatlve ly , the  was well con tro l 'ed  w ith an arteria l b lood pressure In the 
range 150/90 - 140/80 mmHg and no postura l hypotens ion.
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Diazepam  10mg o ra l ly  was a d m in is te re d  the  n igh t  p r io r  to  su rg e ry ,  and 
repeated 30 m inutes preopera tlve ly , together w ith 10 mg m etoc lop ram ide  and 
30 ml sodium citrate. Phenoxybenzamlne and tenorm ln  were given on the 
m o rn ing  of su rgery . On a rr iva l  In the o p e ra t in g  room , her a r te r ia l  b lood 
pressure pressure was 170/100 mmHg, and th is  increased dur ing  the Insertion 
of arteria l and centra l venous lines under local anesthesia tv  200/120 mmHg. A 
bolus of 4 g of MgSO« was adm in is tered by s low Intravenous in jection , and this 
re d u c e d  the  a r te r ia l  b lo o d  p re s s u re  to  150 /90  m m H g bu t p ro d u c e d  an 
u n p le a sa n t  b u rn in g  sensa t ion . F o l lo w in g  3 m inu tes  of pre o xy g e n a t io n ,  
anaesthesia was Induced w ith  th iopentone 4mg/Kg, and the trachea intubated 
under lOOmg succ lny icho l lne  while c r ico id  pressure was applied. In tubation  
p roduced a mild Increase In arteria l b lood pressure to 180/100 mmHg which 
responded well to  a further bo lus of 2 gm MgSCu and a con tinuous Infusion of 
MgSCU was mainta ined at 2 gm /hour th roughou t the procedure . Anaesthesia 
was mainta ined w ith  50% oxygen In n itrous oxide with 0.75% enflurane, and 
re laxation  w ith  In term ittent suxamethonium. Two fu rthe r boluses of MgSCu 
were given In traopera tive ly  to  con tro l small Increases In arteria l b lood pressure 
but at no time d id the b lood  pressure exceed 170/90 mmHg after the Initial 
re s p o n se  to  In tu b a t io n .  A h ea lthy  fem ale  In fant w e ig h in g  1540 gm was 
delivered. Fo llow ing  surgery, spontaneous ven ti la t ion  as resumed readily; 
w h e n  fu l l y  c o n s c io u s  she was e x tu b a te d  and the M gbO < In fu s io n  was 
d is c o n t i n u e d  O ne  h o u r  l a t e r  she  r e q u i r e d  a c o n t in u o u s  In fu s io n  of 
phenoxybenzam lne  In o rder to  con tro l her arteria l b ' j o d  pressure w h ich  had 
Increased to  230/120 mmHg The fo llow ing day, she was restarted on oral
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therapy, and made a sa tis facto ry  recovery. In traopera tive  Mg level was found 
to have been In the range 2.4 - 3.3 mmol/l.
Case 6 . A 48 year old male was d iagnosed as having a large phaeochrom o- 
cytoma aris ing  from  the left adrenal gland. Good preopera tive  card iovascu la r 
con tro l was established with a dally  dosage of I60m g phenoxybenzam lne. On 
arrival In the opera t ing  theatre his blood pressure was 195mmHg which settled 
fo l low ing  200p.g of fentanyl to  115 mmHg and remained stable at th is level for 
the Induction , In tubation and in itial surgery. At laparo tom y the tum our was 
found to  be loca l ly  invasive and e :tending along the renal vein and into the 
In ferior vena cava. It was not therefore poss ib le  to  gain con tro l of the venous 
dra inage from the tum our and during  tum our m anipu la tion  MgSO* alone proved 
Inadequate to con tro l b lood pressure. An Infusion of sodium n itrop russ ide  was 
r e q u i r e d  In a d d i t i o n  to  m a g n e s iu m  b o lu s e s  a n d  In fu s io n s  to  c o n t r o l  
hype rtens ive  ep isodes. Once the tum ou r  had been removed the pa t ien t 's  
cond it ion  stabil ized and he made an uneventfu l recovery.
Case 7. This patient was a 22 year old white female who presented with 
unstab le hypertens ion  and was d iagnosed as having a phaeo'- i om ocytom a 
a r is in g  f r o m  th e  r ig h t  a d re n a l  g la n d .  G ood  p r e o p e ra t iv e  c o n t r o l  was 
estab lished with prazosin 4mg b.d. and atenolo l lOOmg dally. She arrived In 
thea tre  we ll  c o n t ro l le d  and anaesthes ia  was Induced w ith  fen tany l 100p.g.
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th io p e n to n e  200mg and a lcu ron lum  20mg fo l lo w in g  p re trea tm en t w ith  3gm 
MgSOe. During surgery a con tinuous Infusion of 2gm per hour MgSCe was used 
w i th  tw o  a d d i t io n a l  2gm  b o lu s e s  d u r in g  t u m o u r  m a n 'p u la t lo n .  G ood  
ca rd iovascu la r con tro l was maintained th roughou t and the patient made an 
uneventfu l recovery.
Case 8. A 26 year old white female presented w ith  long stand ing hypertension 
w h ic h  w as  fo u n d  to  be a t t r i b u t a b le  to  a sm a l l  r ig h t  a d re n a l  tu m o u r .  
P re o p e ra t ive  EC G ’s showed a le ft v e n t r ic u la r  s tra in  pa tte rn  w ith  Inverted 
T -w ^v e s  and d e p re s s e d  ST s e g m e n ts .  G ood  p re o p e ra t iv e  c o n t ro l  was 
estab lished wi»h phenoxybenzam ine 240mg per day and atenolo l EOmg dally, 
and over the two week preopera tive period the 6CG changes resolved. The 
patient arr ived in the opera ting theatre m ild ly  hypertensive with a sys to l ic  blood 
pressure of 186mmHg but no tachycard ia  An Infusion of 4gm MgSOx resulted 
In s ta b i l iz a t io n  of the b lood  pressure  at 130mmHg sys to l ic .  In d u c t io n  of 
anaesthes.a  was perfo rm ed using fen tany l 150|ig, th io p e n to n e  300mg and 
a lcuron lum  15mg. A con tinuous infusion of MgSOx was used th roughou t the 
p rocedure  at the rate of 2gm per hour and four add it iona l 2gm boluses were 
a d m in is te re d  d u r in g  tu m o u r  h a nd l in g  Good c a rd io v a s c u la i  c o n t ro l  was 
mainta ined th roughou t the procedure and neurom uscu lar b lockade was readily 
reversed at the end of surgery (Figure 9.4).
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Case 9 . This patient was a 42 year old male w ith  long-s tand ing  hypertens ion 
who had been d iagnosed as having a left adrenal gland tumour. Preoperative 
prepara tion  cons is ted of tenorm ln  100mg b d and a small dose (40mg daily) of 
phenoxybenzamlne. This patient did not meet the c r ite r ia  fo r f itness for surgery 
at the t im e of operation . The dec is ion  to proceed w ith  surgery had a lready been 
taken by the surg ica l team, but It was nevertheless dec ided to  use MgSCM In 
th is  case  In o rde r  to  assist the  ca rd io v a s c u la r  c o n tro l .  On arr iva l In the 
opera ting  theatre his systo lic  b lood pressure was 205mmHg but this responded 
well to fentanyl 20'j ^ q and a 4gm Infusion of MgSO*. In traopera tive  blood 
pressure con tro l w ith a con tinuous infusion of 2gm per hour M gSO i and three 
boluses of 2gm each was sa t is factory  but at the t im e of tum our removal there 
was a sudden haemorrhage of approx im ate ly  2 l i tres  from a to rn  spleen. This 
w as a c c o m p a n ie d  by se ve re  h y p o te n s io n  and b r a d y c a r d ia  w h ic h  was 
unresponsive to  transfusion and vasopressor d rugs The patient required an 
a d re n a l in e  in fu s io n  fo r  24 h o u rs  p o s to p e r a t i v e ly  to  s u s ta in  a d e q u a te  
ca rd iovascu la r function . At the time of tum our exc is ion the serum magnesium 
level was 2 8mmol/l and this had d ropped to 1 2m m ol/ l 6 hours postopera tive ly . 
After 24 hours the adrenaline Infusion was gradua lly  weaned and the patient 
made a good recovery.
Case 10 T h is  p a t ie n t  w as a 34 y e a r  o ld  b la c k  fe m a le  w i th  a s m a l l  
phaeochrom ocy tom a arising from  the left adrenal gland. Good preopera tive 
contro l was established on phenoxybenzam lne alone and her Intraopera tive 
c o u r s e  w a s  u n e v e n t f u l .  She r e c e iv e d  a t o t a l  o f  1 1 gm  m a g n e s iu m
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Case 9 . This patient was a 42 year old r e with long-s tand ing  hypertens ion 
who had been diagnosed as having -  ' - ad-enal gland tumour. Preoperative 
prepara tion  consisted of tenorm ln  lOUmg b.d. and a small dos j  (40mg daily) of 
phenox /benzam lne  This patient did not meet the cr i te r ia  fo r f itness for surgery 
at the t im e of operation. The dec is ion  to proceed with surgery had a lready been 
taken by the surgical team, but It was nevertheless dec ided to ise MgSO* In 
th is  case In o rde r  to  ass is t the  c a rd io va scu la r  co n tro l .  On a rr iva l in the 
opera t ing  theatre his systo lic  b lood pressure was 205mmHg but th is responded 
well to  fentanyl 200p.g and a 4gm in fus ion of MgSO*. In traopera tive  b lood 
pressure con tro l w ith a con t inuous in fus ion of 2gm per hour MgSO* and three 
boluses of 2gm each was sa t is factory  but at the t ime of tum our removal there 
was a sudden haemorrhage of approx im ate ly  2 l i tres from a torn spleen. This 
w as  a c c o m p a n ie d  by se ve re  h y p o te n s io n  and b r a d y c a rd ia  w h ic h  was 
unresponsive  to transfus ion and vasopressor drugs. The patient required an 
a d re n a l in e  In fu s io n  fo r  24 h o u rs  p o s to p e r a t i v e ly  to  s u s ta in  a d e q u a te  
card iovascu la r function . At the time of tum our exc is ion  the serum magnesium 
level was 2.8mm ol/ l and this had dropped to  1.2rnmol/l 6 hours pos tope ra t ive ly  
After 24 hours the adrenaline Infusion was gradua lly  weaned and the patient 
made a good recovery.
Case  10. T h is  p a t i e n t  w a s  a . o ld  b l a c k  f e m a l e  w i t h  a s m a l l
phaeoch romocy toma arising f rom the left adrenal  gland. Good preoperat ive 
cont ro '  was establ ished on phenoxybenzamlne alone and her In t raoperst lve 
c o u r s e  w a s  u n e v e n t f u l .  She  r e c e i v e d  a t o t a l  o f  l l g m  m a g n e s i u m
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in traopera t lve ly  and was well con tro l led  th roughou t the procedure . There were 
no postopera tive  com plica tions.
Case 11. A 32 year old b lack female presented with a small r ight adrenal tum our 
and was well con tro l led  on prazosin 4mg b.d. and atenolo l 50mg dally. Good 
In traopera tive con tro l was maintained with magnesium Infus ions alone and she 
made an uneventfu l recovery. Catecholamine levels were measured In this 
patient pr io r to Induction and fo l low ing  in tubation and again during  tum our 
handling. Fo llow ing the Initial ca techo lam ine measurement, 4gm MgS04 were 
given fo l lowed by a th iopen tone-fentany l a lcuron lum  Induction sequence. Both 
adrenaline and noradrenaline concentra t ions  were m arkedly e levated pr io r to 
In d u c t io n  and fo l lo w in g  In tubaf on the leve ls of bo th  ho rm ones  had been 
re duced  a l th o u g h  It Is Im poss ib le  to  say th a t  th is  re d u c t io n  was due to 
m agnes ium  as the o the r  d rugs used In the In d u c t io n  sequence may have 
c o n t r ib u te d .  D ur ing  tu m o u r  hand ling  both ad re n a l in e  and n o ra d re n a l in e  
c o n c e n t ra t io n s  Inc reased  to p re in d u c t io n  leve ls  but good  ca rd io v a scu la r  
con tro l was mainta ined despite this.
C a s e  1 2 . T h is  p a t i e n t  w as  a 51 y e a r  o ld  fe m a le  w i t h  a la rg e  
ph ochrom ocy tom a aris ing from the left adrenal gland. Preoperative contro l 
was established with 4mg prazosin b.d and 50mg atenolo l dally. On arrival In 
the operating  theatre th is  patient was markedly hypertensive (sys to lic  b locd
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In traopera tlve ly  and was well con tro l led  th roughout the procedure . There were 
no postopera tive  com plica t ions .
Case 11. A 32 year old black female presented with a small r igh t adrenal tu;nour 
and was well con tro l led  on prazosin 4mg b.d. and a teno lo l 50mg daily. Good 
In traopnratlve con tro l was mainta ined with magnesium Infus ions alone and she 
made an uneventful recovery. Catecholamine levels were measured In this 
oatlent p r io r to  Induction and fo llow ing  in tubation  and again during tum our 
handling. Fo llow ing the Initial ca techolam ine measurement, 4gm MgSC>4 were 
given fo l lowed by a th iopen tone  fen tany l-a lcu ron lum  induc t ion  sequence. Both 
adrenaline and noradrena line concentra tions  were marked ly  elevated p r io r  to 
Ind 'c t lo n  and fo l lo w in g  In tuba t io n  the leve ls of bo th  ho rm ones  had been 
reduced  a l th o u g h  It Is Im poss ib le  to  say tha t th is  re d u c t io n  was due to 
m agnes ium  as the o the r  d rugs  used In the In d u c t io n  s e q u a n je  may have 
c o n t r ib u te d  D uring  tu m o u r  hand l ing  both a d re n a l in e  and no ra d re n a l in e  
c o n c e n tra t io n s  Inc reased  to  p re in d u c t io n  leve ls  but good  ca rd io va sc u la r  
con tro l was mainta ined desp ite  this.
C a s e  1 2 . T h is  p a t ie n t  w a s  a £1 y e a r  o ld  fe m a le  w i t h  a la r g e  
phaeochrom -'cy tom a aris ing from the left adrenal g land. P reoperative contro l 
was estab lished with 4mg prazosin b.d. and 50mg ateno lo l da lly . On arr ival In 
the opera t ing  theatre th is patient was markedly hypertens ive  (systo lic  blood
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pressure 240mmHg) cut this lesponded well to  the adm in is tra t ion  of 200p.g 
fentanyl and 4gm MgSOe. Noradrenaline and adrenaline levels were markedly 
e le va te d  at the  t im e  of a r r iv e ' In the  o p e ra t in g  th e a t re .  F o l lo w in g  the  
adm in is tra t ion  of magnesium adrenaline levels fell to  w ith in  the normal range 
and noradrena line  levels were reduced by 45%. Anaesthesia was induced with 
350mg th iopen tone  and muscle relaxation achieved w ith  20mg a lc j ro n lu m . 
Further ca techo lam ine  estim ations were performed at th is po int which showed 
a s l ight fu r the r reduction  In both adrenaline and noradrena line  concen tra t ions  
In tu b a t io n  of the trachea  p roduced  no c a rd io va scu la r  d is tu rb a n ce  and no 
Increase In catecho lam ine levels Extensive tum our handling was navo'dable 
in th is case and th is  produced increases of both adrena line  a id noradrenaline 
to  above baseline values An infusion of sodium n lt rop rusV ue  was necessary 
In add it ion  to  a tota l dose of 16gm MgSO* In order to  mainta in adequate b lood 
pressure contro l.  Once the tum our had been remrvp-, the re ,ra in ing  procedure 
was uneventfu l and the patient made a good recovery (Figure 9.5).
Case 13. This patient, a 39 year old female, was d iagnosed as having a large 
r igh t-s ided  adrenal tum our. Good card 'ovascu lar was atta ined with prazosin 
4mg b.d. and atenolo l 100mg daily. On arrival In the opera t ing  theatre the 
pa t ien t 's  b lood  pressure was well con tro lled  and anaesthesia was Induced with 
ISOpg fen tany l,  300mg th iopen tone  and 15 mg a lcu ron lum . ca techo lam ine  
levels were estimated p r io r to  Induction and were found to be m oderate ly  
e leva ted  w ith  a m arked  Increase In c o n c e n tra t io n  o f bo th  ad rena line  and
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noradrenaline fo l low ing  Induction of anaesthesia. Four gm MgSOe were then 
adm in is tered and catecholam ine levels again estimated. Both adrenaline and 
noradrena line concentra t ions  were decreased fo l low ing  the adm in is tra t ion  of 
magnesium and endotracheal In tubation was accom pan ied  by a con tinu ing  
dec l ine  In the concentra t ion  of both catecholam ines. In traopera t lve ly  both 
noradrena line and adrenaline levels were marked ly  elevated dur ing  periods of 
tu m o u r  hand ling  and an In fus ion of n l t ro p ru s s ld e  was requ ired  to  provide 
adequate card iovascu la r contro l. Postopera tive  course was uneventful
Case 14. This patient was a 28 ysar old female who had a small r ight-s ided 
adrenal tum our. Symptoms were well con tro l led  on prazos in  and a tenolo l and 
she arrived In the operating theatre well con tro l led . Fo llow ing  a bo lus of 4gm 
r7lgS04 preceded by I00p.g fentanyl, anaesthesia was Induced with th iopen tone 
250mg and '  Icuron lum 15mg. Catecholam ine levels were m odera te ly  elevated 
p r i o r  to  th e  a d m in i s t r a t i o n  o f  a n y  d r u g s  and  w e re  r e d u c e d  by  th e  
m a g n e s lu m / fe n ta n y l  t r e a tm e n t .  N e i th e r  In d u c t io n  o f  a n a e s th e s ia  no r  
e n d o t r a c h e a l  I n t u b a t io n  p r o d u c e d  a n y  In c r e a s e  In c a t e c h o la m in e  
c o c -A n tra t lc n s  and a lthough both hormones Increased in concen tra t ion  during 
tum our hand ling good card iovascu la r con tro l was mainta ined th roughou t the 
p rocedure  using a tota l j f  14ym of MgSCU. The patient made an uneventful 
recovery.
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Cuss 15. A 55 year old female p resented  fo r  a d ia g n o s t ic  la p a ro to m y  to 
In v e s t ig a te  an abdom ina l mass. The moss had been no ted  p re v io u s ly  at 
hys te rec tom y 2 months previously, but a lthough m an ipu la tion  of the mass had 
produced severe Intraoperative hypertens ion and card iac dysrhythm ias, the 
d ia g n o s is  o f a p h a e o c h ro m o c y to m a  hao not been m ade. P re o p e ra t iv e  
Investigation had Included a CT-scan of the abdom en w h ich  had shown a 
r igh t-s ided  para-aort ic  mass. Induc t ion  of anaesthesia was perform ed using 
100p.g fe n ta n y l,  350mg th io p e n to n e  and 6mg pancu ron ium . Endotracnea l 
in tuba tion  produced a mild increase in b lood pressure fo l low ed by a d rop  In 
p r e s s u r e  aM e r th e  I n t r o d u c t i o n  o f  h a lo th a n e  to  fO m m H g  s y s t o l i c .  
Com mencem ent of surgery was accom panied by m u lt ifoca l supraventr icu lar 
and ven tr icu la r  ec top ic  heart beats and a rapid rise in arteria l b lood pressure 
to  260 /1  4 0 m m H g  w h e n  th e  t u m o u r  w as  t o u c h e d  A d ia g n o s i s  of 
p h a e o c h r o m o c y t o m a  w as  e n t e r t a in e d  and 4 g m  MgSCU a d m in is te re d  
In travenous ly . This p ro d i  ,o a trans ien t reduc t ion  In b lood  pressure and 
tem pora ry  con tro l of the arrhythm ias Two further 4pm bo,uses of MgSO* and 
one of 2gm  es tab l ishe d  c a rd io v a s c u la r  co n t ro l ,  at w h ich  t im e  the  serum 
magnesium level was 3.68mmol/l (F igure 9 9). The tum our was then removed 
and subsequ en t ly  proven to  be a phaeo ch ro m o cy to m a  on h is to logy . The 
patient made a good recovery.
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Case 16. This patient was a 14 year old b lack male who was d iagnosed  as 
having a large left-s ided para aort ic  phaeochrom ocytom a Good preopera tive  
con tro l was established with 4mg prazosin b.d. and 50mg ateno lo l daily. On 
arrival In the opera ting theatre the patient was stable and after p lacem ent of 
m o n i to r in g  l in e s  a n a e s th e s ia  was in d u c e d  w : ' I50p.g fe n ta n y l ,  300m g 
t h io p e n to n e  and 15m g a lc u ro n lu m .  C a te c h o la m in e  le v e ls ,  p a r t i c u la r l y  
noradrenaline, were markedly elevated p r io r  to induct ion  of anaesthesia and 
Inc reased  fu r th e r  fo l lo w in g  the In d u c t io n  sequence , a c c o m p a n ie d  by an 
increase In systo lic  blood pressure *o 170 mmHg An infusion of 4gm MgSO* 
im m edia te ly  reduced the arteria l b lood pressu.e  to 100/60mmHg and produced 
a m a rk e d  d r o p  in n o r a d r e n a l in e  c o n c e n t r a t i o n s  w i th  th e  a d r e n a l in e  
concen tr  ion being reduced to  within normal values. Fo llow ing in tuba tion  
there was no Increase in blood pressure and the levels of both ca techo lam ines 
con t inued  to decline A ccn t lnuous  Infusion of 2gm/hr MgSO* was mainta ined 
dur ing  the procedure and six 2gm boluses of K, gSO* were adm in is tered dur ing  
the course of the procedure. The tum our was adherent to  the In fer ior vena cava 
a n d  to  b o w e l  b u t  d e s p i t e  c o n s id e r a b le  t u m o u r  h a n d l in g  v e r y  l i t t l e  
c a r d io v a s c u la r  d is tu r b a n c e  o c c u r r e d  T h is  p ro m p te d  th e  e r ro n e o u s  
assum ption  that the tum our had been devascularlzed pr io r to  its removal and 
magnesium  was withdrawn. Within a few m inutes the blood pressure rap id ly  
rose to 200/1 lOmmHg but the adm in is tra t ion  of bolus doses of 3gm and 2gm 
MgSO* regained con tro l w ith in  a few minutes. At the time of tum our exc is ion  
serum magnesium levels were 3.8mmol/l. Neurom uscu la r b lockade was readily  
reversed and the patient made an uneventful recovery (Figure 9 8).
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Appendix C
Glossary of Abbreviations
ABP Arteria l b lood pressure
AP Arteria l pressure
ASA l- l i  American Society of Anesthes io log is ts  patient f itness cr ite r ia  
Ind ica tes minimal In tercurrent disease.
ATP Adenosine tr iphospha te
BP Blood pressure
Cl Cardiac Index
CNS Central nervous system
CO Cardiac ou tpu t
CO2 Carbon d iox ide
CSF Cerebrosp ina l fluid
CT Com puterised tom ography
CVP Central venous pressure
DBP D iasto lic  b lood  pressure
DNA Deoxyrlbose nucleic acid
ECG E lec troca rd iog raph
Mg Magnesium
MgSO* Magnesium sulphate
K
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MIBG M eta- lodobenzy lguaneth ld lne
PA Pulmonary artery
PCWP Pulmonary cap il la ry  wedge pressure
p g e 2 Prostag land in  Ea
PGI2 Prostag landin I2
PVR Pulm onary vascular resistance
RNA Ribose nucle ic  acid
QTc OT interval corrected fo r  heart rate
SA node Sino atria l node
SBP Systo lic  b lood pressure
SEM Standard error of the mean
SeMg Serum magnesium
SPSS Statis tica l package for the Social Sciences
SV Stroke volume
SVI Stroke volume index
SVR Systemic vascular resistance
SW Stroke work
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